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ABSTRACT 
The mitochondrion is best known as the energy transducing organelle 
responsible for generating adenosine triphosphate that the cell requires for life.  
Transcription and compaction of the multicopy mitochondrial genome is performed by 
mitochondrial transcription factor A (TFAM).  Unlike the nucleus, regulation of 
mitochondrial transcription and compaction is poorly understood.  Recently varying 
levels of cytosine methylation (5mCpG) have been identified throughout the 
mitochondrial genome.  These 5mCpG levels have correlations to altered mitochondrial 
RNA transcripts levels in several disease models including diabetes, neurodegenerative 
diseases and various cancers.  Previous work has shown that oxidation by reactive 
oxygen species (ROS) is detrimental to the function of high mobility group box proteins.  
TFAM, a high mobility group box protein is localized to the mitochondria, the organelle 
responsible for generating ROS in the cell.  In this thesis I uncover how TFAM DNA-
dependent functions are influenced by mitochondrial DNA 5mCpG and oxidation of 
TFAM.   
To understand the details by which mitochondrial DNA 5mCpG levels and 
oxidation of TFAM alter the DNA-dependent functions of TFAM I employed well-
established in vitro biophysical techniques.  I used cytosine methylation sensitive 
restriction enzyme digestion to confirm the presence of 5mCpG in mtDNA isolated from 
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cell tissue culture.  Fluorescence resonance energy transfer assays and electrophoretic 
mobility assays facilitated a thermodynamic analysis of TFAM’s interaction with 
mitochondrial 5mCpG promoter DNA and oxidized TFAM’s interaction with mitochondrial 
promoter DNA.  Electrophoretic mobility assays coupled with transmission electronic 
microscopy revealed insight into TFAM’s ability to compact 5mCpG DNA and oxidized 
TFAM’s ability to compact DNA.  To determine mtDNA 5mCpG impact on mitochondrial 
transcription initiation I used in vitro run-off transcription assays.    
I discovered that 5mCpG had a clear and context-dependent effect on 
transcription initiation from the three mitochondrial promoters.  This was due to an 
increased affinity and a higher degree of multimerization exhibited by TFAM to 5mCpG 
heavy strand promoter (HSP1).  I also discovered that oxidized TFAM has decreased 
nucleoid formation activity due to a decrease in its ability to bind and bend promoter 
DNA.  Together these findings show that TFAM functions are altered by modifications to 
both DNA and the protein itself.  
The form and content of this abstract are approved.  I recommend its publication. 










 In this journey I have had the privilege of developing relationships with some 
astounding people.  I would like to take the opportunity to thank and acknowledge them.  
First and foremost, I would like to express my eternal gratitude to my thesis advisor Mair 
Churchill.  Her support and belief in me fueled my confidence and I have evolved into a 
more stringent scientist.  To the members of my committee I am deeply grateful to have 
received not only professional advice, but also personal advice that has guided me 
throughout the years.  My success is built on a strong foundation.  I would not have 
chosen this path if it weren’t for Christopher Link and the amazing members of his lab.  I 
feel very privileged and forever grateful that he took a chance with me and exposed me 
to this wonderful world of research.   
 To my friends that I have made in this journey I would like to express my sincere 
love and admiration to you all.  To Jovylyn Gatchalian for being the person I can rely on, 
from my first and most favorite belay partner to the person I never grow tired of having a 
conversation with.  To Catherine Musselman, whose is not only the best listener I know, 
but is also the only other person on the planet who shares my enthusiasm for scotch 
and whiskey.  To Jennifer Salstrom, your life is an inspiration to me.  To Jennifer and 
Jerimiah French, you’ve been there for me at my lowest and highest points in life.  To 
Christine Roberts, from the moment I met you in the Link lab every bit of advice that 
you’ve ever given me has opened up innumerable opportunities in my life.    To Ruben 
Rosas-Ospina and Ying-Chih Chi, thank you for creating such a fun and very supportive 
lab environment.   
	 vi	
 Finally, but most importantly I would like to express my deepest gratitude to my 
family for the many sacrifices and unconditional love you’ve given me throughout this 
journey.  I will never forget the hard work and unwavering dedication that my mom and 
dad gave every day to their family.  To my sister, the most brutally honest person I 
know, thank you.  I may not always agree with you, but your intentions are always pure.  
To my exceptionally brilliant husband Jesse, I could not begin to express how lucky I am 
to have your unwavering love and support.  You are constantly making me a better 
person, wife and mother. To my daughter Anaya, you have given me a beautifully new 
purpose in life.  Kerry, Steve, Chelsea, Rick, Beth and Jason thank you for opening your 















TABLE OF CONTENTS 
CHAPTER 
I.  INTRODUCTION .......................................................................................................... 1 
The Mitochondrion .................................................................................................... 1 
Significant discoveries ........................................................................................... 1 
The origin and evolution ........................................................................................ 1 
Structure and functions ......................................................................................... 3 
Implications in diseases ........................................................................................ 7 
Mitochondrial DNA .................................................................................................... 9 
The genome .......................................................................................................... 9 
Nucleoid formation .............................................................................................. 13 
Mitochondrial Transcription ..................................................................................... 18 
Mitochondrial RNA polymerase (POLRMT)......................................................... 18 
Mitochondrial transcription factor A (TFAM) ........................................................ 20 
Mitochondrial transcription factor B2 (TFB2M) .................................................... 23 
Mechanism of promoter recognition and transcription initiation .......................... 24 
Regulation of transcription initiation .................................................................... 27 
Regulation of transcription elongation ................................................................. 27 
Regulation of transcription termination ................................................................ 31 
Mitochondrial Replication ........................................................................................ 33 
Mitochondrial DNA Methylation ............................................................................... 36 
Nuclear DNA methylation .................................................................................... 36 
	 viii	
DNA methyltransferase and hydroxylases in the mitochondria ........................... 40 
5mCpG DNA content in the mitochondria: the controversy .................................. 41 
Investigations into mitochondrial DNA methylation: the early years .................... 44 
Investigations into mitochondrial DNA methylation: correlations to RNA levels, 
diseases and aging ............................................................................................. 46 
Investigations into mitochondrial DNA methylation: 5mCpG and 5hmCpG levels .. 54 
Investigations into 5mCpH existence in nuclear and mitochondrial DNA ............. 58 
Is mitochondrial 5mC epigenetic? ......................................................................... 60 
Mitochondrial Reactive Oxygen Species ................................................................ 60 
Generation of mitochondrial reactive oxygen species (ROS) .............................. 60 
The many functions of mitochondrial reactive oxygen species ........................... 63 
Elevated levels of reactive oxygen species ......................................................... 65 
Reactive oxygen species cause post-translational modifications on sulfur 
containing amino acids ........................................................................................ 67 
Reactive oxygen species cause post-translational modifications on HMG proteins
 ............................................................................................................................. 69 
Thesis Statement .................................................................................................... 72 
II.  MATERIALS AND METHODS .................................................................................. 75 
Preparation of TFAM and Mutant Proteins ............................................................. 75 
Preparation of DNA Used in EMSA and FRET Studies .......................................... 78 
Preparation of pLSP3 Used in In Vitro Run-Off Transcription Assays, Electron ..... 80 
Microscopy and Compaction Assays ...................................................................... 80 
Preparation of Isolated Mitochondrial DNA for Restriction Enzyme Digestion ........ 81 
	 ix	
Fluorescence Resonance Energy Transfer Assays ................................................ 82 
Electrophoretic Mobility Shift Assays ...................................................................... 85 
Electron Microscopy and Electrophoretic Mobility Shift Assays .............................. 86 
In Vitro Run-Off Transcription Assays ..................................................................... 87 
Matrix Assisted Laser Desorption/Ionization Time of Fight Mass Spectrometer ..... 89 
III.  CYTOSINE METHYLATION OF MITOCHIONDRIAL DNA AT CPG SEQUENCES 
IMPACTS TRANSCRIPTION FACTOR A DNA BINDING AND TRANSCRIPITON 
INITIATION ..................................................................................................................... 91 
Introduction ............................................................................................................. 91 
Results .................................................................................................................... 93 
Mitochondrial DNA is 5mCpG ............................................................................... 93 
5mCpG methylation of the HSP1 increases the DNA binding affinity of TFAM .... 95 
Oligomerization properties of TFAM are influenced by 5mCpG ............................ 99 
5mCpG has no significant impact on TFAM-induced DNA condensation ........... 101 
5mCpG influences mitochondrial transcription in vitro ........................................ 104 
Discussion ............................................................................................................. 109 
Mechanism of 5mCpG on TFAM-dependent processes ..................................... 110 
Effects of mtDNA 5mCpG on mitochondrial transcription initiation and the 
biological impact of that effect ........................................................................... 112 
The distribution of -C5mCpGG- is nonrandom in mtDNA ................................... 115 
Conclusions .......................................................................................................... 115 
	 x	
IV.  OXIDATION OF MITOCHONDRIAL TRANSCRIPTION FACTOR A INHIBITS 
MITOCHONDRIAL TRANSCRIPTION FACTOR A-DNA DEPENDENT PROCESS OF 
NUCLEOID FORMATION ............................................................................................ 116 
Introduction ........................................................................................................... 116 
Results .................................................................................................................. 118 
Formation of an intramolecular disulfide bond reduces the binding and bending 
ability of TFAM ................................................................................................... 118 
oxTFAM is deficient at nucleoid formation ........................................................ 129 
Discussion ............................................................................................................. 132 
The effect of oxTFAM on DNA binding and bending properties ........................ 132 
The effect of oxTFAM on nucleoid formation and the biological implications .... 134 
Conclusion ............................................................................................................ 135 
V.  CONCLUSIONS AND FUTURE DIRECTIONS ...................................................... 136 
Conclusions for Chapter III ................................................................................... 136 
Future Directions for Chapter III ............................................................................ 138 
mtDNA 5mCpG controversy ................................................................................ 138 
5mCpG HSP1 and 5mCpG MTIC structural and biophysical studies ................... 139 
mtDNA 5mCpG influencing replication ................................................................ 140 
mtDNA 5mCpG influencing mitochondrial transcription termination ................... 141 
5mCpH mtDNA ................................................................................................... 142 
Conclusions for Chapter IV ................................................................................... 142 
Future Directions for Chapter IV ........................................................................... 144 
	 xi	
oxTFAM influencing transcription initiation ........................................................ 144 
The functional consequences of oxTFAM in vivo .............................................. 145 
REFERENCES ............................................................................................................. 146 
APPENDIX ................................................................................................................... 190 
Immunofluorescence to Detect mtDNA 5mCpG In Vivo ......................................... 190 






Identified over one hundred and thirty-eight years ago, the mitochondrion was 
originally named bioblast by Richard Altmann in 1880.  Altmann astutely hypothesized 
that these granules observed in cells have a symbiotic relationship with both metabolic 
and genetic autonomy (Altmann, 1894).  Eighteen years later in 1898 Carl Benda 
coined the name mitochondria because the granule looked like “mitos” thread, and 
“chondros” granules (Benda, 1898).  The discovery of the conversion of glycogen to 
lactic acid under anaerobic conditions and the conversion of lactic acid back to glycogen 
under aerobic conditions led to a Noble prize in Physiology or Medicine in 1922 for Otto 
Meyerhoff and Archibald Hill.  In the same year of the Noble prize, Otto Warburg 
discovered that glycolysis energy production could be independent of respiration.  This 
discovery led to the now famous hypothesis in cancer cell of aerobic glycolysis, also 
known as the Warburg effect (Warburg et al., 1924).  In 1953 another Noble prize was 
awarded to Sir Hans Krebs and Fritz Lipmann for the discovery of the citric acid cycle.  
Lipmann further went on to identify the “energy-rich phosphate bond” of adenosine 
triphosphate as the product of pyruvate oxidation (Lipmann, 1941).   
The origin and evolution 
Despite such scientific notoriety, the origin of the mitochondria remains a mystery 
with ongoing debates between three different hypotheses.  The maintenance of the 
mitochondria’s own genome supports the hypothesis that the α-proteobacterium over 2 
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billion years ago developed a symbiotic relationship with eukaryotic cells (Gabaldon and 
Huynen, 2004; Lane and Martin, 2010; Sagan, 1967; Wallin, 1925).  Proteome 
phylogenetic studies have also identified a core of 10%-20% conserved proteome from 
the mitochondria that are related to α-proteobacterium (Gray et al., 2001; Gray, 2015).  
A higher level of divergence of the remaining 80%-90% of the mitochondrial proteome is 
believed to have eukaryotic or eubacteria origin (Karlberg et al., 2000; Kurland and 
Andersson, 2000; Gray et al., 2001; Szklarczk and Huynen, 2010; Stairs et al., 2015, 
2014; Gray, 2015).   
Three endosymbiotic models have arisen to explain how a α-proteobacterium 
could have inserted itself into the ancestral amitochondriate eukaryote (also known as 
last eukaryote common ancestor) (Koonin et al., 2010).  The first is the archezoan 
model in which the evolution of the nucleus preceded the engulfment of the α-
proteobacterium by the cell.  This was followed by extensive remodeling to become the 
mitochondrion.  The second is the symbiogenesis model.  This model proposes that 
cellular fusion of the α-proteobacterium by the cell preceded the evolution of the 
nucleus.  Finally, the third model called the pre-endosymbiont hypothesis proposes that 
a fusion occurred between a premitochondrion that had a proteome but relied on 
exogenous adenosine triphosphate and an α-proteobacterium to become the ancestral 
mitochondrion that produces endogenous adenosine triphosphate (Gray, 2014).  All 
three models are in agreement that the mitochondria originated only once and 
descended from a common ancestor, however the exact α-proteobacterium lineage and 
the origin of the mitochondrial proteome is still unclear (Gray, 2012; Lang and Burger 
2012; Szklarczyk and Huynen, 2010).   
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Structure and functions 
Despite the lack of origin consensus, extensive studies have been done on the 
mitochondrial structure and many functions since it was first discovered.  Structurally, 
the mitochondria are ubiquitous eukaryotic double membraned organelles.  The 
organelle can range in size from 0.2-1.0 μm in diameter to 2-8 μm in length.  The 
organelle is most abundant in tissue that require high energy including the muscle, heart, 
kidney and the endocrine system (Wang et al., 2016) (Figure 1.1A).  Under optimal 
conditions in nondividing cells, healthy mitochondria exist not as individual globular 
organelles, but as a highly connected reticular network (Chen et al., 2005; Jezek et al., 
2009) (Figure 1.1B).   
The composition of the mitochondrion is quite elegant (Figure 1.1C).  The 
permeable outer membrane is similar to that of the cell membrane with a protein to 
phospholipid ratio of 1:1. There are two methods of import that occur at the outer 
membrane: porin allow for free diffusion of molecules and proteins <5 kDa, and 
translocase proteins allows for active transport of larger proteins (Mokranjac et al., 
2005).  Approximately 1000 mitochondrial proteins are encoded by the nuclear genome 
(Becker et al., 2012; Gray et al.,1998).  Active transport is imperative to mitochondrial 
function because some of these proteins get shuttled by the translocase of the outer 
membrane via a mitochondrial localization sequence tag to the inner membrane space 
(Becker et al., 2012; Gray,1998).  Translocase of the outer membrane works in 
conjunction with the translocase of the inner membrane to move the proteins to the 
matrix.  The mitochondrial localization sequence tag is an amphipathic a-helix varying in 















Figure 1.1: Features of the mitochondrial organelle.  (A) Scanning electron 
micrograph of normal cardiac mitochondria with cross section of lamelliform cristae, 1 
μM Bar, magnification 30,000x. (Figure 1.1A obtained from Kanzaki et al., 2010).  
(B) Confocal image of immunofluorescence staining mitochondria with mitotracker 
(Red) in HEK293 cells depicts the highly connected reticular network of the 




2000; Rapaport, 2003).  Inactive transport gives rise to the inner membrane space 
having a similar chemical composition to that of the cytosol.  The outer membrane also 
associates with the endoplasmic reticulum.  This association plays a key role in the 
transport of calcium and lipids from the ER to the mitochondria (Roger et al., 2017).   
In contrast to the outer membrane, the inner membrane forms folds called cristae 
that are highly impermeable to ions and small molecules.  Sodium-calcium exchanger 
channels in the inner membrane maintain the membrane potential necessary for 
adenosine triphosphate synthesis and cell homeostasis (Mannella, 2006).  The inner 
membrane also houses the five membrane-bound proteins involved in oxidative 
phosphorylation.  This leads to a higher than 1:1 ratio of protein to phospholipid in the 
inner membrane (Mannella, 2006).  The area of the inner membrane can also be 3 to 4 
times greater than that of the outer membrane due to more cristae folds in tissue that 
require more energy (Robin and Wong, 1988).  Such tissue includes heart, kidney and 
skeletal muscle (Robin and Wong, 1988).   
The principal function of the mitochondria is to produce energy in the form of 
adenosine triphosphate via the oxidative phosphorylation system (OXPHOS) (Johnson 
et al., 2002).  The metabolism of sugar into fuel occurs via a process known as 
glycolysis (Figure 1.2A).  In the cytoplasm sugar is broken down into 2, 3-carbon 
compounds, pyruvate and lactate.  In the mitochondria, pyruvate dehydrogenase 
converts pyruvate into a 2-carbon compound, acetyl CoA.  Via β-oxidation, fatty acids 
are also converted to a 2-carbon compound, acetyl CoA.  Both of these reactions also 
result in the production of a hydrogen atom, which is transiently stored as nicotinamide 
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Figure 1.2: Major cellular functions of the mitochondrial organelle. (A) 
Illustration of ATP production in the mitochondria. (B) Illustration of calcium shuttling 
in the mitochondria.    
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cycle takes the 2-carbon compound acetyl CoA and oxidizes it to CO2, NADH and 
FADH.  Oxidative phosphorylation is the last pathway in which a series of proton pumps 
converts all of NADH and FADH made thus far to H2O, NAD and FAD.  This conversion 
results in an electrochemical proton gradient across the inner membrane complexes I-V 
of the mitochondria that facilitates the conversion of ADP by ATP synthase to ATP 
(Figure 1.2A).   
Other functions of the mitochondria include facilitating apoptosis with the release 
of cytochromes into the cytoplasm (Green et al., 1998).  The mitochondrion is also one 
of two organelles that can transiently store calcium (Ca2+) (Figure 1.2B).  Mitochondrial 
Ca2+ uptake is crucial for mitochondrial movement, activation of metabolic enzymes and 
cytosolic calcium buffering.  An overload in Ca2+ uptake by the mitochondria leads to 
mitochondrial membrane rupture and release of pro-apoptotic factors resulting in cell 
death (Hoppe, 2010).  The mitochondria are also involved in regulating cellular redox 
status with the production of reactive oxygen species (ROS), nucleotide biosynthesis, 
cellular differentiation and fatty acid metabolism (Oh-hama et al., 1997, Klinge, 2008).  
Implications in diseases 
Due to the mitochondria’s numerous integral cellular functions, the high mutation 
rate in the mitochondrial genome by inheritance or environmental factors can lead to 
detrimental chronic afflictions.  In fact, 1 in 10,000 individuals has a genetic 
mitochondrial disease (Tuppen et al., 2010).  In addition, over 250 pathogenic 
mitochondrial genome mutations have been identified (Schaefer et al., 2008; DiMauro 
































































Figure 1.3: Mitochondrial diseases based on location of mutations on the 
mitochondrial genome  (Figure obtained from DiMauro and Schon, 2003). 
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As the genome is strictly inherited maternally, and >100 copies of genome exist in 
one mitochondrion, the transmission of mutated genomes are complex (Roger et al., 
2017).  Homoplasmic mutations in which all copies of the mtDNA encode for an 
inheritable single amino acid substitution have been identified in optic neuropathy, 
deafness, myopathy and diabetes (Figure 1.3).  Heteroplasmic mutations in which a 
subset of the genome population has inheritable mutations or deletions for several 
genes have been identified in Kearns-Sayre syndrome, Pearson syndrome, Leigh 
syndrome, Parkinson’s disease, mitochondrial encephalopathy, lactic acidosis, and 
stroke-like episodes (MELAS) (Cortopassi et al., 1992; Kraytsberg et al., 2006; Choi et 
al., 2008) (Figure 1.3).  Heteroplasmic mutations can result in varying severity of 
ailments due to the random distribution of each normal and mutant mitochondrial 
genome during mitosis.  The mitochondrial theory of aging states that a buildup of 
reactive oxygen species (ROS) causes somatic mutations to the mitochondrial genome.  
These age-related mutations have been linked to numerous tumor developments, 
Alzheimer’s disease and Parkinson’s disease (Figure 1.3). 
Mitochondrial DNA 
The genome  
The high mutation rate of the mitochondrial genome highlights how important the 
integrity and composition of the mitochondrial genome is for cellular health.  
Interestingly among various organisms and plants, variation in the composition of the 
mitochondria can be quite drastic.  This is due to the endosymbiosis gene transfer 
where the majority of the mitochondrial genes were relocated to the nucleus (Margulis, 
1971; Nass et al., 1963; Nas et al., 1966; Anderson et al., 1981; Burger et al., 2003).  
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The size variation of the genome can be as small as 10,000 base pairs in the 
ctenophore Mnemiopsis leidyi and as large as 48,000 base pairs for the 
bivalve Anadara sativa (Pett et al., 2011).  Genetic content can vary from 511,000 base 
pairs encoding of 221 genes in the pepper plant Capsicum annuum, to 1,300 base pairs 
encoding for 1 gene in the fungus Cryphonectria parasitica (Ladoukakis et al., 2017).   
Among mammals the structure and organization of mitochondrial DNA is both 
highly conserved and economical (Wolstenholme et al., 1992).  The human 
mitochondrial genome (mtDNA), which was first sequenced in 1981, consists of 16,569 
base pairs that is circular and double stranded.  It encodes for 13 subunits of the 
oxidative phosphorylation system, 2 ribosomal RNAs and 22 tRNAs  (Anderson et al., 
1981) (Figure 1.4).   The strands consist of uneven nucleotides characterized by the 
heavy strand (guanine rich) and the light strand (guanine poor).  So named because 
each strand separates at different buoyant densities in a denaturing cesium chloride 
gradient (Kasamatsu et al., 1974).  The heavy strand contains 28 genes, while the light 
strand has 9 genes (Anderson et al., 1981; Macreadie et al., 1983; Chomyn et al., 1986) 
(Figure 1.4).   
Taking a closer look at the composition of the human mitochondrial genome, 
there lies a single noncoding region.  The highly conserved 1,124 base pair long 
noncoding region is called the displacement-loop (D-loop).  The D-loop is located at 
nucleotide position 576-16024 on mtDNA (Figure 1.4).  There are two hypervariable 
regions (HVR) located in the D-loop, hypervariable region 1 (nucleotide position 16024-
16383) and hypervariable region 2 (nucleotide position 57-372 and 438-574).  











































































Figure 1.4: The human mitochondrial genome.  Schematic of the human 
mitochondrial genome, with features of the displacement loop (D-loop) highlighted.  
Genes encoded by the heavy strand are separated from genes encoded by the light 
strand.  Origin of heavy strand of replication (OH) is located in the D-loop, while origin 
of light strand (OL) is in the coding region of the light strand.  The displacement loop 
(D-loop) has arrows indicating the location of the heavy strand promoter 1 (HSP1), 
heavy strand promoter 2 (HSP2) and light strand promoter (LSP) transcription 
initiation start sites.  The location of the three conserved sequence blocks (CSBs) 
and termination associated sequence (TAS) located the 3’ end.  Location of both the 
RNA and DNA primers for replication are highlighted in green and pink.  This 
schematic is scaled to proportion.     
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position 213-236), CSBII (nucleotide position 300-315) and CSBIII (nucleotide position 
363-346) that are highly conserved in eukaryotes (Walberg and Clayton 1981; Sbisa et 
al., 1997). The D-loop also contains all of the regulatory elements involved in 
transcription, the origin of replication for the heavy strand (OH), and a termination 
associated sequence (TAS) located at the 3’ end (Doda et al., 1981) (Figure 1.4).    
Transcription and replication initiation occur at the bidirectional promoter region 
in the D-loop.  Light strand promoter (LSP) and heavy strand promoter 2 (HSP2) 
produce long polycistronic RNA products, while heavy strand promoter 1 (HSP1) 
produce the 2 ribosomal RNAs (Figure 1.4).  The D-loop region also contains the origin 
of heavy strand replication (OH), whose RNA primer is transcribed from the LSP 
promoter.  The 120 base pair RNA primer (7S RNA-loop) is truncated at the conserved 
G-rich sequence block II (CBSII) (Korhonen et al., 2004, Wanrooij et al., 2012; Fuste et 
al., 2010; Chang and Clayton 1985; Gillum et al., 1979) (Figure 1.4).  Generation of an 
approximately 600 base pair DNA primer (7S DNA) at the OH is what gives the 
noncoding region its name as it was first discovered as a very stable G-quadruplex 
triple-strand region that looked like a ‘D’ (Wanrooij et al., 2010) (Figure 1.4). The origin 
of light strand replication (OL) is located in the coding region between tRNA asparagine 
and tRNA cysteine (Figure 1.4). 
The genes of the mitochondrial genome not only lack introns, they also lack 
termination codons, which are generated post-transcriptionally (Wolstenholme et al., 
1992; Montoya et al., 1981).  Economically, in addition to a lack of intergenic regions 
there is some overlapping of genes occurring for ATP8, ATP6, ND4L and ND4.  Both of 
the rRNAs and the 22 tRNAs are unusually small when compared to the nucleus.  Only 
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22 tRNAs are required for the translation of the 13 complex I-IV subunits (Ojala et al., 
1980, Barrel et al., 1979; Osawa et al., 1992).   
Nucleoid formation 
Unlike the nucleus, the economically compact mtDNA is multicopy.  In fact, a 
range of 100-10,000 copies can exist in each organelle (Lightowler et al., 1997; Kai et 
al., 2006; Legros et al., 2004).  With each mtDNA having a contour length of 
approximately 5 microns, and the diameter of a mitochondrion ranging from 0.2-1.0 μm, 
it follows that the multicopy mtDNA much like nuclear DNA has to be compacted in 
order to fit (Ryan et al., 1978; Nass, 1966; Kukat et al., 2015) (Figure 1.5A and B).  
Each compact structure of the mtDNA and the associated proteins is called a nucleoid.  
The nucleoids are located in between the folds of the cristae (Satoh and Kuroiwa, 1991; 
Legros et al., 2004; Kukat et al., 2011; Kopek et al., 2012) (Figure 1.5A and B).  This is 
akin to the bacterial genomes being compacted into nucleoprotein structures called 
nucleoids (Robinow et al., 1994; de Vries, 2010; Tolstorukov et al., 2016).  Unlike the 
architectural histone like protein (HU) that compacts the bacterial nucleoid, the mammal 
mitochondrial nucleoid is compacted by mitochondrial transcription factor A (TFAM) 
(Bogenhagen et al., 2008; Hensen et al., 2014; Rajala et al., 2015).  TFAM binds to 
mitochondrial DNA nonspecifically in a highly cooperative manner like beads on a string 
(Kukat et al., 2015).  Additional TFAM binds and slides along the DNA to form patches 
in order to facilitate compaction (Farge et al., 2012; Kukat et al., 2015) (Figure 1.5C).  
TFAM also partially unwinds the duplex DNA, dimerizes and forms cross-strand 




Figure 1.5: Mitochondrial nucleoids observed by cryo-electron tomography in 
situ and electron microscopy. (A) Image of a bovine heart mitochondrion showing 
mitochondrial nucleoids, boxes 1, 2 and 3. (Scale bars: 100 nm.). (B) The orientation 
and position of the nucleoids surrounded by cristae depicted in a segmented surface 
representation. Nucleoids green, outer membrane grey, cristae gray-blue. (C) Top 
image: electron microscopy image of TFAM (beads) on DNA (string).  Outline of 
TFAM in red and DNA in green highlight TFAM cooperativity binding to each other 
and clustering. Bottom image: electron microscopy image of TFAM binding and 
looping DNA (Scale bars: 50 nm.) (Figure obtained from Kukat et al., 2015). 
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Friddle et al., 2004; Kukat et al., 2015) (Figure 1.5C).  All of this results in the mtDNA 
becoming negatively supercoiled and compacted (Fisher et al., 1992).   
Organization and maintenance of the nucleoid structure is paramount for normal 
mitochondrial transcription, replication and segregation, as both replication and 
transcription occur at the nucleoid.   Transcription and replication proteins: mitochondrial 
polymerase (POLRMT), mitochondrial transcription factor B1 and B2 (TFB1M, TFB2M), 
mitochondrial termination factor (mTERF), mitochondrial topoisomerase I (TOPIM), 
mitochondrial single-stranded DNA binding protein (SSB), polymerase γ (POLG) and 
TWINKLE all associate with the core region of the nucleoid (Malka et al., 2006; 
Bogenhagen et al., 2008; Rebelo et al., 2011; Gilkerson et al., 2013; Hensen et al., 
2014; Rajala et al., 2015).  More than 50 other putative proteins have been found to 
associate with the nucleoid that are not related to mitochondrial DNA replication or 
transcription including ATP-dependent Lon protease, mitochondrial nucleoid factor 1, 
leucine-rich pentatricopeptide-repeat motif containing protein 130 and heat shock 
protein 60 (Bogenhagen, 2012; Gilkerson et al., 2013; Bogenhagen et al., 2008; 
Sumitani et al., 2009; Wang and Bogenhagen, 2006).   
Lastly, factors involved in mitochondrial RNA (mtRNA) processing and the initial 
steps in assembly of mitoribosomes have been shown to associate with the nucleoid 
(Bogenhagen et al., 2014).  A total of 31 mitoribosomal proteins have been identified 
including 13 from the 39S mitochondrial ribosomal subunit, and 17 from the 28S 
mitochondrial ribosomal subunit that can assemble onto the nucleoid (Bogenhagen et 
al., 2014).  It has been speculated that ribosomal protein assembly onto the mtRNA 
occurs at the same time as mtRNA is being transcribed from the nucleoid (Bogenhagen 
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et al., 2014).  Of notable interest is that TFAM immunoprecipitated with the 
mitochondrial ribosomal recycling factor, mRRF (Rorbach et al., 2008).  In addition, 
TFAM binds with nanomolar affinity to mitochondrial tRNA and RNA 4-way junctions 
(Brown et al., 2015).  With these two pieces of evidence, one can formulate a model in 
which TFAM has a role in mitochondrial translation.     
The number of mitochondrial genomes that constitute one nucleoid is a 
controversial topic.  Numerous publications using a variety of techniques from 
conventional light microscopy to direct stochastic optical reconstruction microscopy on 
various cell line have reported 1-8 genomes per nucleoid and various nucleoid sizes 
ranging from 85 nm to 271 nm (Satoh and Kuroiwa, 1991; Bereiter-Hahn and Voth, 
1996; Kukat et al., 2011; Legros et al., 2004; Brown et al., 2011).  One group reported 
an average of 1,400 TFAM/nucleoid, 1.4 mitochondrial DNA molecules per nucleoid and 
one TFAM molecule per 10-20 base pairs in mouse embryonic fibroblast cells (Kukat et 
al., 2011).  While another group reported an average of 3 mitochondrial DNA molecules 
per nucleoid in mouse fibroblast cells (Brown et al., 2011).  Legros et al., did extensive 
work and found that both human male and female fibroblast cells have 2.4 mitochondrial 
DNA molecules per nucleoid, HeLa cells have 5.7 mitochondrial DNA molecules per 
nucleoid and 143B cells have 7.5 mitochondrial DNA molecules per nucleoid (Legros et 
al., 2004).   
Varying reports on the number of TFAM molecules that coat the mitochondrial 
genome also exist.  A ratio of 1,700:1 TFAM/mtDNA, that is, one TFAM molecule per 10 
base pair was reported in HeLa cells (Takamatsu et al., 2002).  A ratio of 35:1 
TFAM/mtDNA was reported in HEK293 cells (Maniura-Weber et al., 2004).  A ratio of 
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900-1,000:1 TFAM/mtDNA, that is one TFAM molecule per 15-20 base pairs was 
reported in mice (Ekstrand et al., 2004).  Evidence also points to the ability of TFAM to 
coat and compact some DNA regions while leaving other DNA regions relatively bare 
(Farge et al., 2014).   
 In vitro studies have reported that TFAM levels determine the productivity of 
transcription and replication.  At a range of one TFAM molecule per 40-80 DNA base 
pair coverage, transcription was optimal, but at a range of one TFAM molecule per 8-10 
DNA base pair coverage transcription was inhibited (Farge et al., 2014).  At a range of 
one TFAM molecule per 60-160 DNA base pair coverage replication occurred, but at a 
range of one TFAM molecule per 8-20 DNA base pair coverage replication was inhibited 
(Farge et al., 2014).   
In vivo studies have also found that TFAM levels have a direct correlation to 
cellular mtRNA levels and mtDNA copy number.  TFAM overexpression studies are 
consistent with in vitro studies revealing that with an abundance of TFAM mtDNA copy 
number were decreased, as were mtRNA levels (Prohjoismäki et al., 2006).  TFAM 
RNAi knockdown studies reveal that with a substantial decrease in TFAM both mtDNA 
copy number and mtRNA levels also decreased (Prohjoismäki et al., 2006).   Another in 
vivo study generated overexpression and knockout TFAM mice models and measure 
both mtDNA copy number and 7S DNA levels (Ekstrand et al., 2004).  They found that 
both levels are directly proportional to levels of TFAM (Ekstrand et al., 2004).  These 
results demonstrate that in the organelle, the number of TFAM that forms nucleoids is 
essential for protecting the mitochondrial DNA from degradation and mutagenesis by 
ROS (Bogenhagen, 2012, Wang et al., 2013).  At lower levels of TFAM, the mtDNA is 
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exposed and susceptible to damage and degradation, resulting in significant decreases 
to both mtRNA levels and mtDNA copy number.   
Mitochondrial Transcription  
Taking a closer look at how mtDNA transcription occurs, one would predict that 
the mechanism of mitochondrial transcription would be homologous to that of bacteria.   
After all, the mitochondrial genome is compacted similar to that of bacterial plasmids.  
That assumption was incorrect with the discovery that the mitochondrial RNA 
polymerase (POLRMT) was related to the bacteriophage T3 and T7 family of RNA 
polymerases (Masters et al., 1987).   However, unlike T7 RNA polymerase, which 
requires no auxiliary transcription factors, POLRMT is unable to bind, bend and melt the 
promoter regions on its own, as such it requires two transcription factors: TFAM and 
TFB2M (Cheetham and Steitz, 1999; Litonin et al., 2010).  These three proteins in 
addition to promoter mtDNA make up the mitochondria transcription initiation complex 
(MTIC) (Figure 1.6). 
Mitochondrial RNA polymerase (POLRMT) 
POLRMT is a 140 kDa single subunit DNA-dependent mitochondrial polymerase 
that was first discovered in yeast (Rpo41) (Greenleaf et al., 1986; Kelly and Lehman, 
1986). It consists of three domains: a highly conserved C-terminal domain, an N-
terminal domain and an N-terminal extension domain (Figure 1.6A).  The x-ray 
structures of the apo POLRMT and MTIC were recently solved (Ringel et al., 2011; 
Hillen et al., 2017) (Figure 1.6A).  The structure of POLRMT C-terminal domain 
(residues 648-1230) revealed that it has a characteristic right-hand fold that is essential 





Figure 1.6: Structure of HSP1-TFAM-POLRMT-TFB2 initiation complex (A) 
Schematic of mtRNAP (POLRMT), TFAM and TFB2M. Crystal structure of the TFAM, 
mtRNAP (POLRMT) and TFB2M in complex with LSP (PDB ID 6ERP).  Specific 
structure features are labelled.  (B) Zoomed in view of mtRNAP (POLRMT) 
interacting with TFAM.  Dashed line for mtRNAP (POLRMT) indicate the putative 
trajectory of the polypeptide connecting the tether helix to the PPR domain. (C) 
TFB2M at the transcription initiation bubble.  Intercalating arginine and lysine 




addition to nucleotide incorporation all occurs at the C-terminal domain.  The N-terminal 
domain (residues 369-647) consists of an AT-rich recognition loop and an intercalating 
hairpin (Figure 1.6A).  The T7 RNA polymerase has extensive DNA interactions with the 
AT-rich recognition loop and the sequence specificity loop that inserts in the bacterial 
promoter regions -17 to -13 and -5 to -11, however neither of these features in the 
POLRMT have mtDNA promoter contact (Cheetham and Steitz, 1999).  This highlights 
the need for TFAM and TFB2M.  The POLRMT intercalating hairpin is involved in 
promoter melting during transcription initiation and becomes repositioned during the 
switch to elongation by TFB2M (Figure 1.6A).  The N-terminal extension (residues 1-
368) consists of a flexible region and a pentatricopeptide repeat (PPR) domain (Figure 
1.6A).  The flexible region (residues 120-134) is involved in the recruitment of POLRMT 
to the promoter region by directly interacting with TFAM high mobility group box B 
(Figure 1.8A and B).  This flexible region is essential for promoter positioning as 
deletions of the N-terminal extension region result in a loss of promoter specific 
transcription, but not a loss of polymerase activity (Hillen et al., 2017). 
Mitochondrial transcription factor A (TFAM) 
The first of the two transcription factors to be identified in the mitochondria was 
TFAM.  TFAM is a 25 kDa highly basic protein that consists of two high mobility group 
(HMG) boxes A and B which consist of 75 amino acids each connected via a linker 
region that is 28 amino acids long and ends with a C-terminal tail that is 26 amino acid 
long (Dairaghi et al., 1995) (Figure 1.6A). Like other HMG box proteins, TFAM binds 
and unwinds mtDNA specific promoter (LSP, HSP1) and nonspecific mtDNA (NS) with 







Figure 1.7: Structures of TFAM-DNA complexes (A) TFAM bound to 28 base pair 
sequence specific LSP (PDB ID 3TMM).  (B) TFAM bound to 22 base pair sequence 
specific HSP1 (PDB ID 4NOD).  (C) TFAM bound to 22 base pair nonspecific DNA 
(PDB ID 4NNU).  D) Superimposition of all three TFAM-DNA complexes.  The major 
intercalating leucine resides 58 (red) and 182 (blue) are depicted as spheres (Figure 
obtained from Ngo el al., 2014). 
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al., 2012; Ekstrand et al., 2004; Kakat and Larsson, 2013; Farge et al., 2012).  The 
structures of TFAM bound to LSP, HSP1 and NS DNA, are almost completely 
superimposable (Ngo et al., 2011; Rubio-Cosials et al., 2011; Ngo et al., 2014) (Figure 
1.7D).  Each TFAM HMG box induces a ~ 90° kink via a series of hydrophobic and polar 
amino acids that intercalate into the minor groove of LSP and HSP1 (Figure 1.7A and 
B).  Each TFAM HMG box induces a ~ 72° kink via the same series of hydrophobic and 
polar amino acids that intercalate into the minor groove of nonspecific (NS) DNA (Figure 
1.7C).  The hydrophobic amino acid residues for HMG box A intercalation are leucine 
58 and isoleucine 81.  The polar and hydrophobic amino acid residues for HMG box B 
intercalation are asparagine 163, proline 178 and leucine 182.  These 5 amino acids, in 
addition to a positively charged linker region have hydrophobic and electrostatic 
interactions with the minor groove negatively charged phosphate backbone that all 
contribute to a stable U-turn of LSP, HSP1 and NS DNA.   
The stable TFAM induced U-turn in promoter DNA is essential for the formation 
of the MTIC complex.  One can observe in the MTIC complex that HMG box B (residues 
214-221) directly interacts with POLRMT N-terminal tether helix to anchor it to the 
promoter region (Hillen et al., 2017) (Figure 1.6A and B).  The C-terminal tail of TFAM 
contacts the POLRMT PPR domain (residues 444-462) (Hillen et al., 2017; Dairaghi et 
al., 1995; Morozov and Temiakov, 2016; Morozov et al., 2015).   The C-terminal tail and 
HMG box B of TFAM are responsible for the recruitment of POLRMT to the promoter 
regions of the mtDNA (Dairaghi et al., 1995) (Figure 1.6A and B).  In fact, deletions and 
truncations of the C-terminal tail of TFAM have been reported to significantly reduces 
transcription initiation efficiency, but not affinity towards promoter DNA (Seng Wong et 
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al., 2009; Ohgaki et al., 2007; Malarkey et al., 2011).  Interestingly, the yeast ortholog, 
Abf2 has the same structural features of TFAM, but lacks a C-terminal tail.  In yeast, 
Abf2 sole responsibility is nucleoid formation (Dairaghi et al., 1995; Diffley and Stillman, 
1988; Diffley and Stillman, 1992). 
Mitochondrial transcription factor B2 (TFB2M) 
The second transcription factor in the MTIC is TFB2M, a 42 kDa protein (Sologub 
et al., 2009). There are two isoforms of this methyltransferase enzyme, TFB1M and 
TFB2M.  Both share sequence homology to the bacteria rRNA methyltransferase and 
are able to methylate ribosomes in vitro (Guja et al., 2013; Cotney and Shadel, 2006).  
Both TFB1M and TFB2M are also able to stimulate transcription initiation in vitro, 
although TFB2M is several magnitudes more efficient (10-100x) (McCulloch et al., 2002; 
Falkenberg et al., 2002. McCulloch and Shadel, 2003).   
Recently the x-ray structures of apo TFB2M and MTIC have revealed how 
TFB2M assist POLRMT in forming the transcription initiation bubble (promoter bases -4 
to +1) (Ramachandran et al., 2017; Hillen et al., 2017) (Figure 1.6A and C).  The MTIC 
x-ray crystal structure and biophysical assays have also revealed that TFB2M has no 
association with TFAM and no function in promoter recognition (Ramachandran et al., 
2017; Hillen et al., 2017) (Figure 1.6A and B).  The TFB2M C-terminal domain residues 
arginine 330 and arginine 331 interact with the double stranded promoter region at base 
-7.  This association leads to a conformational change in the C-terminal domain 
(residues 306-396) of the POLRMT PPR domain which involves a rotation of 7 
Angstroms.  In addition, the C-terminal tail (residues 389-396) of TFB2M stabilizes the 
POLRMT intercalating hairpin.  The positively charged surface of the N-terminal domain 
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(residues 72-305) of TFB2M also has several key conserved positively charged lysine 
and arginine residues that guide the non-template DNA away from the template strand 
in the initiation bubble (Figure 1.6C).  TFB2M is essential for positioning POLRMT 
intercalating hairpin and specificity loop in a similar orientation to that found in T7 RNA 
polymerase bound to bacterial promoter DNA (Hillen et al., 2017).  These structural 
changes all lead to TFB2M facilitating promoter melting and recruitment of the initiating 
RNA nucleotide, and ultimately the initiation of mtRNA synthesis. 
Mechanism of promoter recognition and transcription initiation 
The initiation of mtRNA synthesis begins at three functionally independent 
promoter sequences, LSP, HSP1 and HSP2.  The exact location of the mtDNA LSP and 
HSP1 have been well characterized by numerous techniques including nuclease S1 
protection, footprinting analysis and inter-promoter sequence substitutions for in vitro 
run-off transcription assays (Walberg and Clayton, 1983; Chang and Clayton, 1984; 
Hixson and Clayton, 1985; Topper and Clayton, 1989) (Figure 1.8).  The LSP start site 
was reported to be at position 407/+1, and the HSP1 start site was reported to be at 
position 561/+1 in mtDNA (Montoya et al., 1982; Bogenhagen and Yoza, 1984; Hixson 
and Clayton, 1985; Topper and Clayton, 1989) (Figure 1.8). Both LSP and HSP1 are 
separated by 150 base pairs.   
The third and least understood promoter is HSP2 (Montoya et al., 1982; Montoya 
et al., 1983; Martin et al., 2005; Lodeiro et al., 2012; Zollo et al., 2012).  HSP2 is 
believed to be located in the coding region of the mtDNA at tRNA phenylalanine.  S1 
nuclease protection assays were done on HeLa cells to locate the HSP2 start site at 























Figure 1.8: Mitochondrial promoter DNA regions (A) Mitochondrial promoter DNA 
initiation complex footprint sequences for LSP, HSP1 and HSP2.  Purple indicates 
TFB2M DNA footprint, blue indicates POLRMT DNA footprint/crosslinking and green 
indicates TFAM DNA footprint.  The blue line under the purple line indicates where 
both TFB2M and POLRMT associate at the initiation bubble.  Arrows indicate start of 
transcription for LSP, HSP1 and HSP2.   The sequence is the human mitochondrial 
genome, residues 361-660 (DNA footprints obtained from Posse et al., 2014; 
Morozov and Temiakov, 2016; Hillen et al., 2017). (B) Illustration of mitochondrial 
transcription initiation complex stepwise assembly.  TFAM binds and induces a U 
shape bend in the promoter DNA.  POLRMT is then recruited and binds to the 
promoter region both upstream and downstream of TFAM.  Finally, TFB2 is recruited 
to the DNA-TFAM-POLRMT complex to facilitate promoter melting with the formation 
of the mitochondrial transcription initiation complex (MTIC). 
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the literature for footprinting analysis to identify the specific binding site of HSP2 MTIC.  
In figure 1.8, I extrapolated HSP2 MTIC footprint based on HSP1 and LSP (Figure 1.8 
and 1.12). 
The affinity that TFAM has to the specific promoter sequence is quite high, with 
apparent dissociation constants reported in the range of 4-7 nM (Malarkey et al., 2012; 
Ramachandran et al., 2017).  HMG box A has a high affinity towards promoter DNA 
when compared to HMG box B (Gangelhoff et al., 2009; Ngo et al., 2011; Wong et al., 
2009).  Both HMG box A and HMG box B deform each promoter site by interacting with 
the minor groove of DNA located in an ApC rich region at position -16 to -39, resulting in 
severe bends at each HMG box (Gaspari et al., 2004; Ngo et al., 2011; Malarkey et al., 
2012; Hillen et al., 2017).  This binding/bending mechanism is also responsible for 
unwinding the DNA region (Dairaghi et al., 1995; Ramachandran et al., 2017; Hillen et 
al., 2017).  Once this happens, TFAM is now in position to recruit POLRMT to the 
transcription start site (Figure 1.8B).  The apparent dissociation constant for POLRMT to 
promoter DNA is 11 nM, but the apparent dissociation constant for POLRMT and TFAM 
is 3.6-fold lower at 3 nM (Ramachandran et al., 2017).   
Finally, TFB2M binds 7 nucleotides upstream of position +1.  The interaction of 
POLRMT and TFB2M facilitates and stabilizes promoter melting (Sologub et al., 2009; 
Ramachandran et al., 2017).  In fact, the stabilization of the MTIC shares a similar 
apparent dissociation constant to POLRMT:TFAM complex at 4 nM (Ramachandran et 
al., 2017).  The N-terminus of TFB2M separates the two strands of DNA to form an 
open complex.  Interestingly the DNA downstream of position +1 also undergoes a 135° 
bend at the POLRMT/TFB2 binding site (Hillen et al., 2017) (Figure 1.6A).  The 
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recruitment of each component onto the promoter regions occurs in a well-documented 
stepwise manner with identical topology for HSP1 and LSP (Morozov et al., 2016; Hillen 
et al., 2017).  The assembly of the MTIC onto promoter DNA is essential for the efficient 
initiation of transcription and can be reconstituted in an in vitro system (Falkenberg et al., 
2002) (Figure 1.8B).   
Regulation of transcription initiation 
The regulation of transcription initiation is largely unknown.  However, TFAM high 
mobility box A serine 55 and serine 56 can be phosphorylated by the mitochondrial 
cAMP-dependent protein kinase, which results in the rapid and selective degradation by 
mitochondrial Lon protease (Lu et al., 2012).  Phosphorylation rates are equal for apo 
TFAM and TFAM complexed to DNA (Lu et al., 2012).  It has been hypothesized that 
phosphorylation of serine 55 and serine 56 could regulate TFAM binding.  Specifically, 
the negative charge of each phosphate group could cause electrostatic repulsion of 
HMG box A with the DNA backbone.  This repulsion could result in decreased binding 
affinity of TFAM to DNA, thus decreasing transcription initiation.  Another level of 
transcription initiation regulation also involves TFAM levels.  The three promoter regions 
have different sensitivity to TFAM levels in vitro (Shutt et al., 2010; Lodeiro et al., 2012).  
At lower levels of TFAM, LSP transcription is optimal.  At higher levels of TFAM, HSP1 
and HSP2 transcription is enhanced, and LSP transcription is repressed.           
Regulation of transcription elongation 
 The regulation of mitochondrial transcription elongation is performed by 
mitochondrial transcription elongation factor (TEFM), a 37 kDa protein.  TEFM is 
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proposed to be a switch between replication of the OH and transcription elongation at 
LSP (Asin-Cayuela et al., 2007; Agaronya et al., 2015; Minczuk et al., 2011; Posse et  
al., 2015; Hillen et al., 2017) (Figure 1.9A).  The presence of this molecule has been 
implicated to favor mitochondrial transcription elongation over mitochondrial replication.  
It does so by associating with POLRMT to add stability and processivity (Agaronyan et 
al., 2015; Minczuk et al., 2011; Hillen et al., 2017).  The x-ray crystal structure of TEFM 
bound to POLRMT/RNA-DNA hybrid to mimic the mitochondrial elongation complex 
(EC) was recently solved (Hillen et al., 2017) (Figure 1.9B).   
In the absence of TEFM, POLRMT specificity and intercalating loops clash with 
the formation of a strong G-quadruplex structure (Wanrooij et al., 2012; Mukundan and 
Pan 2013; Hillen et al., 2017) (Figure 1.9B).  The G-quadruplex structure consists of 3 
G-tetrad layers located 8 nucleotides away from the AT rich region of the CSBII 
sequence.  This clashing likely results in the dissociation of mtRNA and mtDNA from 
POLRMT (Hillen et al., 2017).  The dissociation generates the 120 base pair RNA 
primer (7S RNA) needed for the association of mitochondrial DNA polymerase γ 
(POLG) and initiation of mtDNA heavy strand replication (Figure 1.4, Figure 1.10).  This 
is reminiscent of POLRMT related T7 bacteriophage transcription termination in which 
RNA hairpins cause the T7 RNA polymerase to fall off (Kochetkov et al., 1998).   
In the presence of TEFM, TEFM binds as a dimer to POLRMT to form a sliding 
clamp (Agaronyan et al., 2015; Minczuk et al., 2011; Posse et al., 2015; Hillen et al., 
2017).  The N-terminal domain and linker region of TEFM binds to the POLRMT 
specificity and intercalating loops which inhibits the formation of the G-quadruplex as 





Figure 1.9: Structure of mitochondrial elongation complex (A) TEFM prevents 
POLRMT from stalling at the G-quadruplex.  This event is the switch from mtDNA 
replication to mtDNA transcription elongation.  (B) Structure of POLRMT bound to the 
G-quadruplex region and clashing with the specificity and intercalating loops on the 
right.  On the left, structure of TEFM bound to POLRMT promoting antitermination 
(PDB ID 4BOC) (Figures obtained from Hillen et al., 2017). 
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B).  This interaction between TEFM and POLRMT is also what reinforces the RNA exit 
channel which contributes to POLRMT stability as it transcribes long polycistronic 
RNAs.  The C-terminal domain of TEFM interacts with the N-terminal domain of 
POLRMT as a processivity factor by enhancing the interaction of the EC with the 
downstream DNA (Hillen et al., 2017).  As TEFM only has affinity towards POLRMT in 
the EC conformation.  TEFM dissociates from POLRMT when POLRMT dissociates 
from mtDNA and mtRNA (Hillen et al., 2017).   
 TFAM levels may also have a role in governing transcription elongation.  An in 
vitro study found that TFAM coverage of DNA at >50% inhibited DNA strand separation 
(Farge et al., 2014).  DNA strand separation is key to transcription, transcripts levels 
generated from a template DNA containing dual direction HSP1 promoters was 
measured with varying amounts of TFAM.  Transcription from one direction generated a 
short RNA molecule and transcription from the other direction generated a long RNA 
molecule.  The in vitro transcription results showed that there was a 2.5-fold decrease in 
longer RNA levels when compared to the shorter RNA levels at a 1 TFAM to 20 base 
pair coverage (Farge et al., 2014).  At a 1 TFAM to 160 DNA base pair coverage and 1 
TFAM to 80 DNA base pair coverage transcripts levels were similar for both lengths of 
RNA (Farge et al., 2014). Taken together these results indicate that stability of the 
increased TFAM:DNA complexes leads to impairment of transcription elongation to 
initiate strand separation (Farge et al., 2014).  TFAM levels regulate transcription 




Regulation of transcription termination 
 The regulation of transcription termination is performed by the 39 kDa protein 
mitochondrial termination factor (mTERF).  Of the three promoter start sites in the D- 
loop, HSP1 and LSP are the only ones that share a termination binding site (Kruse et al., 
1989; Asin-Cayuela et al., 2005; Yakubovskaya et al., 2010).  This site is located at a 22 
base pair region on the 3’ end of tRNA leucine gene (residues 3232 to 3253) (Figure 
1.10A).  Binding of mTERF to this site terminates transcription bidirectionally 
(Christianson and Clayton, 1988; Kruse et al., 1989; Fernandez-Silva et al., 1997; 
Yakubovskaya et al., 2010).  The x-ray structure of mTERF bound to the tRNA leucine 
sequence was solved (Yakubovskaya et al., 2010) (Figure 1.10B).  In it, mTERF binds 
to the major groove of DNA with a 20 base pair footprint (Yakubovskaya et al., 2010) 
(Figure 1.10B).  As a result of this interaction the DNA is bent 25° and unwound with 
partial duplex melting (Yakubovskaya et al., 2010).  mTERF stacking interactions and 
hydrogen bonding stabilize a novel 3 nucleotide eversion (Yakubovskaya et al., 2010) 
(Figure 1.10A and C).  This triple nucleotide base flipping is essential for transcriptional 
termination (Yakubovskaya et al., 2010).   
The A3243G MELAS mutation (mitochondrial myopathy, encephalopathy, lactic 
acidosis and stroke-like episodes) reduces the affinity of mTERF to its binding site 
(Chomyn et al., 1992; Shang and Clayton, 1994).  However, this mutation does not alter 
HSP1 transcription, it reduces LSP transcription (Asin-Cayuela et al., 2005).  mTERF’s 
affinity and termination activity is the greatest towards the inverted residues 3232 to 
3253, which is the LSP transcription termination mTERF orientation (Asin-Cayuela et al., 















Figure 1.10: Structure of mTERF-tRNA leucine DNA (A) Sequence of tRNA 
leucine gene (mtDNA residues 3232-3253) highlighting the novel 3 nucleotide 
eversion.  All of the mTERF amino acids involved in electrostatic interactions with the 
DNA are depicted. (B) Structure of mTERF bound to tRNA leucine gene.  (C) Zoom 
in view of A3243 of the light strand and T3243 and C3242 of the heavy strand that 
have a novel everted confirmation (PDB ID 3MVA) (Figure obtained from 
Yakubovskaya et al., 2011).  (D) The binding to mTERF in the heavy stand 
orientation facilitates the looping of the DNA so that the MTIC can be recycled over 
and over again to generate the rRNAs.   
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towards LSP termination would prevent the EC originating from LSP to proceed beyond 
tRNA leucine gene.  The EC originating from the HSP1 can proceed without clashing 
into the EC originating from LSP.   
A mitochondrial termination factor binding site location between mitochondrial 
DNA nucleotide residues 524 and 768, close to the HSP1 transcription start site was 
discovered in 2005, but its existence is controversial (Martin et al., 2005; Park et al., 
2007).  Electron microscope studies reveal that a loop is formed between the two 
mitochondrial termination factor binding sites thereby facilitating reinitiation of 
transcription for HSP1 (Martin et al., 2005; Asin-Cayuela et al., 2005) (Figure 1.10C).  
This looping is proposed to recycle POLRMT onto HSP1 and could be the reason for a 
15 to 60-fold abundance of ribosomal 12S and 16S rRNA observed both in vivo and in 
vitro (Montoya et al., 1982; Montoya et al., 1983; Martin et al., 2005).  Thus, mTERF 
could have an additional role in enhancing HSP1 transcription initiation (Asin-Cayuela et 
al., 2004; Martin et al., 2005).  Interestingly HSP2 has one putative termination site 
upstream of tRNA phenylalanine gene, in which two unidentified 45 and 70 kDa proteins 
have associated (Camasamudram et al., 2003).  
Mitochondrial Replication 
In addition to transcription, the mitochondrial genome undergoes continuous 
replication independent of both the cell cycle and nuclear DNA replication (Bogenhagen 
et al., 1977).  Two models have been proposed for mtDNA replication.  The first is the 
asymmetric model of replication (Figure 1.11A).  In this model POLRMT generates a 
120 base pair primer (7S RNA) starting from light strand promoter and ending at 
conserved sequence block II in the D-loop that is located near the OH at mtDNA 
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nucleotide position 191 (Robberson et al., 1972; Crews et al., 1979; Anderson et al., 
1981; Clayton, 1985; Clayton, 2000) (Figure 1.4).  Replication then proceeds uni- 
directionally with mitochondrial DNA polymerase γ (POLG) associating to the RNA 
primer and DNA.   
POLG is a heterodimeric, 140 kDa protein.  POLG has a catalytic subunit that 
possess 3’ to 5’ exonuclease activity and 5’-deoxyribose phosphate lyase activity (Olson 
et al., 1995; Kunkel and Soni, 1988; Longley et al.,1998).  POLG also has an accessory 
subunit that binds to double stranded DNA and the RNA primer (Fan et al., 1999; Lim et 
al., 1999).   TWINKLE, a DNA helicase is responsible for unwinding the double stranded 
DNA in the 5’ to 3’ direction in an ATP-dependent manner (Korhonen et al., 2004).   The 
mitochondrial single-stranded DNA binding protein (SSB) stabilizes and protects the 
single stranded DNA as replication proteins proceed.  SSB also has been shown to 
enhance TWINKLE DNA helicase activity at the replication fork (Korhonen et al., 2003; 
Korhonen et al., 2004).  RNase H1, DNA ligase II and topoisomerases are all additional 
accessory proteins that associate with POLG until about two-thirds of the way around 
the circular genome where OL is located  (Hance et al., 2005; Tyynismaa et al., 2004; 
Cerritelli et al., 2003; Simsek et al., 2001; Milenkovic et al., 2013) (Figure1.11A).  This is 
when replication of OL begins with the end of the newly synthesized heavy strand DNA 
forming a stem loop that interacts with POLRMT to generate another primer for light 
strand synthesis (Fuste et al., 2010) (Figure1.11A).  Thus, in this model transcript and 
replication are interconnected as POLRMT are responsible for generating both heavy 





























Figure 1.11: Mitochondrial DNA replication models  (A) Illustration of the 
asymmetric model of mitochondrial replication.  Transcription begins at the LSP 
which generates the 7S RNA and replication from the origin of heavy strand 
replication to the TAS generates the 7S DNA which together make the D-loop.  
Replication continues with polymerase γ (POLG) replicating the DNA as the helicase 
Twinkle and topoisomerase unwinds and relaxes it. Transcription at the OL generates 
the second RNA primer that POLG uses to being replication from the light strand.  (B) 
Illustration of bidirectional model of mitochondrial replication. The origin of replication 
can start anywhere in the first 1/3 of the DNA from the origin of heavy strand 
replication.  This generates a leading and lagging strand.  Proteins not depicted in 
these illustrations include single-stranded DNA binding protein which bind to the 
single stranded DNA to protect it from damage.  RNase H1 degrades the 7S RNA 
primer and DNA ligase II ligates the Okazaki fragments, illustrated by the green 
shorter arrows.   
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2016; Phillips et al., 2017; Ciesielski et al., 2016; Wanrooij et al., 2008) (Figure 1.4, 
Figure 1.11A).   
A second replication model that is bidirectional has been proposed in which a 
coupled leading and lagging strand synthesis is occurring much like the mechanism for 
nuclear DNA replication (Holt et al., 2000; Yasukawa et al., 2005) (Figure 1.11B).  This 
model also predicts that the origin of replication is actually a broad zone encompassing 
anywhere from the OH to about 2/3 along the genome (Bowmaker et al., 2003; Reye et 
al., 2005).  In fact, in this model the OH functions as a replication fork barrier, with the 
synthesis of the leading and lagging strands coupled, and the lagging strand generating 
short DNA fragments (Figure 1.11B).   
Mitochondrial DNA Methylation 
Nuclear DNA methylation   
The existence of reversible methylation (5mCpG) of the mtDNA has been well 
documented in the past 48 years.  However, the role that 5mCpG plays in the 
mitochondria remains unclear.  In mammals, it is well known that reversible 5mCpG 
plays a crucial role in regulating nuclear gene expression via a variety of mechanisms.   
Nuclear DNA cytosine methylation (5mCpG) is often referred to as the fifth DNA 
base and has an essential role in regulating gene expression (Tate et al., 1993; Ehrlich, 
1982; Eden and Cedar, 1994).  Nuclear DNA methyltransferase (DNMT) enzymes are 
responsible for mediating the transfer of a methyl group from S-adensyl-methionine 
(SAM) to the 5th carbon of 5’-deoxycytosine in 5’-deoxycytosine-phosphate-
deoxyguanine-3’ sequence (CpG) (Bacolla et al., 1999; Bestor et al.,1988; Goll and 
Bestor, 2005) (Figure 1.12).  Replacement of the hydrogen atom at the 5th carbon of 5’-
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deoxycytosine with a methyl group does not interfere with CG base pairing.  The initial 
methylation pattern is established by nuclear DNA methyltransferase 3A and 3B  
(DNMT3A, DNMT3B).  The maintenance of symmetrical methylation patterns during 
DNA replication is performed by nuclear DNA methyltransferase 1 and 2 (DNMT1, 
DNMT2).   
The fifth base mediates nuclear transcription repression by two mechanisms.  
The first mechanism directly relates to protein-DNA interactions.  CpG dinucleotides are 
underrepresented in the genome but enriched in some promoter regions called CpG 
islands (Bird, 2002; McClelland and Ivarie, 1982).  Transcription factors interact with the 
CpG islands via hydrophobic and electrostatic interactions.  The steric hindrance of 
methyl groups in 5mCpG islands contributes to increased rigidity of the phosphate 
backbone, which inhibits optimal distortion of the promoter DNA (Derreumaux et al., 
2001; Perez et al., 2012).  Hence transcription factors do not have the correct base and 
shape readouts on nuclear 5mCpG promoter DNA to bind correctly (Machado et al., 
2015; Yin et al., 2017).  In addition, transcription repressors and related factors have an 
affinity towards 5mCpG islands thus inhibiting transcription initiation from occurring 
(Jones et al.,1998; Nan et al.,1998; Klose et al., 2005; Clouaire et al., 2010; Scarsdale 
et al., 2011; Yin et al., 2000).   
The second mechanism directly relates to nucleosome compaction.  Post-
transcriptional histone modifications work in conjunction with 5mCpG and chromatin 
regulation factors to compact nuclear DNA into the transcriptionally inactive structure 
heterochromatin (Zang et al., 2001; Zhang et al., 2005; Cheung and Lau, 2005; Sasai 
and Defossez, 2009).  5mCpG DNA wrapped around a nucleosome is tighter than 
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nonmethylated DNA (Lee and Lee, 2013).  This is due to a reduction in the extent of 
DNA twisting and underwinding all resulting in a 0.5 base pair increase to 11 base pairs 
per turn (Nathan and Crothers, 2002; Lee and Lee, 2013).  During development 
inactivation of X-chromosome, embryogenesis and gametogenesis genome 
reprogramming and genomic imprinting are all controlled by 5mCpG (Li et al., 1992; 
Augui et al., 2011; Bartolomei et al., 2011; Messerschmidt et al., 2014).   
Transcriptionally active gene CpG islands in normal somatic cells are usually 
hypomethylated.  Some CpG islands in somatic cells appear to be primarily protected 
by transcription factors from de novo 5mCpG (Watt and Molloy, 1988; Deaton and Bird, 
2011).  Conversely, DNMT enzymes bind to certain transcription factors to target DNA 
for 5mCpG (Moore et al., 2013).  After embryogenesis, 80% of the CpG sequences are 
5mCpG, that equates to approximately 4% of all genomic cytosines (Breiling et al., 
2015).  Nuclear 5mCpG is thus nonrandom, with the majority of 5mCpG existing at the 
CpG islands. 
The active mechanism by which a nuclear cytosine loses its methyl mark is 
performed by ten eleven translocation methylcytosine dioxygenases 1, 2 and 3 (TET1, 
TET2, TET3) (Figure 1.12).  The TETs facilitate the conversion of 5-methylcytosine 
(5mC) to cytosine (Tahiliani et al., 2009; Wu and Zhang, 2011) (Figure1.12).  TET1, 
TET2 and TET3 systematically oxidize 5mC to 5-hydroxymethylcytosine (5hmC) to 5-
formylcytosine (5fC) and finally to 5-carboxylcytosine (5caC) (Tahiliani et al., 2009; Wu et 
al .2011; Debin et al., 2014).  Both 5fC and 5caC can then be converted by de-


































Figure 1.12:  Mechanism of DNA methylation and demethylation.  De novo 
nuclear CpG methylation is initiated by DNMT 3A and DNMT3B.  DNMT1 is 
responsible for maintenance of methylation.  TET1, TET2, and TET3 are DNA 
hydroxylase enzymes that convert 5mC to 5fC and 5caC.  5fC and 5caC are 
converted by de-carboxylase to cytosine.  
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DNA methyltransferase and hydroxylases in the mitochondria 
The mechanism(s) by which DNMTs and TETs get directed to the mitochondrial 
genome is unknown, however investigations began in the early 1970s.  Two separate 
groups found evidence of DNA methylase activity in the mitochondria of rat liver and 
loach embryos (Shield et al., 1968; Vanyushin et al., 1970; Evans & Evans, 1970).  The  
investigation gained momentum when the Taylor lab first identified a mitochondrial 
isoform of DNMT1 (mtDNMT1) via immunoblots in human colon carcinoma cells and 
mouse embryonic fibroblasts (Shock et al., 2011).  This variant of the nuclear DNMT1 
has a putative in-frame N-terminal mitochondrial localization sequence that is upstream 
of the nuclear gene start site (Shock et al., 2011).   
The identification of other DNMTs and TETs in the mitochondria followed with the 
Martin lab.  In their ALS models they identified two isoforms of human and mouse 
DNMT3A in the mitochondria using both immunoblots and immunofluorescence (Wong 
et al., 2013).  Interestingly they showed that DNMT3A localization is tissue specific with 
detection in the spinal cord, skeletal muscle and testes but absent in the spleen, liver, 
kidney and lungs.  In addition, they identified the ten eleven translocation oxidizers, 
TET1 and TET2 associating with the mitochondria in aging mice brains using both 
immunoblots and immunofluorescence (Wong et al., 2013).   
The confirmation of DNMT1 and TETs localizing to the human mitochondria 
came about with two more studies.  In 2015 Mishra and Kowluru discovered DNMT1 
directly associating with the D-loop.  Human and bovine retinal endothelial cells 
exposed to high glucose levels to mimic diabetic retinopathy underwent chromatin 
immunoprecipitation (ChIP) and immunofluorescence to reveal that DNMT1 D-loop 
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association is 3-fold higher under high glucose conditions (Mishra and Kowluru, 2015).  
The Bamezai lab in 2017 identified a novel DNMT1 isoform 3 that is solely responsible 
for mtDNA 5mCpG in lung and colon cancer cells (Saini et al., 2017).  Three other labs 
have gone on to confirm the localization of DNMTs and TETs in the mouse 
mitochondria and are detailed in appendix table 1.1.  These papers provide clear 
evidence for the localization of DNMTs and TETs to the mitochondria. 
5mCpG DNA content in the mitochondria: the controversy 
One would expect that the DNMTs and TETs localizing to the mitochondria would 
reversibly methylate mtDNA.   This is indeed the case with 47 papers reporting varying 
levels of mtDNA 5mCpG (2%-70%) in different species, tissues and cells (Appendix 
Table 1.3).  However, there are 8 reports claiming that mtDNA 5mCpG does not exist 
(Appendix Table 1.2).    
Contention in the field is based on the techniques used to detect mtDNA 5mCpG.  
The methods used in the literature refuting the existence of mtDNA 5mCpG have been 
predominantly sodium bisulfite conversion based (Appendix Table 1.2).  The techniques 
used to detect the 435 mtDNA CpG sites that are 5mCpG include not only bisulfite 
conversion, but methylation sensitive restriction enzyme digestion, thin-layer 
chromatography, affinity enrichment (MeDIP), enzyme-linked immunosorbent (ELISA) 
and 5mC immunofluorescence (Appendix Table 1.3).     
With such a vast array of techniques used to detect mtDNA 5mCpG, it is hard to 
refute the existence of mtDNA 5mCpG.  Especially when considering the four potential 
limitations for solely using bisulfite conversion to detect mtDNA 5mCpG levels.  The first 
limitation is based on the ability of mtDNA to insert into the nuclear genome creating 
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391 nuclear DNA sequences of mitochondrial origin (numts) (Hazkani-Covo and Graur, 
2007).   Numts contamination can result in 5mC false positives using bisulfite conversion.  
Several papers reporting the existence of mtDNA 5mCpG have verified that numts are 
not a source of false positive and are indicated by an * in Appendix Table 1.2.  The 
second limitation is based on the limits of accuracy for bisulfite conversion techniques 
that is in the range of 3%-5% (Pawar et al., 2017).  Reports of both individual and global 
mtDNA 5mCpG levels are predominantly in the range of 2%-5% (Appendix Table 1.2 and 
1.3).  Different techniques with a more stringent limit of detection have been employed 
to detect lower mtDNA 5mCpG levels (Appendix Table 1.3).   
The third limitation is based on incomplete fragmentation of circular mtDNA using 
bisulfite conversion techniques.  This limitation was first addressed in 2016 (Lui et al., 
2016).  They found significant differences in circular verses linear DNA’s ability to 
undergo bisulfite conversion.  The inability for circular DNA to undergo complete 
bisulfite conversion and/or generate insufficient PCR products can lead to a low signal-
to-noise ratio resulting in artificially higher levels of 5mCpG inferred.  Linearization 
ensures that the various mitochondrial genome species that are supercoiled and 
catenated are completely accessible for sonication to generate optimal fragments of 
DNA in the 100s base pair range.   
They performed bisulfite conversion on both circular and linearized mtDNA (Lui 
et al., 2016).  Circular mtDNA range of 5mC detection was 3%-34% in 6 regions in the D-
loop.  Linearized mtDNA 5mC detection was 6% in 2 regions in the D-loop and 0.2%-5% 
in the gene encoding regions.  In addition, they also used SEQUENOM EpiTYPER 
MassARRAY to measure a range of 1.21%-27.79% 5mC for circular mtDNA and a range 
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of 0.57%-6.86% 5mC for linearized mtDNA.  They concluded that mtDNA 5mCpG does 
not exist because for both methods the limit of detection in the 5% range.  However, a 
flaw in the direct comparison with linear and circular mtDNA which underwent bisulfite 
conversion cannot be made as they did not keep the CpG sites identical in both studies.   
The fourth limitation is based on the belief that if there is detection of mtDNA 
5mCpG it is a small percentage that is random, and biologically irrelevant.  Inconsistency 
exist in the 7 reports in appendix table 1.2 to make direct comparison to the same tissue 
and same 5mCpG sites as the other 47 reports confirming the existence of mtDNA 
5mCpG.  MtDNA 5mCpG appears to be distributed nonrandomly with varying levels at 
specific CpG sites (Appendix Table 1.3).  In addition, there is also varying levels of 
mtDNA 5mCpG between different species, cell and tissue samples (Appendix Table 1.3).  
Performing bisulfite sequencing on linearized mtDNA on the same species, tissue and 
CpG sites that have been previously reported to be methylated at >5% should be 
performed by these 7 groups.  Only then would irrefutable evidence exist for whether or 
not 5mCpG exist in the mitochondria.  The evidence refuting the existence of mtDNA 
5mCpG is not conclusive. 
Some of the reports confirming the existence of mtDNA 5mCpG have been more 
stringent about their isolation of the mitochondrial DNA, used multiple techniques and 
even compared a broad range of tissues to report that mtDNA 5mCpG does exist.  The 
following sections encompass a comprehensive look at these select publications with a 




Investigations into mitochondrial DNA methylation: the early years 
In 1973, Margit Nass was one of the first to publish that mtDNA 5mC exist at a 
ratio of 5 per 500 cytosine and that the nucleus had a ratio of 5 per 36 cytosine in 
mouse fibroblast and baby hamster kidney cells (Nass et al., 1973).  Nass decided to 
use 4 different approaches based on previous work that DNA methylase activity was 
found in mitochondrial extracts from rat liver and loach embryos, and that the 12S rRNA 
and 16S rRNA was reported to be methylated in 1971 (Sheid et al., 1968, Vanyushin et 
al., 1971, Attardi and Attardi, 1971).  Nass acknowledged that with all of the techniques 
she used including a sucrose gradient to fractionate the mitochondria after performing in 
vivo transfer of the methyl group from [methyl-3H]methionine and/or in vivo incorporation 
of [32P]orthophosphate, in vivo incorporation of [3H]deoxycytidine, in vitro methylation of 
DNAs with 3H-labeled S-adenosylmethionine as methyl donor and DNA methylase, that 
limitations exist.  She was stringent with the isolation of mtDNA however that resulted in 
a low yield.  She noted that the quantity of isolated mtDNA obtained needs to be 
drastically increased to obtain better accuracy (Nass 1973).   
The controversy originated early with Igor Dawid using isolated nuclear and 
mitochondrial organelles from HeLa and frog ovarian cells to report that 5mC mtDNA 
does not exist (Dawid, 1974).  Each of the nucleotides were 32P labelled in the nuclear 
and mitochondrial genome and digested to single nucleotides for separation on a thin-
layer chromatography plate.  Based on the ability of 5mC to migrate differently from all 
other nucleotides, he was able to calculate that frogs and HeLa cells contains 1.7% and 
7% nuclear 5mC, and 0.1% and 0.05% mitochondrial 5mC.  Dawid did acknowledge that 
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the differences in species used between his work and Nass’s work could attribute to the 
variation of mtDNA 5mC levels detected.   
In 1973 Vanyushin and Kirnos thought they had unequivocally proven that 
mtDNA 5mCpG exist (Vanyushin and Kirno, 1973).  They measured the 5mC content in 
both nuclear and mitochondrial beef heart using thin-layered chromatography followed 
by spectrophotometry quantification.  They found that the nuclear 5mC content is 60% 
and the mitochondria 5mC content is 46.4%.  By the end of the 1970s there were 3 
papers claiming 5mC exist in the mitochondrial genome and 1 paper refuting this claim.   
The Goldstein lab was the first to look for mtDNA 5mCpG in human cells 
(Shmookler et al.,1983).  By the 1980’s it was known that the size of the human mtDNA 
is 16,569 base pairs, with 435 CpG sites.  Running into the same low mtDNA yield 
limitation that Nass encountered from mitochondrial organelle separation followed by 
DNA gradient purification, they decided instead to phenol:chloroform the early and late 
stage human skin fibroblast cells to isolate mtDNA.  The mtDNA was then digested with 
the restriction enzyme isoschizomer pair HpaII and MspI for southern blot.  Both 
restrictions enzymes share the same -CpCpGpGp- 22 mtDNA cut site, but HpaII is 
sensitive to -Cp5mCpGpGp- sites.  Their results showed that 90%-98% of the isolated 
mtDNA population was 100% digested with HpaII, but 2%-10% of the entire 
mitochondrial genome was 100% undigested.  This means that 2%-10% of the entire 
population is methylated at all 22 -Cp5mCpGpGp- sites.  These results provide the first 
evidence that human mtDNA contains a highly nonrandom distribution of 5mCpG.   
The Eide lab in 2017 tried to refute the results obtained from the Goldstein lab.  
Using the same restriction enzymes as the Goldstein’s lab, they digested mtDNA from 
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mouse brain cells and found similar amount of 3%-5% undigested mtDNA by HpaII 
(Pawar and Eide, 2017).  However, Pawar and Eide chose to explain the results as 
invalid due to the limit of sensitivity of the assay.   
Another global study of mtDNA 5mCpG comes from mice fibroblast cells (Pollack 
et al., 1984).  Using the same technique as Dawid, each of the nucleotides were 32P 
labelled in the mitochondrial genome and digested to single nucleotides for separation 
on a thin-layer chromatography plate.  The 5mC mtDNA level from this experiment was 
reported to be 3%-5%, equating to 17-29 5mC per mtDNA molecule.  Pollack et al., then 
when on to address Dawid’s 1974 results by claiming that the technique Dawid used 
could not detect anything lower than 30 5mC residues per DNA molecule.  Their current 
limitation of sensitivity was much better at 0.1% in 1984.   
In summary these early studies reported variable amount of global mtDNA 
5mCpG from mouse, human, bovine and hamsters with a range of 17-201 5mC per 
mtDNA molecule (Appendix Table 1.3).  In addition, two independent studies measured 
the global mtDNA 5mCpG from mouse fibroblast cells and reported a similar range of 17-
201 5mC per mtDNA molecule (Appendix Table 1.3).   
Investigations into mitochondrial DNA methylation: correlations to RNA levels, 
diseases and aging 
The observation that mtDNA 5mCpG levels vary between different species has 
been expanded to include variation between different tissue and cells.  The use of 
various techniques in the past 48 years have also highlighted that mtDNA 5mCpG varies 
with diseases and aging as well.  This section highlights the body of work 
encompassing how mtDNA 5mCpG alters RNA and mtDNA copy levels in aging, 
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airborne pollutants and diseases including nonalcoholic fatty liver disease, diabetes, 
Alzheimer’s disease, Parkinson’s disease, malignant glioblastoma, colon cancer and 
rectal cancer.   
Aging plays a significant role in altering the 5mCpG landscape of nuclear DNA in 
the brain.  In the cerebellum and cortex of older human brain, nuclear hypermethylation 
and increased 5hmC levels have been observed (Hernandez et al., 2011; Siegmund et 
al., 2007; Kriaucionis and Heintz, 2009; Munzel et al., 2011).  In 2012 the Manev lab 
measured mtDNA 5mC and 5hmC levels from the cerebellum and frontal cortex of old (24 
months) and young (4 months) mice (Dzitoyeva et al., 2012).  They isolated the 
mitochondria organelle by centrifugation for 5hmC and 5mC ELISA, RT-PCR, qPCR, beta-
glucosyltransferase DNA treatment followed by CviAII and CviQI digestion and qPCR.  
They discovered that the TET levels were increased while the DNMT1 levels were 
decreased in the mitochondrial frontal cortex of aging mice.  They also discovered an 
inverse correlation of decreased mtDNA 5hmCpG levels corresponding to an increase in 
mtRNA levels in the frontal cortex of aging mice.  No changes were observed for the 
mitochondrial DNMT and TET levels in the cerebellum of aging mice.  No change was 
observed for the mtDNA 5mCpG levels in either the frontal cortex or cerebellum of aging 
mice.   
 Bianchessi et al. investigated whether mtDNA 5mCpG alters mitochondrial 
transcription and replication in aging cells.  The mtDNA of human umbilical vein 
endothelial cells (HUVEC) passage 15 were bisulfite converted, PCR amplified and 
cloned into the pGEM-T vector for transformation into E. coli before undergoing one 
more round of PCR amplification (Bianchessi et al., 2016).  They found that 5mCpG were 
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distributed in clusters and exhibited asymmetry between the light and heavy strand 
mtDNA, suggesting that mtDNA 5mCpG is nonrandom.   In addition, they discovered an 
inverse correlation between a decrease in 5mCpG of the D-loop region and an increase 
in mtRNA levels.  An inverse correlation for a decrease in 5mCpG D-loop region and an 
increase in mtDNA copy number also exist in older HUVEC cells.   
Oxidative stress due to airborne pollutants have been implicated in altering 
5mCpG patterns in the nucleus (Baccarelli et al., 2009; Bollati et al., 2007; Madrigano et 
al., 2011; Tarantini et al., 2009). The mitochondrial genome is particularly susceptible to 
increased levels of oxidative stress and airborne pollutants have been linked to 
mitochondrial damage (Hou et al., 2010).  This led to an investigation of the mtDNA 
5mCpG landscape for people exposed to airborne pollutants.  The promoter region and 
16s rRNA region of steel workers, gas station attendant and truck drivers blood samples 
were selected to undergo bisulfite conversion followed by pyrosequencing and qPCR 
(Byun et al., 2013).  The results revealed that steel workers were the only ones to 
exhibit an increase in mtDNA 5mC levels.  A positive correlation between mtDNA 5mC 
levels and mtDNA copy number was also observed for steel workers.  Gas station 
attendants and truck drivers had unaltered levels of 5mC. 
Over consumption of sugars and carbohydrates leads to elevated levels of 
fructose which has been linked to oxidative stress and dysfunctional mitochondria in 
nonalcoholic fatty liver disease (NAFLD) (Sanyal et al., 2001; Perez-Carreras et al., 
2003; Carabelli et al., 2011; Wei et al., 2008).  In 2013 the Sookoian group investigated 
whether NAFLD dysfunctional mitochondria have altered mtDNA 5mCpG levels.  They 
performed sodium bisulfite conversion, PCR amplification and RT-PCR on human 
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NAFLD liver biopsies (Pirola et al., 2013).  They found an inverse correlation in which 
an increase of the mtDNA ND6 gene 5mCpG level corresponded to a decrease in ND6 
mtRNA levels in human NAFLD.    
In 2016 the Ohashi group wanted to distinguish between mtDNA 5mC from 5hmC 
in NAFLD and investigated if mtDNA transcription and replication are altered (Yamazaki 
et al., 2016).  They performed 5hmC and 5mC ELISA, RT-PCR and qPCR on the liver and 
blood of rats fed a high fructose diet.  They found that both 5mC levels and 5hmC levels 
were decrease by a high fructose diet.  These studies also show that there is an inverse 
correlation between a decrease in mtDNA 5mC levels and an increase in mtRNA levels.  
In addition, there is an inverse correlation between a decrease in mtDNA 5mC levels 
corresponding to an increase in DNA copy number.  Interestingly the rat NAFDL results 
are opposite to the human NAFLD studies performed by the Sookoian group.  These 
varying results emphasize that the mtDNA 5mCpG content varies between species in the 
same disease.     
Elevated mitochondrial superoxide levels fueled by a leakage of electrons from 
the ETC ultimately leads to accelerated microvessel apoptosis in diabetic retinopathy 
(Kowluru and Abbas, 2003, Mishra and Kowluru, 2014). Global elevated 5mC levels has 
been investigated as a potential biomarker for diabetic retinopathy (Maghbooli et al., 
2015).  In 2015 Mishra and Kowluru did an extensive study investigating the role that 
DNMT1 has in human and bovine diabetic retinopathy mtDNA 5mCpG and mtRNA levels 
(Mishra and Kowluru, 2015).  They used ChIP to show that DNMT1 not only directly 
associated at the D-loop region, the association was 4-fold higher under high glucose 
conditions in both bovine and human retinal endothelial cells.  Using bisulfite 
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sequencing they found that a 2-fold increase in DNMT1 transcription levels 
corresponded to an increase in mtDNA 5mCpG levels.   
To further confirm that DNMT1 is directly responsible for the elevated levels of 
mtDNA 5mC, Dnmt1-siRNA or 5’-aza-2’deoxycytidine treatment of both cell lines under 
high glucose conditions was performed before bisulfite sequencing and RT-PCR 
(Mishra and Kowluru, 2015).  Knockdown of Dnmt1 and 5’-aza-2’deoxycytidine 
treatment both resulted in the restoration of mtDNA 5mCpG levels and mtRNA levels to 
that of control cells.   
These results were confirmed in retinal microvessels harvested from human 
donors diagnosed with diabetic retinopathy (Mishra and Kowluru, 2015).  An increase in 
DNMT1 RNA levels corresponded to a 3-fold increase in DNMT1 association with the D-
loop, a 3-fold increase in D-loop region 5mCpG levels, and a decrease in mtRNA levels.  
Together these results show direct evidence of DNMT1 associating with the mtDNA in 
both bovine and human diabetic retinopathy.  There is also evidence for an inverse 
correlation between mtDNA 5mC levels and mtRNA levels for both human and bovine 
diabetic retinopathy.   
Dysfunctional mitochondria have been linked to both Alzheimer’s (AD) and 
Parkinson’s disease (PD) (Schapira et al., 2008; Keeney et al., 2006; Ferrer, 2009).  
Specifically, a decrease in AD ND4 and PD ND6 results in reduced activity of the ETC 
(Fukuyama et al., 1996, Schapira et al.,1990).  The Barrachina group set out to 
investigate the mtDNA 5mCpG patterns and mtRNA levels in AD human entorhinal 
cortex tissue, PD human substantia nigra tissue and AD mouse neocortex tissue 
(Blanch et al., 2016).  Using bisulfite pyrosequencing they found that AD tissue had 
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increased D-loop 5mC.  Using 5mC Me-DIP they found that the increase in AD D-loop 
5mCpG observed was isolated to a small population of mtDNA and corresponded to an 
increase in ND1 RNA levels.  PD had a decrease in 5mC levels in the D-loop region but 
no change to ND6 RNA levels.  The decrease in PD 5mC D-loop levels could be the 
result of neuronal loss in the PD substantia nigra resulting in an underestimation of 5mC 
levels.  Together these results indicate a positive correlation to AD mtDNA 5mC levels 
and mtRNA levels in human and mice brain tissue.   
Mitochondria are a key component in oncogenesis.  The mitochondria have 
prominent roles in tumor initiation with the generation of oncometabolities and increased 
oxidative stress (Vyas et al., 2016).  The mitochondria have also been implicated in 
tumor growth and survival with fission/fusion dynamics, metabolic reprograming, 
oxidative stress and mitophagy (Vyas et al., 2016).  Many groups have focused their 
attention on discovering a link between cancer and mtDNA 5mCpG levels.   
In 2011 the Taylor lab investigated mtDNA 5mCpG levels and mtRNA levels in 
colon cancer (Shock et al., 2011).  Using 5mC and 5hmC Me-DIP, they reported a 10-20-
fold enrichment of 5mC in both the D-loop and coding regions, and an astounding 38-
580-fold enrichment for 5hmC in both the D-loop and coding regions in human colon 
carcinoma cells.  They also manipulated mtDNMT1 levels by deleting the tumor 
suppressor p53 to measure mtRNA levels.  Deletion of p53 in mouse embryonic 
fibroblast cells (p53-/-) resulted in an increase in both nuclear and mitochondrial DNMT1 
levels.  Overexpression of mtDNMT1 resulted a repression LSP RNA levels and 
enhancement of HSP2 RNA levels.   
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The Hsieh group in 2013 examined the same mtDNA  5mCpG sites as Shock et 
al. using bisulfite genomic sequencing in human colon carcinoma cells (Hong et al., 
2013).  They found only 2 out of 136 mtDNA CpG sites in the coding region to be 
5mCpG.  Next, they used the same bisulfite primers to look at human blood samples and 
found 4 out of 136 mtDNA CpG sites in the coding region to be 5mCpG.  They also 
performed genome-wide bisulfite sequencing on human colon carcinoma cells with 
29,471 reads and found only 0.46% global 5mCpG in the mitochondria.  The limit of 
detection for this technique is 0.5%.  They concluded that human colon carcinoma cells 
have a minimal, if any 5mCpG.  They also concluded that the previous reports of high 
levels of 5mCpG in human colon carcinoma cells by the Taylor lab were due to the use 
of a higher concentration of anti-5mC antibody which led to false positives.  With such a 
vast discrepancy in the reports of these two groups looking at the same CpG sites in the 
same cell line, it is unclear whether 5mCpG exist in human colon carcinoma cells.  
Performing other 5mCpG detection techniques to clarify this discrepancy is needed. 
From 2011 to 2014 three studies came out linking an elevated level of 
mitochondrial copy number to an increase in mortality rate for the progression of 
colorectal cancer patients (Feng et al., 2011; Zhang et al., 2013; Lin et al., 2014).  Feng 
et al. also published in 2012 a decrease in D-loop 5mC having an inverse correlation to 
an increase in ND2 RNA levels using bisulfite conversion and PCR amplification in 
colon and rectal cancer cells (Feng et al., 2012).  In 2015 the Feng group revisited the 
link between hypomethylation of the D-loop in relation to ND2 RNA levels and also 
measured mitochondrial copy number and protein levels (Gao et al., 2015).  Using the 
same technique of bisulfite conversion in addition to immunoblots and qPCR they found 
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a decrease in mtDNA 5mCpG, an increase in ND2 protein levels and an increase in 
mtDNA copy number for colorectal cancer cells.   
Using the cytosine analogue, 5’-aza-2’-deoxycytidine which incorporates into 
DNA and inhibits DNA methyltransferase activity, the Feng group measured mtRNA 
levels in human colon cancer (Momparler, 2005; Gao et al., 2015).  Treatment of caco-2 
human colon adenocarcinoma cells with 5’-aza-2’-deoxycytidine decreased 5mC in the 
D-loop, increased ND2 protein levels and increased mtDNA copy number.  These 
combined results are not only reproducible, but they show an inverse correlation 
between mtDNA 5mC and ND2-RNA levels.  They also show an inverse correlation 
between D-loop 5mC levels and mtDNA copy number.   
Under normal conditions when cells undergo differentiation the mtDNA copy 
number expands from a set point of 200 to varying amounts due to cell specificity.  In 
some cancers including human glioblastoma, mtDNA copy number fails to expand (Lee 
et al., 2015).   Conversely, hypermethylation of the nuclear genome in some cancer 
cells has been shown to correlate to increased mtDNA copy number (Kelly et al., 2012; 
Lee et al., 2015).  The St. John group in 2018 focused on global DNA demethylation 
and mtDNA copy number in human malignant glioblastoma cells (Sun et al., 2018).  
This particular cell line exhibits both hypermethylation of the nuclear genome and a 
deficiency to differentiate.  They treated the cells with either demethylation compound L-
ascorbic acid (VitC) or 5’-aza-2’-deoxycytidine to measure the nuclear genomic regions 
that encode for mtDNA transcription and replication factors, mtDNA 5mCpG levels and 
mtDNA copy number by Me-DIP, Me-DIP-Seq and qPCR.  Both VitC and 5’-aza-2’-
deoxycytidine were sufficient to reduce the 5mCpG levels of 20 nuclear genomic regions 
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that encode for mitochondrial transcription and replication factors.  The reduction of 
mitochondrial nuclear encoded gene 5mC levels led to a 2-fold increase in nuclear 
transcription of all of the mitochondrial transcription and replication factors except for 
single stranded binding protein, TFAM and TFB2M.  Both VitC and 5’-aza-2’-
deoxycytidine treatment was sufficient to reduce 5mC mtDNA D-loop and coding regions 
levels.  The reduced mtDNA 5mCpG corresponded to a global decrease in mtRNA 
levels.  These results show that both nuclear DNMT1 and TET1 are responsible for 
regulating mitochondrial 5mC levels in human glioblastoma cells.  These results also 
show a positive correlation to 5mC levels in mtDNA and mtRNA levels.  In addition, an 
inverse correlation between mtDNA 5mC levels and mtDNA copy number was also 
observed.   
In summary, a decrease in mtDNA 5mCpG correlated to an increase in mtRNA 
levels in human aging.  Exposure to airborne pollutants led to an increase in both 
mtDNA 5mCpG and mtDNA copy number.  NAFDL had varying correlations on the levels 
of mtDNA 5mCpG in relation to mtRNA levels.  Diabetes led to an increase in mtDNA 
5mCpG correlating to a decrease in mtRNA levels.   Various cancers had varying 
correlations on the levels of mtDNA 5mCpG in relation to mtRNA levels. 
Investigations into mitochondrial DNA methylation: 5mCpG and 5hmCpG levels  
As stated in the nucleoid section of this thesis, various cell types have various 
amount of TFAM coating the mitochondrial genome into nucleoid like structures.  The 
ability of the DNMTs and TETs to access mtDNA would be dependent on the availability 
of the CpG sites.  One would predict that the 5mCpG landscape of the mitochondrial 
genome to be dependent on TFAM coverage and to have heterogeneity between cell 
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lines and even within a single organelle.  This could account for the large variation and 
smaller percentage of 5mCpG methylation that has been reported in the literature and 
highlighted in this section. 
The Kono lab developed a new method to analyze the entire 5mC profile from 
both nuclear and mitochondrial DNA called whole bisulfitome-amplified DNA 
sequencing (Kobayashi et al., 2012).  They agarose gel purified DNA samples from 
mouse oocytes and sperm to shear them into 100-200 base pair fragment before 
bisulfite conversion and PCR amplification.  To prepare the whole WBA-seq library a kit 
was used to extract, and sodium bisulfite convert mtDNA before agarose gel purification 
and PCR amplification.  Another library was generated called the PBAT library by 
bisulfite conversion, before annealing with random biotin tagged primers containing 
Illumina PE adaptors (Kobayashi et al., 2012).  These libraries were sequenced by 
standard Illumina base-calling pipeline for methylation analysis.  Their results show that 
there is indeed mtDNA heterogeneity between mouse cell lines.  Mouse sperm had the 
highest level of global mtDNA 5mC at 15%.  Knockout of DNMT3-/- in mouse oocytes, 
resulted in a reduction in global mtDNA 5mC levels.  Blastocysts and embryonic stem 
cells had negligible amount of global mitochondrial 5mC levels.    
 The methylation landscape of the D-loop region of the mitochondrial genome 
from several cells lines and human samples have revealed 5mCpG at key DNA-protein 
interacting regions in LSP and HSP1 (Bellizzi et al., 2013).  Bisulfite sequencing on 
individual human blood samples revealed 5mCpG in the D-loop is variable from one 
individual to another.  Bisulfite sequencing also revealed that mice blood samples 
mtDNA 5mCpG levels were significantly higher than that of human blood, whereas mice 
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fibroblasts and human fibroblasts cells mtDNA 5mCpG levels were similar.  This study 
also found a higher level of enrichment for mtDNA 5hmC levels when compared to 
mtDNA 5mC levels using immunoprecipitation (Bellizzi et al., 2013).  Immunoprecipitation 
results were targeted for both heavy strand promoter sequences.  These results 
demonstrated that different cell lines have different mtDNA 5mCpG levels.   
In addition, one can postulate from the mice studies that mtDNA 5mCpG patterns 
are established early within the embryonic stem cells and change according to cell and 
tissue differentiation.  Specifically, the mice embryonic stem cell mtDNA 5mCpG levels 
were 50%, while the mice blood mtDNA 5mCpG levels were even higher at 70.6% and 
the mice fibroblasts mtDNA 5mCpG levels were lower at 12.5% (Bellizzi et al., 2013).      
In 2014 the Scaria lab compiled data of 39 cell lines from 5 tissues from the 
Human Epigenome Consortium website to map the 5mCpG landscape of mtDNA (Gosh 
et al., 2014).  Bisulfite conversion and immunoprecipitation data analysis revealed 
similar global mtDNA 5mC patterns in brain, breast, blood, neurosphere, penis and H1 
cells data sets.  The ND6 region was the only region with significant 5mC variability.  This 
lack of variability in 5mC pattern is inconsistent with all other published work on 
mitochondrial 5mC and could be attributed to the limitation of this study’s inability to 
distinguish 5mCpG from 5hmCpG.    
This limitation was addressed when the Scaria lab revisited mitochondrial 
genome methylation, but this time they focused on 5hmC (Ghosh et al., 2016).  Stable 
5hmC existence throughout the nuclear DNA has been attributed to the discovery of 
nuclear DNMT3A role in 5hmC generation (Xu and Corces, 2018).  Stable nuclear 5hmC 
may have a role in gene expression and the ability to regulate stem cells, embryonic 
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development, and has also been implicated in aging and cancers (Szulwach et al., 
2011; Liutkeviciute et al., 2009; Serandour et al., 2012; Gou et al., 2011; Thomson et 
al., 2013).  Stable nuclear 5hmC also appears to have tissue specific profiles (Li and Lui, 
2011; Nestor et al., 2012).  A total of 23 5hmC immunoprecipitation data sets from 5 
different cell and tissue types were compiled (Ghosh et al., 2016).  The computational 
analysis revealed that similar tissue and cells have similar global patterns of mtDNA 
5hmC.  However, for different tissue and different cells the global mtDNA 5hmC patterns 
were different.  Interestingly in embryonic stem cells, the HSP1 site has a higher 
enrichment of 5hmC.   No correlation between mitochondrial gene expression and 5hmC 
enrichment at LSP, HSP1 and HSP2 was found.   
In 2017 Ran et al., looked at 5mCpG levels between mouse embryos and epiblast 
cells (Ran et la., 2017).  Using qRT-PCR they found that mtDNMT1 RNA levels higher 
in epiblasts than embryos and had an inverse correlation to mtDNA 5mC levels.   Using 
CHIP-qPCR  they also found that the D-loop and coding regions 5mC levels were 
significantly higher in embryos when compared to epiblasts.  Interestingly 
immunoprecipitation followed by PCR sequencing results shown that the methylation 
profile for both epiblasts and embryos were similar.  These results provide evidence that 
during organogenesis at the epiblast stage of embryonic development mtDNA 5mC 
levels are decreasing when compared to the embryo stage of development.   
In summary, Shock et al., Chen et al. and Ghosh et al. have all confirmed the 
existence of mitochondrial 5hmC.  Ghosh et al. results confirm that 5hmC is nonrandom 
and contain variation to global patterns of mtDNA 5hmC in different cell and tissue types.  
In addition, there is evidence indicating that mtDNA 5mCpG patterns are established 
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early within the embryonic stem cells and change according to cell and tissue 
differentiation.    
Investigations into 5mCpH existence in nuclear and mitochondrial DNA 
In addition to the nucleus and mtDNA having 5mCpG, there is compiling evidence 
that 5mCpH also exist in both organelles. The nuclear genome of mouse embryonic stem  
cells have been shown to be preferentially methylated at non-CpG sites.  Specifically, 
19.3% of CpA are 5mCpA, 3.8% of CpT are 5mCpT and 1.4% of the CpC are 5mCpG 
(Ramsahoye et al., 2000).  In somatic mouse embryonic stem cells there is 0.8%-3.4% 
non-CpG methylation (Ramsahoye et al., 2000).  Non-CpG methylation was also tissue 
specific in mice, with 15%-20% in mouse embryonic stem cells, and 2% in mouse 
spleen cells (Ramsahoye et al., 2000).  Using the full nearest neighbor analysis, the 
human spleen nuclear nonCpG methylation was reported to be in the 54.5% range for 
CpA, CpT and CpC (Woodcock et al., 1987). 
Mitochondrial DNA has 4747 cytosines at non-CpG sites.  Evidence that some of 
these non CpG sites are methylated exist.  The Passarino’s group discovered CpA, CpT 
and CpC mitochondrial methylation in human blood samples and fibroblasts cells 
(Bellizzi et al., 2013).  In fact, the mtDNA nonCpG methylation levels were 58.8% in 
human blood samples and 17.7% in fibroblast samples.  Zheng’s group in 2013 
reported that mtDNA nonCpG hemimethyation is prevalent in mouse embryonic stem 
cells (Sun et al., 2013).  The Lauri group found that 5mCpG and 5mCpA occur more 
frequently than 5mCpC in both the coding and D-loop regions in human umbilical vein 
endothelial cells (Bianchessi et al., 2016).  Much like the nucleus the functional 
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Figure 1.13:  CpG sites at the transcription promoter regions for mitochondrial 
DNA.  (A) Schematic of the mitochondrial transcription initiation complex footprints 
for all three promoters, light strand promoter (LSP), heavy strand promoter 1 (HSP1) 
and heavy strand promoter 2 (HSP2).  Transcription factor B2 (B2), mitochondrial 
polymerase (Pol) and transcription factor A (TFAM) sequence specific sites have red 
lollipops to indicate the exact location of each CpG site that could be 5mCpG. (B) 
Alignment of all three promoters with the initiation start site indicated with black 
arrows and the CpG sites highlighted in red.   Underlined are the nucleotides that 
TFAM residues intercalate with.    
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Is mitochondrial 5mC epigenetic?   
The literal meaning of the word epigenetic is “in addition to changes in the 
genetic sequence”.  The current scientific meaning of the word epigenetic is two-fold.  
Epigenetic encompasses post-replicative modification to the DNA that are inheritable 
and result in the alteration of gene activity.  The mitochondrial field has been using the  
word, epigenetic to describe mitochondrial 5mCpG incorrectly.  To date direct evidence 
does not exist for the inheritance of the nonrandom pattern of mtDNA 5mCpG observed 
in different cell types and disease.  In addition, only correlative studies have been 
performed to compare mitochondrial genome 5mCpG levels to RNA levels.  These 
results are inconsistent with both positive and negative correlations existing for mtDNA 
5mCpG levels and mtRNA levels.  There is a gap in the literature for the direct 
consequences of mtDNA 5mCpG.  Interestingly in the mitochondrial transcription tri-
promoter region there exist 5 CpG sites (Figure 1.13).  The possible roles that 
methylation of these 5 CpG sites have in mitochondrial transcription regulation is 
unclear.  In vitro studies directly focused on determining the functional significance of 
mtDNA 5mCpG on mitochondrial genome processes including transcription and 
compaction is needed to clarify the in vivo results.   
Mitochondrial Reactive Oxygen Species 
Generation of mitochondrial reactive oxygen species (ROS) 
Reactive oxygen species (ROS) are free radicals, consisting of unpaired valence 
shell electrons that are highly reactive.  They form as the natural byproduct of the 
metabolism of oxygen (O2).  Some of these species include superoxide anion (O2-), 





Figure 1.14. Generation of free radicals. (A) NADH transfer electrons to complex I 
flavin mononucleotide (IF) to travel via Fe-S centers to the ubiquinone binding site 
(IQ).  Electrons at this site can react with O2 to form O2-. (Figure obtained from 
Jastroch et al., 2011).  (B) Superoxide can be generated by specialized enzymes, 
such as the nicotinamide adenine dinucleotide phosphate (NADPH) oxidases or as a 
byproduct of cellular metabolism, particularly the mitochondrial electron transport 
chain (METC). During mitochondrial respiration some electrons go directly to oxygen-
forming superoxide anion (O2•−) that leads to the production of other free radicals 
such as peroxynitrite (ONOO•) through reaction with nitric oxide (NO•), hydrogen 
peroxide (H2O2) through enzymatic dismutase by superoxide dismutase (SOD), and 
hydroxyl radical (•OH) by Fenton reaction. Singlet oxygen (1O2) is the diamagnetic 
form of molecular oxygen (O2). Redox potentials related to these cellular processes 
are adapted.  (Figure obtained from Tang et al., 2011). 
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(Winterbourn, 2008).  Most of these species are short lived, 10-9-10-6 second half-lives 
and do not cross the membrane (Halliwell and Gutteridge, 1989; Demple, 1991).   
The major source of intracellular ROS is generated in the mitochondria as a 
byproduct of ATP production (Loschen and Flohe, 1971: Loschen et al., 1973).  Under  
normal conditions, 1%-5% of 3-30 µM of O2 consumed during respiration can be 
reduced to 10-200 pM of O2- in the mitochondria (Turrens, 2003; Chance et al., 1979; 
Wei et al., 2011).  This is done in the complexes of the ETC that are inefficient at 
transporting electrons donated from NADH and succinate of the citric acid cycle.  
Specifically, in the transport of two electrons to cytochrome c, complex III (ubiquinol-
cytochrome c oxidoreductase) can develop a highly reduce ubiquinol (Q => QH2 => 
QH•) (Jastroch et al., 2011) (Figure 1.14A).  This results in leakage of one electron 
which directly reduces O2 to O2-.  The O2-  generated from complex III is released to 
either the matrix or the intermembrane space (IMS) (Figure 1.14A).  Complex I (NADH-
ubiquinol oxidoreductase) of the electron transport chain is also inefficient at transferring 
an electron from NADH and succinate to complex III via coenzyme Q (Jastroch et al., 
2011).  Leakage of the electron in complex I at either the flavin mononucleotide site (IF) 
or ubiquinone binding site (IQ) results in the reduction of O2 to O2- (Figure 1.14A).  The 
O2- generated from complex I gets released into the matrix (Jastroch et al., 2011) 
(Figure 1.14A).  Generation of both intracellular and extracellular O2- can also be 
catalyzed by nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (Suh et 
al., 1999; Dupuy et al., 1986; Graham et al., 2010) (Figure 1.14B).  Two electrons from 
NADPH are transferred to O2 which generates a proton, two O2-  and NADP+ (Figure 
1.14B).   
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The generation of two additional ROS species in the mitochondria occur because 
of the presence of superoxide dismutase (SOD) and iron (Fe).  Superoxide dismutase 
catalyzes the dismutation of O2- to form the more stable, less reactive H2O2 at a rate of 
7.6 x 105 M-1s-1 (Gray and Carmichael, 1992) (Figure 1.14B).  Copper zinc superoxide 
dismutase (Cu, Zn-SOD) generates H2O2 in the intermembrane space (Weisiger and 
Fridovich, 1973; Marklund, 1974).  Manganese superoxide dismutase (Mn-SOD) 
generates H2O2 in the matrix (Weisiger and Fridovich, 1973; Marklund, 1974; Buettner 
et al., 2008).  If iron concentrations are high the Fenton reaction occurs where H2O2  is 
converted to the highly reactive -OH species (Figure 1.14B).  Myeloperoxidase can also 
convert H2O2 to the highly reactive HOCl species. 
Other sources in the mitochondria that have been reported to leak electrons 
include the TCA cycle enzymes aconitase 2, cytochrome b5 reductase, pyruvate 
dehydrogenase, dihydroorotate dehydrogenase, glycerol-3-phosphate dehydrogenase, 
the monoamine oxidases A and B, and α-ketoglutarate dehydrogenase (Vindis et al., 
2001: Miwa and Brand, 2005; Lin and Beal, 2006: Orrenius et al., 2007; Bortolato et al., 
2008; Mracek et al., 2009).    
The many functions of mitochondrial reactive oxygen species  
The generation of normal levels of mitochondrial ROS has a function in signaling 
pathways involved in regulation of immunity, cellular differentiation, longevity, 
adaptation to hypoxia, regulation of autophagy and mitophagy (Burdon, 1996, Sena and 
Chandel, 2012).  Macrophages and neutrophils ROS are mainly derived from NADPH 
oxidase located in the macrophages and neutrophils membranes and the mitochondria.  
For macrophages, H2O2 molecules diffuse to the cytoplasm where the Fenton reaction 
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converts it to -OH that directly oxidizes the engulfed bacterial proteins, bacterial 
membrane and bacterial DNA (Slauch, 2011).  In addition, H2O2 can initiate signaling of 
receptors involved in the immune response in a ligand-dependent manner (Yang et al., 
2013).  Stem cells have lower ROS levels than normal, and it is hypothesized that 
upregulation of ROS levels is a driving force for stem cell lineage proliferation and 
differentiation (Owusu-Ansah and Banerjee, 2009; Bigarella et al., 2014).   
Increased ROS levels also regulate adaptation to hypoxic conditions.  
Specifically, ROS stabilizes the hypoxia-inducible factors that promote red blood cell 
production and new blood vessel formation (Bell at al., 2007).  ROS may have dual 
roles in autophagy (Sena and Chandel, 2012).  The first role is under normal cellular 
conditions the accumulation of ROS in aging mitochondria promote normal 
mitochondrial organelle and cellular turnover.  This allows for damage mitochondrial 
organelles to be removed and promotes cell survival.  The second role is under high 
levels of ROS controlled autophagic cell death occurs.   
The levels of ROS are tightly regulated by the main antioxidant enzymes 
glutathione peroxidases and catalase.  Catalase converts H2O2 to water and O2 
(Kirkman et al., 1999).  Glutathione peroxidases contain a selenocysteine which uses  
glutathione to reduce H2O2 (Chu et al., 1993).  Regulation of ROS is also done by the 
thiol containing enzymes peroxiredoxins and glutaredoxins (Hanschmannet al., 2013).  
Nonenzymatic reduction of ROS is done by antioxidants glutathione, vitamins C and B.  
The cellular soluble glutathione reduces H2O2 to water and O2 (Masella et al., 2005).  
Vitamin C (ascorbic acid) are scavengers of oxygen free radicals (Bunker, 1992).  Lipid 
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soluble vitamin E in the cellular membrane acts as the principle defense against ROS 
cell membrane injury (Rizvi et al., 2014).      
Elevated levels of reactive oxygen species 
Oxidative stress occurs when the rate of ROS production exceeds the ability of a 
cell’s antioxidant enzymes and antioxidant molecules to neutralize the accumulating 
ROS molecules.  Excessive levels of mitochondrial ROS can result in oxidative damage 
to mitochondrial macromolecules including lipids, carbohydrates, DNA, RNA and 
proteins (Figure 1.14) (Tang et al., 2011).  In a cascade effect, elevated levels of ROS 
oxidize carbohydrates and lipids into reactive carbonyl species.  The ROS electrophilic 
species are highly reactive towards nucleophiles in biomolecules and form byproducts 
that are not susceptible to degradation, and accumulate with age (Semchyshyn, 2014).  
Phospholipids have a very important role in mitochondrial membrane integrity.  Elevated 
levels of ROS result in increased lipid peroxidation which alters membrane structure by 
decreasing fluidity and elasticity, inactivating membrane bound proteins and ultimately 
leads to membrane destruction in the mitochondria (Wong-ekkabut et al., 2007).  
There is controversy in the field as to whether the mtDNA is particularly 
susceptible to ROS damage due to its close proximity to the ETC.  Previously it was 
believed that ROS damage mainly alters thymine into thymine glycol which has a low 
mutagenic rate (Wangner et al., 1994; Cadet and Wagner, 2013).  Thymine glycol 
blocks POLRMT from transcribing mtDNA (Hanes et al., 2006).  ROS was also believed 
to alter guanine to 8-oxo-2’-deoxyguanosine, which has a high mutagenic rate of G to T, 
A and C conversion (Hanes et al., 2006; Nakabeppu, 2014).  And finally, to a lesser 
extent ROS damage was also believed to alter cytosine to 5-hydroxycytosine and 5-
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hydroxymethyluracil (Anson et al., 1999).  However recently data has indicated that 
mtDNA is resistant to ROS damage and that the mutations that are observed in mtDNA 
are the result of replication errors by POLG (Szczepanowska and Trifunovic, 2017; 
Kauppila et al., 2017).     
Mitochondrial messenger RNA (mtRNA) and mitochondrial ribosomal RNA (mt 
rRNA) are also susceptible to oxidative damage than DNA (Nunomura et al., 1999).  
ROS damage alters uracil to 5,6-dihydroxyuracil and 5-hydroxyuracil (Anson et al 1999; 
Alexeyev, 2009).  The RNA guanine base undergoes the same alteration as it does in 
DNA.  Oxidization of RNA guanines results in reduced protein production by causing 
ribosome stalling (Shan et al., 2007).  Mitochondrial RNA oxidation has been implicated 
in a number of diseases including AD, PD, ALS, dementia and Down syndrome 
(Nunomura et al., 1999; Zhang et al., 1999; Chang et al., 2008; Kong and Lin, 2011).   
Proteins are also susceptible to oxidative damage.  Oxidation of the protein 
backbone, cleavage of the peptide backbone, oxidation of aromatic amino acid 
residues, oxidation of the sulfur containing amino acid side chains and protein-protein 
cross linkage all occur during elevated levels of ROS (Berlett and Stadtman, 1997).  
Under normal circumstances these post-translational modified proteins are degraded or 
inhibited by catalase, peroxidases and antioxidants.  Under elevated ROS levels these 
post-translational modified proteins will accumulate and contribute to the detriment of 




Reactive oxygen species cause post-translational modifications on sulfur 
containing amino acids 
 The sulfur atoms in the amino acid side chains of methionine and cysteine are 
susceptible to post-translational modification caused by oxidation.  Methionine and 
cysteine can both undergo reversible oxidation, and both have important roles in oxidant 
defense redox sensing, regulation and protein structure (Figure 1.15).  The functional 
thiol group (SH) of cysteine has a pKa value 8.2 and a redox potential of +220 mV  
(Jocelyn, 1967).  Under low levels of H2O2 cysteine oxidizes to become the reversible 
species sulfenic acid (R-SOH) (Figure 1.16A).  Sulfenic acid plays a significant role in 
protein regulation and cell signaling (Claiborne et al., 1999; Roos and Messens, 2011). 
Reduction of sulfenic acid can create intra- and inter-molecular disulfide bonds (-S-S-) 
with other thiol groups (Figure 1.15A).  Reduction of disulfide bonds and sulfenic acid 
can be performed by the dithiols, phosphite esters and cellular reductases utilizing 
glutathione and thioredoxin.  An excess of H2O2 further oxidizes sulfenic acid to the 
nonreversible species sulfinic (R-SO2H) (Figure 1.15A).  Sulfinic acid is more stable 
than sulfenic acid with a pKa value of 2.  An excess of H2O2 can further oxidize sulfinic 
acid to the irreversible species sulfonic (R-SO3H) acid with a pKa value of -3 (Figure 
1.15A).  Both sulfinic and sulfonic acid have been linked to enhancing the chaperone 
activity of the Prx family (Kumsta and Jakob, 2009; Lim et al., 2008).  Sulfonic acid also 
labels a protein for degradation (Tasaki and Kwon, 2007).   
 The methionine sulfur atom has a redox potential of +160 mV.  Under low levels 
of H2O2 methionine oxidizes to become the reversible species sulfoxide (Wood, 1981) 
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Figure 1.15. Oxidation of Methionine and Cysteine.  (A) Reversible oxidation of 
cysteine results in the formation of sulfenic acid which can be further oxidized to form 
the reversible oxidized disulfide bonds or the irreversible species sulfinic and sulfonic 
acid.  (B) Reversible oxidation of methionine results in the formation of methionine 
sulfoxide and methionine sulfonate.   
 
	 69	
methionine sulfone (Figure 1.15B).  Reduction is performed by methionine sulfoxide 
reductase A and B (Kim, 2013).  These modifications can disrupt protein function but 
can be reversed by reduction with peptidyl methionine sulfoxide reductase (Moskovitz et 
al., 1995; Moskovitz et al., 1996).  Another mechanism to avoid protein dysfunction from 
methionine oxidation is preferential degradation (Stadtman et al., 2005).   
Reactive oxygen species cause post-translational modifications on HMG proteins 
The DNA binding and bending HMGB class proteins contain both methionines 
and cysteines that have altered functions upon oxidation.  The HMGB class HMG box 1 
protein (HMGB1) is a bifunctional protein present in the nucleus and extracellular 
environment.  In the nucleus HMGB1 is a nonsequence specific chromatin binding  
factor that binds and bends DNA 85° which allows for transcription proteins to assemble 
onto nuclear DNA (Mitsouras et al., 2016).  In the extracellular environment HMGB1 
functions as an extracellular mediator for inflammatory responses (Malarkey and 
Churchill, 2012).  HMGB1 consist of a box A connected to box B by a linker, along with 
a C-terminal tail (Figure 1.15).  Under oxidative stress HMGB1 affinity towards DNA is 
decreased from a binding constant of 3 x 10-6 M to 6 x 10-6 M due to the disulfide bond 
formed between cysteine 23 and cysteine 45 and a redox potential of -237 mV 
(Kohlstaedt and Cole, 1994; Sahu et al., 2008).  Terminal oxidation of the other 
cysteine, cysteine 106 inactivates the cytokine function of HMGB1 and also inhibits 
nuclear localization of HMGB1 (Hoppe et al., 2006; Tang et al., 2007; Yang et al., 
2012).   
Another HMGB class protein is HMG-D, a Drosophila melanogaster 
chromosomal protein that binds to nonsequence specific DNA.  It is a single box HMGB  
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Figure 1.16. HMG box protein sulfur containing residues. TFAM cysteine 7, 
cysteine 204, methionine 85, methionine 92, methionine 101, methionine 173 and 
methionine 180.  HMGB1 cysteine 22, cysteine 44, cysteine 106, methionine 1, 
methionine 13, methionine 52, methionine 63, methionine 75, methionine 141.  
HMGD methionine 13 and methionine 46. Cysteines indicated by SH, and 
methionines indicated by C-S-C.  
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class protein that preferentially binds to DNA that is already bent or underwound 
(Churchill et al., 1995) (Figure 1.15).  Oxidation of HMG-D methionine 13 results in 
a decreased affinity towards DNA.   The increase in dissociation equilibrium binding 
constant of 1.4 x 10-9 M to 4.3 x 10-9 M could be the result of a decrease in the 
hydrophobicity that the extra oxygen molecule in methionine 13  imparts on the protein,  
or a perturbation in structure due to the bulky extra oxygen molecule on methionine 13 
(Dow et al., 1997).   
TFAM as a member of the HMGB class protein has 7 sulfur containing amino 
acids, cysteine 7, cysteine 204, methionine 85, methionine 92, methionine 101, 
methionine 173 and methionine 180 (Figure 1.15).  The methionine residues are 
dispersed in box B and the linker region.  The cysteine residues are located at both 
termini of the protein.  TFAM is located in the mitochondria, an organelle that is 
susceptible to an elevated environment of ROS.  TFAM sulfur containing amino acids 
could become oxidized in the mitochondrial matrix.  As TFAM has essential roles in 
mitochondrial transcription, replication and protection of mtDNA, a greater 
understanding of the functional consequences to oxidation of TFAM’s sulfur containing 









We are only in the beginning stages of understanding the variable landscape of 
mtDNA 5mCpG, and the implications of that landscape in relation to mitochondrial 
transcription regulation.  The first half of this thesis focuses on the study of the impact of 
5mCpG on human mitochondrial transcription initiation in vitro.  In Chapter III of this 
thesis, I combined classical biophysical techniques to analyze the interactions of TFAM 
to specific promoter DNA and nonspecific DNA sequences by using EMSA and FRET 
assays.  The results delineated which specific 5mCpG DNA sequence altered TFAM’s 
affinity and cooperativity.  I used EMSA to determine if 5mCpG alters nucleoid formation.  
I also used in vitro run-off transcription assays, to understand the mechanism in which 
5mCpG plays a role in mitochondrial transcription initiation.  I designed and performed all 
of these experiments.  Through these studies I gained biophysical insight into the 
implications of mitochondrial 5mCpG.  I discovered that 5mCpG alters mitochondrial 
transcription initiation in a promoter context dependent manner.  Specifically, an 
enhancement of RNA levels from 5mCpG HSP1 and diminished RNA levels from 5mCpG 
LSP were observed.  5mCpG appeared to have no effect on RNA levels from 5mCpG 
HSP2.  Interestingly, global 5mCpG did not alter nucleoid formation.  
This lab and others have studied how oxidation alters the function of HMG box 
proteins that bind to the minor groove of DNA.  As a member of this group of proteins, 
TFAM’s sulfur containing residues could be altered by oxidation.  The second half of this 
thesis focuses on the study of how oxidation can alter the abilities of TFAM to function 
in promoter recognition and nucleoid formation.  In Chapter IV I combine classical 
biophysical techniques to analyze the interaction of oxidized TFAM to specific promoter 
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DNA.  Christopher Malarkey and I generated mutants of the sulfur containing residues 
in TFAM and performed FRET.  The results revealed which specific oxidized sulfur 
containing residues in TFAM are responsible for binding and bending deficiencies.  I 
used EMSA to determine if oxidized TFAM can form nucleoid structures.  Christopher 
Malarkey designed and performed the initial studies of the FRET experiment involving 
native and oxidized native TFAM.  I designed and performed all other experiments in 
this chapter.  Through these studies I gained in vitro insight into the mechanism behind 
oxidation of TFAM’s deficiencies in bending and binding to DNA leading to an inability to 
form nucleoids.  Specifically, oxidation of the cysteine 7 and cysteine 204 to form 
intramolecular disulfide bonds and the terminal oxidation of cysteine 7 and cysteine 204 
inhibited TFAM from efficiently binding and bending promoter DNA.  The formation of 
the intramolecular disulfide bond and the terminal oxidation of cysteine 7 also abolished 
nucleoid formation, while the terminal oxidation of cysteine 204 decreased nucleoid 
formation.   
Taken together these pioneering studies offer new insight into factors that alter 
mitochondrial transcription factor A functions in the context of transcription initiation and 











Figure 1.17: Thesis premises.  The many DNA dependent processes 
the mitochondrial transcription factor A (TFAM) is involved in, in black 




MATERIALS AND METHODS 
Preparation of TFAM and Mutant Proteins 
Recombinant human wildtype TFAM (amino acid 42-246) (pTFAM) and TFAM 1-179 
(pTFAM179) plasmids were originally created by Todd Gangelhoff (Gangelhoff et al., 
2009).  Each gene was subcloned into the pDEST15 plasmid that encodes for an N-
terminal glutathione S-transferase (GST) tag.  Recombinant human TFAM mutants 
(M85L, M95L, M101L, M173L, M185L, C7S, C204S, 5ML, 2CS) were made using the 
QuickChange II XL approach (Agilent Technologies, catalogue number 200521-5) 
(Table 2.1).  I  used the manufacturer’s instructions for PCR, followed by Dpn I digestion 
to degrade the parental plasmid.  Each of the TFAM mutant plasmids (pTFAM mutants) 
were then transformed into XL10-Gold ultracompetent cells for plasmid amplification.  A 
colony from each mutant was used to inoculate LB supplemented with 100 μg/mL 
ampicillin and 7 μg/mL chloramphenicol for overnight amplification of the Escherichia 
coli (E. coli) cells containing the pTFAM mutants.  The pTFAM mutants were extracted 
from the overnight cultures using a Quiagen MiniPrep kit.  The sequences of each 
pTFAM mutant was verified.   
Each pTFAM mutants was then transformed into the E. coli strain BL21+codon. 
For overexpression, a 4 liter culture was inoculated from each glycerol stock of TFAM or 
mutant and grown for 4-8 hours at 37°C before the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) for induction.  The E. coli cells after 2-4 hours of induction 
were pelleted and resuspended in 50 mL of lysis buffer consisting of 20 mM Tris-HCl 
(pH 8.0), 1 M sodium chloride (NaCl), 1 mM ethylenediaminetetraacetic acid (EDTA), 1 
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mM dithiotheritol (DTT), 10% glycerol, protease inhibitors (Roche) and 10 mg lysozyme.  
This slurry of cells and buffer was then lysed by sonication (Fisher) at 30% power for 10 
seconds on, 5 second off for a total of 3 minutes.  DNase I (Sigma) was then added to 
the lysed E. coli cells before gently rocking at 4°C for ½-1 hour before centrifugation at 
30,000 x g for 45 minutes.  The pellet was discarded, and the cleared lysate incubated 
with glutathione sepharose (GE Healthcare) resin for 4-12 hours.   The resin was then 
washed with 500 mL of lysis buffer followed by an additional wash with 500 mL of 
cleavage buffer consisting of 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA and 
1 mM DTT.  Cleavage of the protein from the resin was done with the addition of 
PreScission Protease (expressed and purified in lab).   
TFAM or TFAM mutant proteins were then further purified using cation exchange 
chromatography (Source S, GE Health Care) with a salt gradient of 0 to 1 M. The next 
step was size-exclusion chromatography (Superdex 200, GE Health Care) using a 
buffer 50 mM Hepes-Na (pH 7.4), 150 mM NaCl, 1 mM EDTA and 1 mM DTT.  The 
oxidized (ox) oxTFAM and oxTFAM mutant proteins were made by incubating 0.01% 
H2O2 (Sigma Aldrich 30%) and purified proteins on ice for 1 hour.  A final purification 
step on the size-exclusion chromatography using buffer 50 mM Hepes-Na pH 7.4, 150 
mM NaCl and 1 mM EDTA (Superdex 200, GE Health Care) got rid of excess H2O2.  
The oxidized and reduced forms of each protein was then verified by loading 
recombinant proteins plus laemmli running buffer without SDS onto a 4-20% Mini-
PROTEAN TGX precast protein gel (Bio-Rad) with Running Buffer 250 mM Tris, 1.92 M 
glycine, 0.11% SDS and run at 120V for 1 hour.  These gels are referred to as semi-
denaturing PAGE gels.  Purified fractions of the oxTFAM and TFAM mutant proteins  
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Both C to S primers Both C to S complement 
primers
Table 2.1: Primers used in the mutagenesis of human TFAM.   
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were then stored at -80 °C.  Recombinant human POLRMT and TFB2M were 
purchased from Enzymax LLC (catalogue numbers 81 and 83). 
Preparation of DNA Used in EMSA and FRET Studies 
Single stranded (ss) 33 base oligomers that encompassed the HSP1 TFAM footprint 
region (ssHSP1 and 5mCpG ssHSP1) were purchased from Integrated DNA 
Technologies (IDT) and used in chapter III EMSA experiments (Table 2.2).  Single 
stranded 33 base oligomers that encompassed a non-site specific (NS) mtDNA 
sequence (ssNS and 5mCpG ssNS) were purchased from Integrated DNA Technologies 
(IDT) and used in chapter III EMSA experiments (Table 2.2).  Corresponding 
fluorophore labelled ssHSP1 and fluorophore labelled 5mCpG ssHSP1 and ssHSP1 
oligomers were purchased from IDT and used in chapter III FRET assays (Table 2.2).   
Fluorophore labelled ssLSP 24 that encompassed the LSP TFAM footprint region base 
oligomers were purchased from IDT and used in FRET assays in chapter IV (Table 2.2).  
Each oligomer was purified using C18 Sep-Pak cartridges (Waters).  Each C-18 
cartridge was first activated with acetonitrile and rinsed twice with water.  Each oligomer 
was then resuspended in TE buffer with 150 mM NaCl, pH 7.0 (STE) and loaded onto 
individual C-18 cartridges.  Each cartridge was then rinsed with STE buffer twice before 
a final rinse with water.  Each oligomer was then eluted from each cartridge using 60% 
methanol and dried using a speed vac.  Finally, each oligomer pellet was resuspended 
in STE for annealing.  For annealing each oligomer to its complement strand, equal 
molar amounts of oligomers and its complement were added to a 1.5 mL centrifuge tube 




























































Table 2.2: DNA oligonucleotides used in the HPLC purification. 
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The HSP1 and NS annealed DNA were purified using a DEAE anion exchange 
column (Tosahass) with a gradient of 0 to 1 M NaCl in buffer 50 mM Tris-HCl (pH 8.0) 
and 1 mM EDTA buffer.  The LSP and some of the HSP1 annealed DNA were also 
purified using a XTerra MS C18 2.5 μM 4.6x50mm column with a gradient of 4.75% to 
8% or 5% to 15% acetronitrile in 0.1 M triethylammonium acetate (TEAA).  Fractions 
with the desired products were then ethanol precipitated and resuspended in TE buffer 
(pH 8.0).  The purity of each fraction was confirmed on 10% acrylamide (37.5:1) 
nondenaturing gels and 5% acrylamide (37.5:1) 7 M urea gels. 
Preparation of pLSP3 Used in In Vitro Run-Off Transcription Assays, Electron 
Microscopy and Compaction Assays 
The pGEMPTEZLSP3 plasmid (pLSP3) containing mtDNA sequence 242-825 
was expressed in Stellar Competent dam-/dcm- cells purchased from Clontech. The 
plasmid then underwent 5mCpG using M.SssI methyltransferase (New England Biolabs).  
The modified protocol involved incubating 500ng of DNA with 1 unit of M.SssI and 64 
μM S-adenosylmethionine (SAM) for 2-4 hours incubated at 37°C, then adding an 
addition 1-2 unit of M.SssI and 128 µM SAM for 8-12 hours incubated at 37°C. The 
5mCpG and nonmethylated pLSP3 were then linearized using Nde I restriction enzyme 
(New England Biotech). The linearized DNA was purified by phenol:ether or 
phenol:chloroform extractions followed by ethanol precipitation.  A final purification step 
using either the DEAE column or PCR clean up kit (Quiagen) was necessary to remove 
excess SAM.  The efficiency of 5mCpG was verified by digestion of pLSP3 with 
restriction enzymes HpaII, MspI and McrBC (New England Biolabs) (Figure 3.5A).   
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For the run-off transcription assays, the pLSP3 plasmid was digested with EcoRI-
HF (New England Biolabs) to generate the 603 base pair ‘tri-promoter’ templates 
containing the human mitochondrial DNA sequence 242-825. The DNA was then 
treated with M.SssI methyltransferase to generate 5mCpG DNA using the modified 
protocol as stated above. The efficiency of 5mCpG incorporation was verified as stated 
above. The 603 base pair templates were then isolated by gel extraction followed by 
phenol:ether or phenol:chloropform extractions and ethanol precipitation.  A final 
purification step using either the DEAE column or PCR clean up kit (Quiagen) was 
necessary to get rid of excess SAM, a cofactor for M.SssI methyltransferase.  Followed 
by another round of ethanol precipitation.  The purified tri-promoter template was 
resuspended in STE buffer (pH 7.4) and stored at -20°C.   
Preparation of Isolated Mitochondrial DNA for Restriction Enzyme Digestion 
The Clayton and Shadel Cold Spring Harbor Laboratory protocol (CSHLP) for the 
isolation of mitochondria from cells 
(http://cshprotocols.cshlp.org/content/2014/10/pdb.prot080002.full)., was used to isolate 
mitochondrial organelles from HEK293 cells.  I then lysed the isolated mitochondria by 
freeze thawing in 100 mM Tris, 1% SDS, 2% TritionX-100, 10 mM EDTA and 100 mM 
NaCl (x3).  Centrifugation of the lysed mitochondrial organelles at 16000 rpm for 10 
minutes isolated the mitochondrial matrix.  The mitochondrial matrix was then 
phenol:chloroform or phenol:ether extracted followed by ethanol precipitation and run on 
a 1% agarose gel.  Using ethidium bromide to visualize the mitochondrial genome, I cut 
a slit on the gel below the band of the mitochondrial genome and inserted a glass fiber 
filter paper backed with dialysis tubing.  I then electrophoresed the gel until the 
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mitochondrial genome migrated into the glass fiber filter paper.  Extraction of the mtDNA 
was done by allowing the glass fiber filter paper to soak in TE buffer (pH 8.0) overnight 
at 4°C before further phenol:chloroform or phenol:ether extraction, and ethanol 
precipitated.  The final isolated mtDNA was sequenced verified using the ssHSP1 33 
base forward and complement oligonucleotides.  The mtDNA then digested with 
restriction enzymes HpaII, MspI, and McrBC (New England Biolabs).  Following the 
manufacturer’s protocol with a few modifications, 1 μg or 0.5 μg of mtDNA was 
incubated with 2 units of enzyme for 4 hours at 37°C.  The reactions were heat 
inactivated, then run on a 1.2% agarose gel and visualized using Sybr Green I dye 
(Invitrogen) on a Typhoon 8400 Imager (Molecular Dynamics).  Quantization of digested 
band intensities were measured using ImageQuant Software and graphed using Prism 
software   
Fluorescence Resonance Energy Transfer Assays 
Employing the principles of fluorescence resonance energy transfer I calculated the 
apparent dissociation constants as TFAM binds to, and bends DNA (Clegg, 1992).  
FAM (donor) fluorescence emission is at 520 nm and TAMRA (acceptor) fluorescence 
emission is at 580 nm.  Spectral overlap exists between FAM and TAMRA when a 
decrease in the fluorescence emission of FAM at 520 nm and an increase in the 
fluorescence emission of TAMRA at 580 occurs.  This overlap occurs when there is a 
decrease in the end-to-end distance between the two fluorophores.  In my system, the 
distance between the ends of the linear DNA decreases due to TFAM inducing a U turn 
on the DNA.  This results in an increase in the FRET effect.   
The FRET effect can be calculated using the equation:  
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FE	=	I490/I560	
I490 is the fluorescence emission of extracted TAMRA at 580 nm when excited at 490 
nm.  I560 is the fluorescence emission of TAMRA at 580 nm when excited at 560 nm.  
The extracted TAMRA signal is obtained by fitting the spectrum of the appropriate 3 ́-
FAM only labeled DNA excited at 490 nm to the donor region of the of the dual labeled 
DNA spectra exited at 490 nm and subtracting the fluorescence intensity of the 3 ́-FAM 
only labeled DNA from the dual labeled DNA. A plot of normalized FE vs. [TFAM] of FE 
vs. [TFAM] was then used to calculate the apparent dissociation constants (KDapp) for 
5mCpG HSP1 and nonmethylated HSP1 and LSP using the ligand depletion binding 
model equation:  
𝑌	
= 	 (𝐵𝑚𝑎𝑥	 ∗) ∗ (((𝐷𝑁𝐴 + 𝑥 + 𝐾𝑑) − 𝑠𝑞𝑟𝑡(((𝐷𝑁𝐴 + 𝑥 + 	𝐾𝑑)2) − (4 ∗ 𝑥 ∗ 𝐷𝑁𝐴)))/(2
∗ 𝐷𝑁𝐴))) 
and cooperative binding model (Hill):  
𝑌	 = 	 (𝐵𝑚𝑎𝑥 ∗ 𝑥𝑛)/(𝐾𝑑𝑛 + 𝑥𝑛) 
The Bmax is the maximum intensity of the FRET effect, the KDapp is the apparent 
dissociation constant (mol/L) and n is the cooperativity measurement.  The magnitude 
of the FRET effect for DNA template only compared to DNA bound to TFAM can 
indicate if the final change in end-to-end distance is different.       




The values of εFAM490/εTAMRA560 and εTAMRA490/εTAMRA560 are constants, 0.511 
and 0.112 for LSP, 0.811 and 0.211 for HSP1 and 0.801 and 0.401 for 5mCpG HSP1.  
Using the value of E one can then solve for Dr, the Forster radius between the two 
fluorophores.   
Dda	=	((1/E)-1)1/6)Dr	
The Dda in absence of protein was 82.3 Å for LSP, 108.89 Å for HSP1 and 110.61 Å for 
5mCpG HSP1.  The Dda for LSP was 58.72 Å, HSP1 was 48.18 Å and 5mCpG HSP1 was 
47.03 Å with TFAM at full occupancy.  Change in Dda (∆ Dda) describes change in end-
to-end distance of the DNA, thus degree in which the DNA is bent.  Under the 
assumption that TFAM will bend the DNA, the estimated bend angle can then be 
calculated using the equation:  
Bend	angle	=	2cos-1	(Dda/oDda)	
Dda is the end-to-end distance with TFAM present and oDda is the end-to-end distance 
for DNA only.   
FRET assays were performed with 3.4 nM of either nonmethylated HSP1 dual 
fluorophore labeled or 5mCpG HSP1 dual fluorophore labeled DNA, and increasing 
concentration of TFAM (0 nM, 0.63 nM, 1.25 nM, 1.88 nM, 2.5 nM, 3.13 nM, 3.75 nM, 
4.38 nM, 5.00 nM, 5.63 nM, 6.25 nM, 6.88 nM, 7.50 nM, 8.13 nM, 8.75 nM, 10.0 nM, 
12.5 nM, 15.0 nM, 20.0 nM, 25.0 nM, 30.0 nM, 35.0 nM, 40.0 nM, 45.0 nM and 50.0 nM) 
at 20°C.  Each reaction contained 50 nM HEPES-Na (pH 7.4), 150 mM NaCl and 1 mM 
DTT.  On the Horiba Fluorolog 3 spectrofluorimeter , the experiments were performed at 
20 °C in a 1 ml quartz cuvette with a 0.4 cm path length.  Excitation and emission 
bandpasses were 4 nm and 7 nm.   
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FRET assays were also performed with 3.4 nM of LSP dual fluorophore labeled 
DNA (Table 2.3), and increasing concentration of TFAM (0 nM, 2.5 nM, 5 nM, 7.5 nM, 
10 nM, 12.5 nM, 15 nM, 20 nM, 25 nM, 30 nM, 40 nM and 50 nM).  Each reaction 
contained 50 nM HEPES-Na (pH 7.4), 150 mM NaCl and 1 mM DTT.  On the Horiba 
Fluorolog 3 spectrofluorimeter , the experiments were performed at 20 °C in a 1 ml 
quartz cuvette with a 0.4 cm path length.  Excitation and emission bandpasses were 4 
nm and 7 nm.   
Electrophoretic Mobility Shift Assays 
Quantitative electrophoretic mobility shift assays (EMSA) were used to determine 
the KDapp . These EMSAs were performed using either 10 nM 5mCpG HSP1 or 10 nM 
HSP1.  Various increasing concentrations of TFAM were added (0 nM 1.0 nM, 2.0 nM, 
3.0 nM, 4.0 nM, 5.0 nM, 6.0 nM, 7.0 nM, 8.0 nM, 9.0 nM, 10.0 nM, 15.0 nM, 20.0 nM, 
25.0 nM and 30.0 nM).  Each 10 μl EMSA reaction contained Binding Buffer 2 μg/ml 
BSA, 20 mM HEPES-Na (pH 7.5), 50 mM KCl, 2 mM MgCl2.  The reactions incubated 
on ice for 45 minutes before loading into a pre-run 8% native polyacrylamide gel 
(37.5:1, acrylamide: bis-acrylamide) and run for 45 minutes on ice.  SYBR Green I 
nucleic acid gel stain (Invitrogen) was used to visualize the bands on the EMSA and the 
images were taken using the Typhoon 8400 Imager (Molecular Dynamics).  The 
intensity of each band was measured using ImageQuant Software, and after 
background subtraction, the fraction of DNA bound was calculated, fitted with the Hill 
equation:  
(𝑌 = ([𝑃]W/KD)/(1 + [𝑃]W/KD)) 
and graphed using Prism software. 
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Stoichiometric EMSA was performed with increasing concentrations of TFAM (0 
nM, 50 nM, 100 nM, 200 nM, 300 nM, 400 nM, 500 nM, 600 nM, 700 nM and 800 nM) 
incubated with either 100 nM 5mCpG NS or 100 nM NS.  Each 10 μl EMSA reaction 
contained Binding Buffer 2 μg/ml BSA, 20 mM HEPES-Na (pH 7.5), 50 mM KCl, 2 mM 
MgCl2.  The reactions incubated on ice for 45 minutes before loading into a pre-run 8% 
native polyacrylamide gel (37.5:1, acrylamide: bis-acrylamide) and run for 45 minutes 
on ice.  SYBR Green I nucleic acid gel stain (Invitrogen) was used to visualize the 
bands on the EMSA and the image was taken using the Typhoon 8400 Imager 
(Molecular Dynamics).  Quantitation of each stoichiometric EMSA band intensities was 
used to calculate the fraction DNA bound in each shifted band and the results were 
graphed using Prism software.   
Electron Microscopy and Electrophoretic Mobility Shift Assays 
For electron microscopy images, 1 nM linearized 5mCpG or nonmethylated pLSP3 
DNA was incubated at room temperature for 30 minutes with varying concentrations of 
TFAM (0 nM, 60 nM, 90 nM, 120 nM or 240 nM, corresponding to 0, 1:60, 1:45, 1:30 
and 1:15 TFAM:DNA base pair coverage, which also corresponded to 0% coverage, 
50% coverage, 75% coverage, 100% coverage and 200% coverage of DNA by TFAM) 
in 10 μL reactions containing 20 mM HEPES-Na (pH 7.5), 50 mM KCl, 2 mM MgCl2.  
Samples were then diluted 1:1 with 4 mM Mg-acetate and applied to glow discharged 
EM grids.  Samples were then washed with 4 mM Mg-acetate before staining with 
0.02% (wt/vol) uranly acetate.  Grids were then imaged on a JEOL 1230 (or JEOL 1200) 
transmission electron microscope (Peabody, MA) with a Gatan digital camera at a 
magnification of 120,000x. 
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The remaining samples from each independent replicate EM experiment were run 
on a 0.8% agarose gel (SeaKem Gold agarose, Lonza) and then visualized using SYBR 
Green I nucleic acid stain (Invitrogen) on a Typhoon 9400 Imager (Molecular 
Dynamics).  Migration of each DNA:protein complex was measured using ImageJ 
software.  These values were analyzed by subtracting the migration distance of the free 
DNA from those of the TFAM:DNA complexes.   
For the oxTFAM mutant study, 1 nM linearized nonmethylated pLSP3 DNA was 
incubated at room temperature for 30 minutes with varying concentrations of TFAM (0 
nM, 60 nM, 90 nM, 120 nM or 240 nM, corresponding to 0, 1:60, 1:45, 1:30 and 1:15 
TFAM:DNA base pair coverage, which also corresponded to 0% coverage, 50% 
coverage, 75% coverage, 100% coverage and 200% coverage of DNA by TFAM) in 10 
μL reactions containing 20 mM HEPES-Na (pH 7.5), 50 mM KCl, 2 mM MgCl2.  These 
samples were run on a 0.8% agarose gel (SeaKem Gold agarose, Lonza) and then 
visualized using SYBR Green I nucleic acid stain (Invitrogen) on a Typhoon 9400 
Imager (Molecular Dynamics).  Migration of each DNA:protein complex was measured 
using ImageJ software.  These values were analyzed by subtracting the migration 
distance of the free DNA from those of the TFAM:DNA complexes. 
In Vitro Run-Off Transcription Assays  
ssLSP 88 base pair template (position 390-477) that encompassed the LSP MTIC 
footprint with and without the 5mCpG modification was ordered from IDT, annealed and 
purified using a DEAE column under the same conditions as stated in preparation of 
DNA used in EMSA and FRET section.  The LSP88 fractions were ethanol precipitated 
and stored in STE (pH 7.4) at -20°C.   
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Transcription reactions for both LSP88 templates and the tri-promoter templates 
containing 10 mM Tris-Cl (pH 8.0), 10 mM MgCl2, 100 µM DTT, 100 µg/mL BSA, 400 
µM ATP, 150 µM CTP, 150 µM GTP, 10 µM UTP, 0.2 µM 32P UTP, 3.4 nM template 
DNA and 4 units of RNAaseOut (InVitrogen) were incubated with 16 nM POLRMT, 16 
nM TFB2M and varying concentrations of TFAM (0 nM, 6.8 nM, 16 nM, 34 nM, 51 nM, 
68 nM or 136 nM) at 32 °C for 3 hours.  All reactions were stopped with the addition of 
100 µL stop buffer that contains 10 mM Tris-Cl (pH 8.0), 0.2 M NaCl, 0.5% SDS and 
22.5 µg proteinase K.  Transcription reactions were then ethanol precipitated and 
resuspended in loading buffer that contains 98% formamide, 10 mM EDTA (pH 8.0), 
0.025% xylene cyanol and 0.025% bromophenol blue.  Samples were run on an 8% 
polyacrylamide/7M urea gel for the tri-promoter template and 20% polyacrylamide/7M 
urea gel for the LSP88 template.  Visualization of transcripts was done on a phosphor 
screen using the Typhoon 9400 Imager (Molecular Dynamics). An RNA ladder 
(RiboRuler Low Range, Thermo Fisher) was used to verify transcription sizes for the tri-
promoter template.  RNA ladder (Decade Marker, Thermo Fisher) was used to verify 
transcript sizes for the LSP88 template. For an internal loading control, the DNA 
template was quantitated from SYBR Green II nucleic acid staining (Invitrogen) of the 
same gel.  Loading was consistent and essentially no corrections were needed.   
Due to the variation of pixel intensities of 32P-UTP in each independent 
autoradiogram, different exposure and specific activity variations between gels had to 
be normalized using a scale factor that Mair Churchill devised.  The scale factor was 
randomly assigned to autoradiogram 1 and then applied to autoradiogram 2 and 3.  For 
each promoter transcript the average intensity over lanes 1-7 were calculated from the 
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nonmethylated templates to give ILSP#1, IHSP#1, IHSP2#1, ILSP#2, etc.  Normalization to #1 for 
each promoter transcription gave  
ILSP#1/	ILSP#1=	1,	ILSP#1/	ILSP#2	=	#2	scale,	ILSP#1/	ILSP#3	=	#3	scale 
and the same for HSP1 and HSP2.  Finally, the average scale factor for each gel was 
calculated as #2: 
scale	factor	=	(#2scaleLSP	+	#2scaleHSP1	+	#2scaleHSP2)/3	
Now the scale factors for #2 and #3 were applied to integrated intensities of every band 
in #2 and #3 and the generation of raw pixel intensity scaled to nonmethylated DNA vs 
TFAM concentration.   
Transcription reactions for oxTFAM mutants were set up using the same conditions 
using the tri-promoter template, except TFAM concentrations were kept constant at 16 
nM .  Reactions were run on a 8% polyacrylamide/7M urea gel.  Visualization of 
transcripts was done on a phosphor screen using the Typhoon 9400 Imager (Molecular 
Dynamics).    
Matrix Assisted Laser Desorption/Ionization Time of Fight Mass Spectrometer 
 To determine the molecular weights of the oxidized TFAM protein and the mutant 
oxidized TFAM proteins 0.5-1 mg/mL of protein was acidified with 1% trifluoroacetic 
acid.  Each µ-C18 Zip Tip (Millipore) was washed with 100% acetonitrile (x2) followed 
by 1% trifluoroacetic acid (x2) before the addition of the acidified protein.  Each acidified 
protein was pipetted (x10) into the Zip Tip to allow for optimal binding.  Each Zip Tip 
was then washed with 0.1% trifluoroacetic acid (x2) , followed by 10% methanol (x2).  
Each protein was eluted from the Zip Tip using 80% acetonitrile in 0.1% trifluoroacetic 
acid (x2).  Finally, 0.5 µL of eluted protein and 0.5 µL of sinapinic acid was placed on 
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the MALDI plate.  Each sample was allowed to evaporate before performing MALDI-
























CYTOSINE METHYLATION OF MITOCHIONDRIAL DNA AT CpG SEQUENCES 




The field of reversible mtDNA 5mCpG is coming out of its infancy but continues to 
be a controversial topic (Maresca et al., 2015) (Appendix Table 1.2 and 1.3). Numerous 
techniques from restriction enzyme digestion and thin-layered chromatography in the 
early days to bisulfite conversion, Me-DIP, ELISA, and mass spectrometry have been 
used.  However, an underlying issue has been the limit of detection for most of these 
techniques are within the range that the majority of mtDNA 5mCpG occurs (2%-10%) 
(van Der Wijst et al., 2015; Margulis et al., 1970; Woischnik et al., 2002) (Appendix 
Table 1.3).  Additional evidence in support of reversible mtDNA 5mCpG is accumulating 
with the identification of human DNMT1, DNMT 3A and 3B, and human TET 1 and 2 in 
the mitochondria (Shock et al., 2011; Chen et al., 2012; Dzitoyeva et al., 2012; Wong et 
al., 2013; Bellizzi et al., 2013; Mishra and Kowluru, 2015; Ren et al., 2017).  Isoform 3 of 
human mtDNMT1 directly associates with mtDNA (Saini et al., 2017).  In addition, 
chemical knockdown and genetic knockout of DNMTs and TETs correlate to a reduction 
of mtDNA 5mCpG levels (Feng et al., 2012; Bellizzi et al., 2013; Gao et al., 2015; Tong 
et al., 2017; Sun et al., 2018).   
In the nucleus the DNMTs and TETs are responsible for reversible 5mCpG.  
Nuclear 5mCpG plays a crucial role in repressing and mediating gene expression.  N-
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terminal histone modifications including methylation, acetylation and phosphorylation 
work in conjunction with nuclear 5mCpG and methyl binding proteins to form 
heterochromatin that regulate gene expression (Felsenfeld et al., 2003).  Nuclear 
5mCpG also directly alters the protein-DNA specific interactions involved in transcription 
initiation which can lead to transcription repression or enhancement (Machado et al., 
2015; Zhu et al., 2016).  In contrast, the mitochondria lack histones.  Instead, TFAM 
protects and compacts the multi-copied mtDNA into nucleoid complexes (Bogenhagen 
et al., 2003; Legros et al., 2004; Wang et al., 2006; Bonawitz et al., 2006).  TFAM is 
also involved in coordinating mtDNA transcription and replication initiation (Campbell et 
al., 2012).  
It does so by functioning as a transcription factor.  TFAM binds to each of the 
three promoter (tri-promoter) sites located in the D-loop and induces a stable U-turn for 
the recruitment of POLRMT and TFB2M (Rubio-Cosials and Sola 2013).  The 
mitochondrial genome has 5 CpGs sites located in the tri-promoter region that have 
been reported to be 5mCpG (Bellizzi et al., 2013; Armstrong et al., 2016; Sun et al., 
2018) (Figure 3.7A).  Interestingly 3 out of the 5 tri-promoter CpG sites are located at 
TFAM binding sites on HSP1 and HSP2 (Figure 3.7A).  Numerous papers have 
reported altered levels of mtDNA 5mCpG in cancers, neurodegenerative diseases, 
diabetes, nonalcoholic fatty liver disease and aging corresponding to altered mtRNA 
levels, however a direct causal link has not been identified (Bianchessi et al., 2016; 
Yamazaki et al., 2016; Blanch et al., 2016; Jia et al., 2016; Mishra et al., 2015; Gao et 
al., 2015; Dzitoveva et al., 2012) (Appendix Table 1.3).   
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In this study I propose to investigate the direct impact of mtDNA 5mCpG on 
mitochondrial transcription initiation, using an in vitro approach.  To confirm that mtDNA 
contains 5mCpG I performed 5mCpG sensitive restriction enzyme digestion on isolated 
mtDNA from HEK293 cells.  To gain insight into the interaction of TFAM with 5mCpG 
promoter DNA I used a combination of FRET and EMSA assays.  To gain insight into 
the nucleoid formation of 5mCpG DNA I used electron microscope studies in conjunction 
with EMSA.  Finally, I used in vitro run-off transcription assays to determine the impact 
of 5mCpG on transcription initiation.  My results confirmed that 5mCpG exist in mtDNA.  
My results also revealed that 5mCpG at the promoter regions led to an enhancement of 
transcription initiation from 5mCpG HSP1 and diminished transcription initiation from 
5mCpG LSP.  In addition, 5mCpG appeared to have no effect on transcription initiation 
from 5mCpG HSP2.  Finally, my results revealed that global 5mCpG did not alter nucleoid 
formation.     
Results 
Mitochondrial DNA is 5mCpG 
To address the controversy in the field that 5mCpG may or may not exist, pure 
mtDNA extracted from HEK293 cells was used to perform 5mCpG sensitive restriction 
enzyme digestion.  HpaII and Msp1 recognize the same cut site -CpCpGpG-, however 
HpaII is sensitive to -Cp5mCpGpG-.  McrBC is unique in that it will cleave -Pu5mC(N40-
3000)Pu5mC-. The restriction enzyme digestion assay revealed that MspI digested 
100% of mtDNA, however HpaII only digested 90-94% of mtDNA (Figure 3.1A and B).  
The mtDNA -CpCpGpG- sites from HEK293 cells are either 100% methylated or 100% 










































Figure 3.1: mtDNA contains 5mCpG.  (A) Digestion of purified mtDNA  with 5mC 
sensitive restriction enzymes, HpaII and McrBc.  Extended 1kb DNA ladder in lane 5 
and 1kb DNA ladder lane 6.  (B) Quantification of the undigested band from HpaII 
and MspI (n=3; error bars ± SD.).   
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half sites of Pu5hmC are present in the DNA.  I observe a smearing effect on my mtDNA 
migration with McrBC digestion indicating that there are Pu5hmC nucleotides in HEK 293  
mtDNA (Figure 3.1C).  My findings are consistent with an earlier publication in which 
isolated human fibroblast mtDNA was digested with HpaII and MspI (Shookler et al., 
1983).  The results indicated that 2-10% of the genome had 100% methylation of -
CpCpGpG- sites (Shookler et al., 1983). 
5mCpG methylation of the HSP1 increases the DNA binding affinity of TFAM  
5mCpG has been observed in the D-loop, which contains the sequences that 
direct transcriptional initiation (Bianchessi et al., 2016) (Figure 1.13). The 1,124 base 
pair D-loop contains the three mitochondrial promoters, LSP, HSP1 and HSP2 (Figure 
1.4). HSP1 directs the transcription of the 12S and 16S rRNAs and HSP2 directs all of 
the protein-encoding genes except for ND6 and 5 tRNA genes, which are transcribed 
from the LSP (Bonawitz et al., 2006; Gaspari et al., 20004).  In somatic cells nuclear 
CpG islands appear to be primarily protected by transcription factors and have essential 
functions in the regulation of DNA methylation (Aimee and Bird, 2011).  Specifically, 
DNMTs bind to certain transcription factors to target DNA for 5mCpG (Moore et al., 
2013).  Conversely, 5mCpG is known to directly inhibit and alter the specificity of 
transcription factor DNA binding (Watt and Molloy 1988; Yin et al., 2017). There are 2 
CpG sites located within the HSP1 TFAM 30 base pair footprint binding site, and both 
have been reported to be methylated (Figures 3.2, Figure 1.13).  
To determine whether the DNA bending and binding of TFAM was altered by 
5mCpG, I used a FRET assay to measure the binding affinity of TFAM to the HSP1 and 







Figure 3.2: TFAM has increased affinity towards 5mCpG HSP1.  (A) TFAM HSP1 
footprint sequence.  (B) Representative FRET fluorescence emission spectra of 
3.4nM FAM/TAMRA labeled HSP1 and 5mCpG HSP1 as TFAM was titrated (0-50 








Figure 3.3: TFAM has increased affinity towards 5mCpG HSP1.  (A) 
Representative EMSA of 10nM HSP1 as TFAM was added (0-30 nM).  (B) 
Representative EMSA of 10nM 5mCpG HSP1 as TFAM was added (0-30 nM).  (C)  
Binding curve of normalized fraction bound DNA vs [TFAM] (n=3; error bars ± SD.).  
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HSP1 that were labeled with a fluorescein (FAM) donor fluorophore on the 3¢ end of one 
strand and a tetramethylrhodamine (TAMRA) acceptor fluorophore on the other strand.   
Due to TFAM’s ability to bend the DNA, the reduced distance between the fluorophore 
pair resulted in a large FRET effect (Figure 3.2B), in which the donor signal at 520 nm 
decreased and the acceptor signal at 580 nm increased. The apparent binding affinity 
(KDapp) of TFAM for HSP1 was 7.7 ± 0.3 nM and for 5mCpG-HSP1 it was 3.3 ± 0.3 nM 
(Figure 3.2C). The magnitude of the FRET effect at full protein-DNA occupancy was 
similar for both templates, indicating no major change in the final DNA end-to-end 
distance.  The calculated Hill coefficients for overall DNA binding were 2.2 ± 0.4 for 
5mCpG-HSP1 and 1.6 ± 0.3 for HSP1. 
Next, I carried out electrophoretic mobility shift assays (EMSA) using the same 
DNA sequence, but without fluorophore labeling (Figure 3.3).  The addition of increasing 
concentrations of TFAM caused distinct shifted bands for both HSP1 and 5mCpG-HSP1 
DNA (Figure 3.3A and B). The EMSA binding affinities (KDapp) of TFAM for HSP1 was 
11.3 ± 2.2 nM and for 5mCpG-HSP1 was 8.1 ± 0.3 nM (Figure 3.3C). Interestingly, a 
second shifted band appeared in the EMSA at lower concentrations of TFAM for the 
5mCpG-HSP1 lanes compared to HSP1, even though the calculated Hill coefficients for 
overall DNA binding were 2.4 ± 0.4 for 5mCpG-HSP1 and 2.5± 0.4 for HSP1 in the 
EMSA assay. Together these results show that TFAM binds with a higher affinity to 
HSP1 when it is methylated at CpG sites, and points to a difference in the formation of 




Oligomerization properties of TFAM are influenced by 5mCpG 
TFAM is known to oligomerize onto nonspecific DNA as part of its mechanism for 
compacting DNA. TFAM binds to single DNA binding sites inducing a “U-turn” shaped 
144° bend which promotes protein-protein interactions that stabilize the higher order  
complexes (Rubio-Cosials and Sola 2013; Malarkey et al., 2012; Rubio-Cosials et al., 
2011; Ngo et al., 2011; Ngo et al., 2014). Therefore, examination of the oligomerization 
properties of TFAM using stoichiometric EMSA with the HSP1 DNA was performed 
(Figure 3.4). At concentrations of DNA above the KDapp, TFAM binding to HSP1 DNA 
gives rise to a population of higher order complexes. The stoichiometric EMSA with 
DNA:TFAM ratios from 1:0 to 1:8 revealed three major complexes 1, 2 and 3 (Figure 
3.4A, B, C and D). A plot of the fraction bound of each complex as a function of TFAM 
concentration showed a clear preference of TFAM to form the higher-order complexes 
at lower DNA:TFAM ratios for the 5mCpG-HSP1 DNA (compare Figure 3.4A and B blue, 
red and green lines). However, as seen from the fraction of free DNA remaining at each 
concentration (black line), as expected the overall fraction bound was the same for both 
HSP1 and 5mCpG-HSP1. These results show that 5mCpG of the HSP1 provides an 
environment which enhances the multimerization of TFAM on DNA.  
In addition to the recognition of specific promoter sequences, TFAM condenses 
mtDNA to form the mitochondrial nucleoid (Ngo et al., 2014; Kukat et al., 2015). To 
accomplish this, TFAM coats the mtDNA using a non-sequence specific DNA binding 
mode that is highly cooperative (Malarkey et al., 2012; Ngo et al., 2014; Kukat et al., 
2015; Wong et al., 2009). Therefore, I used a stoichiometric EMSA to determine 







Figure 3.4: TFAM has increased multimerization towards 5mCpG HSP1, but not 
NS.  (A) Representative EMSA of 100nM HSP1 as TFAM was added (0-800 nM).  
(B) Representative EMSA of 10nM 5mCpG HSP1 as TFAM was added (0-800 nM).  
(C) Representative EMSA of 100nM NS as TFAM was added (0-800 nM). (D) 
Representative EMSA of 100nM 5mCpG NS as TFAM was added (0-800 nM). On the 
right are the graphs for fraction free DNA and fraction bound DNA vs TFAM plots.  
(n=3; error bars ± SD.).  
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formation of higher order TFAM-DNA complexes. The designed 33 base pair sequence 
from the mitochondrial 16S RNA gene has CpG sites located at identical positions to 
that of HSP1. The EMSA with NS and 5mCpG-NS DNA showed no difference in the 
formation of higher order TFAM-DNA complexes (Figure 3.4C and D). In addition, the 
complexes were not as well defined as they were for the HSP1 DNA. These results 
suggest that 5mCpG in short non-sequence specific DNA does not alter TFAM 
multimerization, unlike the HSP1 for which higher order complexes are influenced by 
the 5mCpG.  
5mCpG has no significant impact on TFAM-induced DNA condensation 
TFAM condenses the 16,569 base pair mtDNA to form nucleoids (Kaufman et al., 
2007; Ngo et al., 2011; Kukat et al., 2015). Assuming a TFAM binding site size of 30 bp, 
552 TFAM molecules would bind to a single mtDNA (Farge et al., 2012). However, the 
TFAM-DNA ratio varies in cells; for example, in HeLa cells between 900-1700 
molecules of TFAM can associate with a single mtDNA (Alam et al., 2003; Fisher and 
Clayton, 1988). Thus, oligomerization of TFAM on a short 33 base pair DNA fragment 
does not mimic the physiologically relevant scenario of mtDNA nucleoid formation. 
Therefore, I investigated DNA compaction using an established model system for 
mtDNA nucleoid formation using EMSA compaction assays and electron microscopy 
(Kaufman et al., 2007). For these experiments I used a 3,600 base pair linearized 
plasmid (pLSP3) containing 583 base pair of the mtDNA D-loop region (Shutt et al., 
2010). The pLSP3 plasmid was purified from a dam–dcm–strain of E. coli, linearized and 
methylated to completion at CpG sites using SssI methytransferase (Figure 3.5A). 







Figure 3.5: Nucleoid formation is unaltered by global 5mCpG.  (A) Representative 
agarose gel of confirming 100% 5mCpG of pLSP3 by digestion with HpaII and MspI. 
(B) EMSA of nucleoid formation with 10 nM pLSP3 as TFAM was added (0-240 nM).  
The reactions included DNA alone (lane 1 and 6), and DNA bound to TFAM, at the 
following ratios: TFAM:DNA = 1:60 bp (lane 2 and 7), TFAM:DNA = 1:45 bp (lane 3 
and 8), TFAM:DNA = 1:30 bp (lane 4 and 9), and TFAM:DNA = 1:15 bp (lane 5 and 
10), which are equivalent to estimated DNA coverage by TFAM of 50%, 75%, 100% 
and 200%, respectively. CpG-LSP3 is shown in lanes 1-5 and 5mCpG-LSP3 is shown 
in lanes 6-10. (C) Bar graph shows the quantitation of the difference in 
electrophoretic mobility of each band from (panel A) compared to the free DNA. (n=3; 






Figure 3.6: Verification of nucleoid formation by EM.  (A) Representative EM 
images of TFAM compacting DNA.  Samples were the same as those from figure 
3.5B.  (C) Average diameter of nucleoid from TFAM:DNA = 1:30 bp indication 100% 
coverage. Average diameter of nucleoid from TFAM:DNA = 1:15 bp indication 200% 
coverage. (n=50; error bars ± SD.).  
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ratios of TFAM:DNA base pairs, the complexes exhibit decreased electrophoretic 
mobilities (Figure 3.5B). Quantitative analyses of the EMSA revealed no statistically 
significant difference between the 5mCpG and nonmethylated pLSP3 DNA in the 
distance the complexes migrated through the gel (Figure 3.5C). I also examined the  
samples from the same EMSA experiments using transmission electronic microscopy to 
illustrate the degree of DNA compaction at each TFAM:DNA ratio (Figure 3.6A and B). 
These results demonstrate that 5mCpG of DNA does not alter TFAM-dependent 
condensation of DNA into nucleoids. 
5mCpG influences mitochondrial transcription in vitro 
Mitochondrial transcription initiation requires three proteins, TFAM, POLRMT and 
TFB2M (Bonawitz et al., 2006). TFAM binds to the specific LSP, HSP1 and HSP2 sites, 
which facilitates the recruitment of the POLRMT and TFB2M to form transcription 
initiation complexes (Figure 3.8A) (Morozov et al., 2015). To test whether 5mCpG in the 
promoter regions of LSP, HSP1 and HSP2 alter mitochondrial gene expression, I 
performed in vitro run-off transcription assays. The pLSP3 plasmid includes the 
promoter region of the mitochondrial DNA D-loop, corresponding to nucleotides 242-825 
of the mtDNA. After excision from pLSP3, the resulting 603 base pair DNA is an 
established tri-promoter template for in vitro run-off transcription assays (Shutt et al., 
2010; Malarkey et al., 2012) (Figure 3.7A).  Run-off transcription assays were 
performed with tri-promoter templates that were either nonmethylated or completely 
5mCpG  (Figure 3.7B).  
Transcription occurs in the context of the mitochondrial nucleoid, which is coated 
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Figure 3.7: Transcription initiation is altered in a promoter context dependent 
manner.  (A) Schematic of tri-promoter region with 5mCpG depicted as lollipops and 
sizes of RNA from HSP1, HSP1 and LSP.  (B) Representative autoradiogram of in 
vitro run-off transcription reactions. The increasing TFAM concentration (0-136 nM) is 
indicated by the triangle. Arrows identify the three transcription products. (C) Graphs 
for the LSP, HSP1, and HSP2, quantification of transcripts levels for the combined 
data from raw images that have been scaled to the nonmethylated DNA . (n=3; error 










Figure 3.8: Transcription initiation is altered for 5mCpG LSP88.  (A) Schematic of 
LSP88 promoter region with 5mCpG depicted as lollipops and sizes of RNA from LSP.  
(B) Representative autoradiogram of in vitro run-off transcription reactions. The 
increasing TFAM concentration (0-136 nM) is indicated by the triangle. (C) Graph for 
the LSP, quantification of transcripts levels for the combined data from raw images 
that have been scaled to the nonmethylated DNA . (n=3; error bars ± SD.).  
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concentrations of TFAM. As a function of TFAM concentration, all of the templates 
showed a gradual increase of RNA products from the LSP, HSP1 and HSP2 promoters 
(lanes 3-8 and lanes 12-16) to a point at which additional TFAM results in decreased 
production of transcripts (lanes 8 and 17) (Figure 3.7B). This is commonly observed and  
attributed to potential competition between TFAM fully coating the DNA and the 
preinitiation complex formation in vitro, which results in decreased transcription in vivo 
(Shutt et al., 2010; Furukawa et al., 2012; Farge et al., 2014). In the comparison of 
transcription from the 5mCpG to the nonmethylated template, there is an enhancement 
of 2.4-fold for 5mCpG HSP1 transcription, for 5mCpG LSP there appears to be a 70% 
decrease in transcript levels and for  5mCpG HSP2 transcript levels were not significantly 
altered (Figure 2.7C).   
 Although HPS1 and LSP promoters are impacted by 5mCpG, HSP1 is the only 
promoter that has CpG at well-defined positions in the TFAM binding site. For LSP, the 
only CpG is located in the POLRMT/TFB2M binding region, not the TFAM binding site 
(Figure 3.7A). The 5mCpG in the POLRMT/TFB2M binding region of could be repressing 
LSP transcription independent of the 2 5mCpG at TFAM HSP1 binding site in the tri-
promoter context.   To isolate this region from the tri-promoter context, I investigated the 
impact of 5mCpG on transcription from the LSP alone in a shorter, 88 bp single promoter 
template (LSP88) (Figure 3.8A). Surprisingly, 5mCpG enhanced transcription 2-fold in 
this context (Figures 3.8B and C). Therefore, the impact of 5mCpG shows some context 
dependence in vitro and impacts transcription whether it is located in the TFAM binding 






Figure 3.9: X-ray crystal models of the mitochondrial transcription initiation 
complex. (A) TFAM (green), HSP (grey), blue intercalating DNA nucleotides, red 
highlights the 5mCpG locations (PDB ID 6ERP). (B) TFAM (green), POLRMT (red), 
TFB2 (purple) and LSP (grey) in complex, red highlights the 5mCpG locations. (PDB 
ID 6ERP).    
 
	 109	
The crystal structures of mitochondrial transcription initiation complexes and 
TFAM-DNA complexes provides a context for the CpG sequences examined here. The 
structure of TFAM bound to the HSP1 shows the typical U-turn (Nog et al., 2014). 
Strikingly, the CpG sites are located one base pair away from each of the sites where 
TFAM intercalates the DNA (Figure 3.9A). The structure of the mitochondrial  
transcription initiation complex containing TFAM, TFB2M and POLRMT was produced 
using the LSP DNA with substitutions designed to promote the formation of an “open-
bubble” at the transcription start site (Hillen et al., 2017) (Figure 3.9B). One cytosine of 
the CpG is in the double-stranded region 5¢ to the open bubble, whereas the other C 
has been replaced with a T and is not base-paired. Thus, in the transcription initiation 
complex structure, this CpG is located precisely at the junction between the duplex DNA 
and the open-promoter (Figure 3.9B).  
Discussion 
In this study I examined the effects of 5mCpG on the TFAM-dependent processes 
of nucleoid formation and transcription initiation. FRET and quantitative EMSA assays 
revealed that TFAM had a 2.4-fold enhancement in binding affinity towards 5mCpG 
HSP1 which contains two 5mCpG sites.  Enhanced multimerization of TFAM was specific 
to 5mCpG HSP1 only and not observed for nonspecific 5mCpG DNA, as revealed by 
stoichiometric EMSAs.  The enhanced multimerization of TFAM on 5mCpG HSP1 did not 
extend to all other nonspecific 5mCpG DNA sequences that TFAM would encounter 
upon nucleoid formation.  Thus, nucleoid formation is unaltered by longer 5mCpG DNA. 
5mCpG also had an impact on transcription in a promoter-context dependent manner. 
Finally, I confirmed that the mtDNA exhibits a nonrandom distribution of -C5mCGG- sites 
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using an isoschizomer pair of methylation sensitive restriction enzymes.  These findings 
reveal a new mechanism of 5mCpG regulating mitochondrial transcription that is distinct 
from the role of 5mCpG in nuclear transcription.  
Mechanism of 5mCpG on TFAM-dependent processes 
Biophysical studies on the structural impact that 5mCpG has on DNA have 
revealed that 5mC enhances the stabilization of base stacking relative to cytosine and 
increases the rigidity of B-DNA (Sowers et al., 1987; Mirsaidov et al., 2009).  Multiple 
5mCpG increases the stability of double helix DNA, thus more force is required for strand 
separation (Severin et al., 2011).  Interestingly, a decrease in 5mCpG DNA bend 
flexibility and under-winding does not alter bend magnitude or directionality of the DNA 
(Nathan and Crothers, 2002).  5mCpG DNA wrapped around a nucleosome is tighter 
than nonmethylated DNA (Lee and Lee, 2013).  This is due to a reduction in the extent 
of DNA twisting and underwinding all resulting in a 0.5 base pair increase to 11 base 
pairs per turn (Nathan and Crothers, 2002; Lee and Lee, 2013).   
In the nucleus 5mCpG can have a direct role in determining whether transcription 
factors will bind to promoter regions.  5mCpG promoter islands influence the DNA-
binding properties of transcription factors (Gao et al., 2015; Lui et al., 2013; Ren et al., 
2018). The major groove binding homeodomain, POU and NFAT transcription factors 
preferentially bind to promoter 5mCpG DNA (Yin et al., 2017).  They all experience direct 
stabilizing hydrophobic interactions with 5mC (Yin et al., 2017).  This is in contrast to the 
nuclear transcription factors bHLH, bZIP and ETS that experience steric hinderance 
when the promoter regions are modified by 5mC (Yin et al., 2017).  Thus, some major 
	 111	
groove binding nuclear transcription factors can have either stabilizing hydrophobic 
interactions or steric hindrance to 5mCpG promoter DNA.    
TFAM is a minor groove binding transcription factor.  As an HMG box protein, 
TFAM’s mode of binding and bending results in a compression of the DNA major 
groove.  This leads to a high level of distortion with unusually high roll angles at the 
intercalation bases TpG and CpC.  Interestingly both intercalating bases are one base 
pair away from each of the 2 5mCpG sites on HSP1 (Figure 3.9A).  These segments of 
DNA are relatively undistorted in the TFAM-DNA structure, but this flanking DNA makes 
further contacts with TFAM, including the C-terminal tail (Figure 3.9A).  The enhanced 
stabilization that the 5mCpGs would impart on HSP1 could enhance the base stacking in 
that region and result in TFAM having an increased affinity, as was observed with the 
FRET and quantitative EMSA assays.   
Transcription initiation was enhanced 2-fold by the single promoter LSP.  LSP 
contains a single CpG site located 5 base pairs upstream of the transcription start site.  
The 5mCpG site is located at the beginning of the transcription initiation bubble, as such 
this 5mCpG interacts extensively with both POLRMT and TFB2M (Figure 3.9B).  
Biophysical studies have revealed that a single 5mCpG is enough to decrease the 
stability of double stranded DNA thus facilitating double strand separation (Severin et 
al., 2011).  Enhanced strand separation due to the single 5mCpG located at the 
beginning of the transcription initiation bubble could contribute to a 2-fold increase in 
transcription initiation.   
Global 5mCpG does not appear to alter TFAM’s ability to compact DNA.  TFAM 
does not form well-defined complexes on nonspecific DNA (Figure 3.4C).  The location 
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of 2 5mCpG on the nonspecific DNA mirrored that of 5mCpG HSP1.  However, TFAM’s 
ability to multimerize on nonspecific 5mCpG DNA appeared to be unaltered (Figure 3.4C 
and D).  Previous studies done in the lab showed that TFAM bends nonspecific DNA to 
a lesser degree than the promoter DNA sequences and that TFAM lacking the C-
terminal tail also was impaired in DNA bending (Gangelhoff et al., 2009; Makarkey et 
al., 2012).  These results suggest that any of the enhanced stabilization and/or rigidity 
imparted by 5mCpG on nonspecific DNA has little to no impact on nucleoid formation, as 
the majority of the binding interactions in the nucleoid are non-sequence specific   
Effects of mtDNA 5mCpG on mitochondrial transcription initiation and the 
biological impact of that effect 
The different affinities that TFAM has towards LSP and HSP1 influences 
transcription initiation in vitro (Shutt et al., 2010).  At lower levels of TFAM, LSP RNA 
transcripts are higher than HSP1 RNA transcripts.  This is due to the increased affinity 
that TFAM has towards LSP (4.4 x 10-9 M) when compared to  HSP1 (7.4 x 10-9 M) 
(Malarkey et al., 2012).  At elevated TFAM levels RNA transcript ratios shift to HSP1 
being higher than that of LSP.  At levels of TFAM that coat the DNA >100%, POLRMT 
and TFB2M cannot access the promoter regions, this results in transcription initiation 
inhibition from both promoters (Figure 3.7B).   
Due to the enhanced affinity and multimerization that TFAM has toward 5mCpG 
HSP1, 5mCpG impacts transcription initiation of mtDNA.  My in vitro studies in which 
100% of the tri-promoter is 5mCpG resulted in a 2.4-fold enhancement of HSP1 
transcription initiation, and a 70% reduction of LSP transcription initiation.  
Enhancement of TFAM towards 5mCpG HSP1 would result in preferential recruitment of 
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POLRMT and TFB2 to HSP1 to form the MTIC.  The combination of enhanced 
multimerization and affinity of TFAM towards 5mCpG HSP1 in the 5mCpG tri-promoter 
could lead to the reduction of TFAM binding to LSP.  Thus, less TFAM is available for 
the recruitment of POLRMT and TFB2 to LSP to form the MTIC and a repression of 
transcription initiation is observed.   
The impact of 5mCpG did not extend to HSP2 transcription initiation.  HSP1 is the 
only promoter that has CpG at well-defined positions in the TFAM binding site. Not 
much is known about HSP2.  However, HSP2 does have a predicted transcription start 
site (Martin et al., 2005; Lodeiro et al., 2012; Zollo et al., 2017).  The position of the 
single CpG in the TFAM binding region is uncertain and I extrapolated the MTIC 
footprint based on the known start site for HPS2 transcription and the MTIC footprints of 
HSP1 and LSP (Martin et al., 2005; Lodeiro et al., 2012; Zollo et al., 2017) (Figure 
1.12).  The single 5mCpG at HSP1 may not provide enough added stabilization and 
rigidity to the TFAM binding region to alter transcription initiation.   
Taken together the in vitro run-off transcription results indicate that mtDNA 
5mCpG appears to be context dependent as 5mCpG of the LSP88 template alone also 
enhances transcription initiation 2-fold.  My results suggest that the effect of 5mCpG 
alters not only TFAM binding but also POLRMT and TFB2M binding as well.   
In the mitochondria an increase in mitochondrial ribosomal RNAs 12S and 16S 
from the 5mCpG of HSP1 could influence mitoribosomal assembly.  Normally import of 
the 82 mitoribosomal proteins is in excess to the ribosomal RNAs 12S and 16S 
transcribed in the mitochondria (Bogenhagen et al. 2018).  Assembly of these 
components to form the mitoribosome occurs in the mitochondria (Bogenhagen et al. 
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2018).  The steady state levels of 12S rRNA and 16S rRNA are essential for 
mitoribosomal assembly (Miller et al. 2004; Galmiche et al. 2011; Serre et al. 2013; 
Carroll et al. 2013; Surovtseva and Shadel, 2013).  If 5mCpG of HSP1 results in an 
increase in these rRNAs levels, I would predict that there would be an increase in the 
amount of mitoribosomal assembly, thus leading to more protein production and 
ultimately an increase in ATP production in the mitochondria.  A reduction in ND6 
transcript would also occur with 5mCpG of LSP.  ND6 is a component of the ETC 
complex I.  A decrease in ND6 RNA production could translate to a decrease in ND6 
protein production, leading to a decrease in assembly of complex I and ultimately a 
decrease in ATP production.     
In vivo studies on the correlation between mtDNA 5mCpG levels and mtRNA 
levels have been inconsistent.  A decrease in global or D-loop mtDNA 5mCpG correlated 
to an increase in mtRNA transcript levels (Bianchessi et al., 2016, Yamazaki et al., 
2016, Gao et al., 2015; Dzitoyeva et al., 2012) (Appendix Table 1.3).  In contrast a 
chemically induced decrease in mtDNA 5mCpG levels resulted in a two-fold decrease in 
HSP1 and HSP2 transcripts, a slight decrease in LSP ND6 transcripts and an increase 
in mtDNA copy number (Sun et al., 2018).  Correlations to mtDNA 5mCpG levels and 
mtDNA copy number have also been reported in vivo (Bianchessi et al., 2016; Sanyal et 
al., 2018; Stoccoro et al., 2017; Tong et al., 2017) (Appendix Table 1.3).  The effect of 
mtDNA 5mCpG in the cell is complicated with evidence pointing to both mtDNA 




The distribution of -C5mCpGG- is nonrandom in mtDNA  
 The mtDNA has numerous structural conformations that can be visualized using 
electrophoresis (Kolesar et al., 2012).  Up to 25 distinct structural conformations include 
catenanes, concatamers, linear and nicked single circular species have been identified 
using 2D-electrophoresis (Kolesar et al., 2012).  The catenanes and concatamers are 
believed to be the templates for mtDNA replication (Kolesar et al., 2012).  The single 
closed circles are believed to be the templates for mtDNA transcription (Kolesar et al., 
2012).  In my 1D-electrophoretic separation of mtDNA I observed two forms of mtDNA, 
the catenanes and concatamers (S) and the single circles (C) (Figure 3.1A).  
Interestingly the single circles (C) is the species that contains the nonrandom 
distribution of 100% -C5mCGG- mtDNA.  From these results I can infer that -C5mCGG- 
could potentially tag or regulate which mtDNA structural conformations undergo 
transcription and replication.  
Conclusions 
The results presented here have establish a new form of mtDNA transcription 
initiation regulation.  One can speculate that mtDNA 5mCpG at the tri-promoter region 
would lead to altered mitochondrial protein levels.  In addition, a decrease or increase in 
the generation of the RNA primer for mitochondria replication would be dependent on 
the pattern of 5mCpG at the tri-promoter region.  In addition, mtDNA 5mCpG could also 






OXIDATION OF MITOCHONDRIAL TRANSCRIPTION FACTOR A INHIBITS 
MITOCHONDRIAL TRANSCRIPTION FACTOR A-DNA DEPENDENT PROCESS OF 
NUCLEOID FORMATION 
Introduction 
The bulk of cellular reactive oxygen species (ROS) is produced in the 
mitochondria as a byproduct of ATP production.  Under normal levels of ROS, 
reversible oxidation of proteins can serve as a signaling mechanism altering the 
structure and function of several proteins.  Specifically, post-translational oxidation 
modification of the sulfur containing amino acids function as an antioxidant and are also 
involved in cellular regulation for some proteins (Levine et al., 2000).   Hypochlorite-
responsive transcription factor is activated upon oxidation of 3 methionine residues 
during the oxidant-mediated antibacterial response in E. coil (Drazic et al., 2013).  
α2macroglobulin becomes a functional plasma proteinase inhibitor upon dimerization via 
disulfide bond formation (Reddy et al., 1994).  At sites of inflammation where ROS is 
elevated, up to 14 methionine residues in α2macroglobulin can be oxidized before 
oxidation of tryptophan renders the molecule inactive (Reddy et al., 1994).  The same 
antioxidant properties of methionine occur in glutamine synthetase.  Up to 8 of the 16 
methionine residues can become oxidized before the protein loses catalytic activity 
(Levine et al., 1996).  Oxidation of cysteines in the active sites of many proteases, 
phosphatases and proteinases contribute to the catalytic role of these proteins.  
Oxidation of cysteine 299 and cysteine 304 in 5’-adenosine monophosphate-activated 
protein kinase stimulates activity (Zmijewski et al., 2010).  The formation of an inter-
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disulfide bond between two subunits in guanosine 3’,5’-monophosphate-dependent 
protein kinase directly activates the kinase (Burgoyne et al., 2007).   
 Elevated levels of ROS can be detrimental to other proteins by altering the 
structure and function.  Oxidation of methionine 13 in the single HMG box protein HMG-
D results in a decreased affinity towards DNA (Dow et al. 1997).  This decrease in 
affinity is due to steric hindrance of the oxidized methionine 13 interaction with the DNA 
phosphate backbone (Dow et al., 1997).  Oxidation of the cysteine residues in the dual 
HMG box protein HMGB1 also decreases HMGB1 DNA affinity (Polanská et al., 2014).  
The intramolecular disulfide bond that forms between cysteine 22 and cysteine 44 in 
box A severely decreases the protein’s ability to bind to both the minor groove of DNA 
and histone H1 (Polanská et al., 2014).   
Phosphorylation of serine 55 and 56 in all unbound TFAM by mitochondrial 
cAMP-dependent protein kinase causes TFAM to be preferentially degraded by Lon 
protease (Lu et al., 2013).  Serine 55 and 56 in HMG box A directly interact with DNA.  
As such phosphorylation of these particular residues inhibit TFAM from binding and 
transcribing mitochondrial DNA by electrostatic repulsion (Lu et al., 2013).  Given that 
posttranslational modifications can alter TFAM functions, HMG proteins are susceptible 
to ROS and the fact that TFAM resides in the mitochondria where the production of 
ROS occurs; Christopher Malarkey and I set out to determine if ROS oxidation of sulfur 
containing amino acids in TFAM alter TFAM-DNA dependent mitochondrial process of 
nucleoid formation. 
I used FRET assays to determine if the oxidation of TFAM by H2O2 causes TFAM 
to lose its ability to preferentially distort promoter DNA.  To gain insight into the ability of 
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oxidized TFAM to form nucleoids I used EMSA.  From these assays I was able to 
demonstrate for the first time that nucleoid formation can be inhibited by a ROS 
mediated mechanism.  Oxidized TFAM has deficiencies in binding, bending and 
compacting DNA due to intramolecular disulfide bond formation between the two 
cysteine residues, cysteine 7 and cysteine 204.  In addition, terminal oxidation of the 
individual cysteines in TFAM have varying degrees of deficiency at compacting DNA 
into nucleoids.   
Results 
Formation of an intramolecular disulfide bond reduces the binding and bending 
ability of TFAM  
TFAM’s mode of operation is by binding and bending DNA in order to function as 
both a transcription and compaction factor (Bogenhagen et al., 2008, McCulloh and 
Shadel, 2003: Malarkey et al., 2012).  To determine whether oxidized TFAM (oxTFAM) 
has altered DNA bending and binding capabilities to promoter DNA, Christopher 
Malarkey measured the FRET efficiency of TFAM oxidized with H2O2 as a function of 
TFAM concentration to LSP.  The 25 base pair LSP DNA template was labeled with a 
fluorescein (FAM) donor fluorophore on the 3¢ end of one strand and a 
tetramethylrhodamine (TAMRA) acceptor fluorophore on the other 3¢ end. As TFAM or 
oxTFAM was titrated, the donor signal at 520 nm decreased and the acceptor signal at 
580 nm increased. This strong FRET effect (FE) was due to the TFAM-induced bending 
of the DNA, which reduces the distance between the fluorophores.  From the FRET 
effect versus [TFAM] plot, the apparent binding affinity (KDapp) of TFAM for LSP was 











Figure 4.1: X-ray crystal model of TFAM bound to LSP.  TFAM (green), LSP 
(orange), highlighted are the 7 sulfur amino acids C7, M85, M92, M101, M173, M180.  The 
C204 amino acid was not included in the model, but is highlighted by the dash line.  





































TFAM 2.8 nM ± 0.5 nM
ox TFAM 10.6 nM ± 0.1 nM
oxèred TFAM 4.2 nM ± 0.3 nM
C7S 1.9 nM ± 0.52 nM
oxC7S 8.0 nM ± 0.3 nM
C204S 1.8 nM ± 1.0 nM
oxC204S 31 ± 0.1 nM
M85L 3.1 ± 0.3 nM
oxM85L 9.8 ± 0.3 nM
A
B
Figure 4.2: Oxidized TFAM is deficient at binding to DNA. (A) Binding curve of 
FRET effects vs [TFAM] (n=3; error bars ± SD.).  (B)  Table of KDapp values from the 
binding curves of the FRET effects of the TFAM mutants vs [TFAM] (n=3; error bars 


























































































































Figure 4.3: Oxidized TFAM is deficient at binding to DNA. (A) Representative 
FRET fluorescence emission spectra of 3.4nM FAM/TAMRA labeled LSP as TFAM 
was titrated (0-200 nM).  (B) Representative FRET fluorescence emission spectra of 
3.4nM FAM/TAMRA labeled LSP as oxTFAM was titrated (0-200 nM).  (C) 
Representative FRET fluorescence emission spectra of 3.4nM FAM/TAMRA labeled 
LSP as oxTFAM + DTT was titrated (0-200 nM). (D) Plot of the Δ end-to-end distance 
(Angstroms) vs [TFAM] for TFAM, oxTFAM, oxTFAM + DTT (n=3; error bars ± SD.).  
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nM (Figure 4.2).  The results indicate that oxTFAM has a 3.7-fold decrease in binding 
affinity towards LSP. 
The magnitude of the FRET effect at full protein-LSP occupancy was not similar 
between TFAM and oxTFAM.  This indicated that there were differences in the final 
end-to-end distance between TFAM at full occupancy to LSP and oxTFAM at full 
occupancy to LSP.  As such I further analyzed the FRET data to calculate the change in 
end-to-end distance of the fluorophores (Figure 4.3).  TFAM bound to LSP caused a 
decrease in the end-to-end distance of ~20 Å for the fluorophore pair.  oxTFAM bound 
to LSP caused a decrease in the end-to-end distance of ~10 Å for the fluorophore pair.  
The results indicate that oxTFAM has a 2-fold deficiency in bending LSP.   
TFAM has 7 sulfur containing residues: C7, C204, M85, M92, M101, M173 and M180 
(Figure 4.1).  To determine if all or a combination of the oxidation of the sulfur atoms are 
contributing to oxTFAM’s deficiencies in binding and bending LSP, I made methionine to 
leucine and cysteine to serine substituted mutants and performed FRET (Table 2.2, 
Figure 4.7, 4.8).  Using MALDI-TOF Christopher Malarkey and I confirmed that each 
cysteine in the cysteine mutants was oxidized using matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) (Figure 4.4).  
Christopher Malarkey and I also confirmed that the methionine mutants were oxidized 
by MALDI-TOF (Figure 4.5).  The formation of intramolecular disulfide bonds between 
both cysteine residues in oxTFAM and the oxidized methionine mutants was discovered 
by semi-denaturing PAGE gels (Figure 4.6).  The increased mobility of apo oxidized 
TFAM and the oxidized methionine mutants when compared to TFAM and the cysteine 
mutants indicated that there is a structural change to the protein (Figure 4.6).    
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Figure 4.4: Detecting oxidized methionine and cysteine species using MALDI-
TOF for TFAM, C7S and C204S mutants.  (A) Plot of intensity counts vs m/z, amu 
for TFAM and oxTFAM.  (B) Plot of intensity counts vs m/z, amu for C7S and oxC7S.  

























































































Figure 4.5: Detecting oxidized methionine and cysteine species using MALDI-
TOF for M92L and M101L mutants. (A) Plot of intensity counts vs m/z, amu for M92L 





































































































































Figure 4.6: Detecting oxidized TFAM and oxTFAM mutants using semi-
denaturing gels. (A) Semi-denaturing gel of 250ng/lane of purified proteins.  Human 
recombinant TFAM (lane 2), oxTFAM (lane 3), oxTFAM reduced with DTT (lane 4), 
C7S lane (5), oxC7S lane (6), oxC7S reduced with DTT lane (7), C204S lane (8), 
oxC204S lane (9), oxC204S reduced with DTT lane (10).  (B) ) Semi-denaturing gel of 
250ng/lane of purified proteins. Human recombinant TFAM (lane 2), oxTFAM (lane 
3), oxTFAM reduced with DTT (lane 4), M95L lane (5), oxM95L lane (6), oxM95L 
reduced with DTT lane (7), M101L lane (8), oxM101L lane (9), oxM101L reduced with 
DTT lane (10). 
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I then measured the FRET efficiency of these mutants and their oxidized forms to 
LSP (Figure 4.2 and 4.7, 4.8).  All of the oxidized single methionine mutants (oxM#L) 
had deficiencies in binding and bending LSP similar to that of oxTFAM (Figure 4.7A and 
B).  Indicating that the oxidation of each of the methionine residues are not contributing 
to oxTFAM deficiencies in binding and bending LSP.  The similarity of binding and 
bending that the double cysteine mutant ox2CS has with TFAM confirmed that oxidation 
of all methionines are not contributing to oxTFAM deficiencies in binding and bending 
LSP but eluded to oxidation of one or both cysteines contributing (Figure 4.2 and 4.8C).   
The binding affinities and bending abilities of some other mutants were altered 
when compared to TFAM.  5ML(5L) had a 50% decrease in binding affinity and bending 
towards LSP, indicating that mutations of all 5 methionine to leucine residues is not a 
functional substitution (Figure 4.7C).  The combination of the 5 methionines must have 
a contribution to TFAM’s ability to bind and bend LSP.  However, ox5ML (ox5L) 
displayed the same magnitude of deficiencies in binding and bending DNA as oxTFAM.  
This result further confirmed that one or both cysteines contributing to oxTFAM 
deficiencies in binding and bending LSP.  C204S had a 35% enhancement in binding and 
bending to LSP, indicating that the serine at 204 is a functional substitution enhancer.  
Interestingly the binding and bending deficiencies of oxC204S was further enhanced 3-
fold when compared to oxTFAM (Figure 4.2B and 4.8B).  This indicated that terminal 
oxC7 in oxC204S leads to severe binding and bending deficiencies.  The oxC7S mutant 
FRET results were similar to that of oxTFAM.  This indicated that terminal oxC204 in the 
oxC7S leads to severe binding and bending deficiencies.  Based on the previous FRET 
























































































































































Figure 4.7: Oxidation of the methionines are not responsible for oxTFAM 
deficiency at bending DNA.(A) Plot of the Δ end-to-end distance (Angstroms) vs 
[TFAM] for TFAM, oxTFAM, oxTFAM + DTT vs M92L, oxM92L and oxM92L + DTT 
(n=3; error bars ± SD.).  (B) Plot of the Δ end-to-end distance (Angstroms) vs [TFAM] 
for TFAM, oxTFAM, oxTFAM + DTT vs M101L, oxM101L and oxM101L + DTT (n=3; 
error bars ± SD.).  (C) Plot of the Δ end-to-end distance (Angstroms) vs [TFAM] for 

























































































































































































Figure 4.8: Oxidation of the cysteine residues are responsible for oxTFAM 
deficiency at bending DNA. (A) Plot of the Δ end-to-end distance (Angstroms) vs 
[TFAM] for TFAM, oxTFAM, oxTFAM + DTT vs C7S, oxC7S and oxC7S + DTT (n=3; 
error bars ± SD.).  (B) Plot of the Δ end-to-end distance (Angstroms) vs [TFAM] for 
TFAM, oxTFAM, oxTFAM + DTT vs C204S, oxC204S and oxC204S + DTT (n=3; error 
bars ± SD.).  (C) Plot of the Δ end-to-end distance (Angstroms) vs [TFAM] for TFAM, 
oxTFAM, oxTFAM + DTT vs 2CS, ox2CS and ox2CS + DTT(n=3; error bars ± SD.).  
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deficiencies, individual terminal oxC204 and  oxC7S result in binding and bending 
deficiencies. 
To determine if the intramolecular disulfide bond formation is also responsible for 
binding and bending deficiencies, the oxidized mutant proteins were reduced with DTT 
(Konigsberg, 1972).  I was successful in obtaining reduction for half of the protein 
population (Figure 4.6).  DTT was added to oxC7S and oxC204S as controls.  To 
determine whether DTT reduction of oxTFAM was enough to restore binding and 
bending I performed FRET (Figure 4.3D).  Both the binding and bending of reduced 
oxTFAM was partially restored to that of TFAM (Figure 4.2 and 4.3D).  The apparent 
binding affinity (KDapp) of oxTFAM reduced with DTT for LSP was 4.2 ± 0.3 nM (Figure 
4.2B).  A population of 50% oxTFAM in the reduced oxTFAM in this current study might 
be impeding the binding and bending of the population of 50% fully reduced TFAM.  
These results indicate that partial reduction of the intramolecular disulfide bond restored 
binding and bending by 66%.   
Taken together the FRET results for oxTFAM and oxTFAM mutants revealed that 
the formation of an intramolecular disulfide bond by C7 and C204 results in oxTFAM 
deficiencies in binding and bending LSP.  In addition, oxidation of the individual 
cysteines results in binding and bending deficiencies for LSP.   
oxTFAM is deficient at nucleoid formation 
The mode of compaction by TFAM for nonspecific mtDNA is similar to the 
prokaryotic HU protein family in that TFAM binds to nonspecific DNA with 7.4 x 10-9 M 
affinity at the minor grooves in a highly cooperative manner with a change in end-to-end 
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Figure 4.9: Oxidized TFAM is deficient at nucleoid formation. (A) EMSA of 
nucleoid formation with 10 nM pLSP3 as TFAM was added (0-240 nM).  The 
reactions included DNA alone (lane 1 and 10), and DNA bound to TFAM (lane 2) and 
oxTFAM (lane 3), at the following ratios: TFAM:DNA = 1:60 bp, TFAM:DNA = 1:45 bp 
(lane 4), oxTFAM:DNA = 1:45 bp (lane 5), TFAM:DNA = 1:30 bp (lane 6), 
oxTFAM:DNA = 1:30 bp (lane 7),  TFAM:DNA = 1:15 bp (lane 8) and oxTFAM:DNA = 
1:15 bp (lane 9) which are equivalent to estimated DNA coverage by TFAM of 50%, 
75%, 100% and 200%, respectively. (B) EMSA of nucleoid formation with 10 nM 
pLSP3 and 240 nM of TFAM cysteine mutants.  DNA alone (Lane 1 and 10), 
TFAM:DNA (lane 2), oxTFAM:DNA (lane 3), C7S:DNA (lane 4), oxC7S:DNA (lane 5),  
C204S:DNA (lane 6), oxC204S:DNA (lane 7), 2CS:DNA (lane 8) and ox2CS:DNA (lane 
9).  (C)  EMSA of nucleoid formation with 10 nM pLSP3 as and 240 nM of TFAM 
methionine mutants.  DNA alone (Lane 1 and 10), TFAM:DNA (lane 2), 
oxTFAM:DNA (lane 3), M85L:DNA (lane 4), ox M85L :DNA (lane 5),  M92L:DNA (lane 
6), ox M92L :DNA (lane 7), M101L :DNA (lane 8) and ox M95L:DNA (lane 9).  On the 
right are the bar graph shows the quantitation of the difference in electrophoretic 
mobility of each band from corresponding to nucleoid formation compared to the free 
DNA. (n=3; error bars = ± S.D.). 
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2012).   This mode of binding and bending leads to the compaction of the mitochondrial 
DNA into nucleoids (Kaufman et al., 2007).  To determine whether compaction is altered 
by oxTFAM, I used my established model system for TFAM-mediated mtDNA nucleoid 
formation EMSA.  These experiments used a 3,600 bp linearized plasmid (pLSP3) 
containing a 583 base pair region of the mtDNA located in the D-loop.  Assays were 
performed over a range of TFAM:DNA base pair ratios. At increasing ratios of 
TFAM:DNA base pair, the complexes exhibited decreased electrophoretic mobilities, 
indicating nucleoid formation is occurring.  However, at increasing ratios of 
oxTFAM:DNA base pairs, the complexes exhibit similar electrophoretic mobilities to that 
of free DNA.  Indicating that oxTFAM is deficient at forming nucleoid structures (Figure 
4.9A).   
Assays of oxM85L, oxM95L and oxM101L mutants using the TFAM:DNA = 1:15 
base pair were performed (Figure 4.9B).  Not surprisingly, oxM#L:DNA complexes 
exhibit similar electrophoretic mobilities to that of free DNA.  Assays of oxC7S, oxC204S 
and ox2CS mutants using the TFAM:DNA = 1:15 base pair were also performed (Figure 
4.9C).  The electrophoretic mobility of oxC7S:DNA complex had a 30% increase in 
mobility when compared to the TFAM:DNA complex (Figure 4.9C).  Indicating that 
oxC204 causes a slight deficiency in nucleoid formation.  The migration of the 
oxC204S:DNA complex was similar to that of free DNA (Figure 4.9C).  This indicates that 
the oxC7 is enough to inhibit nucleoid formation.  Together these results demonstrate 
that intramolecular disulfide bonds in oxTFAM inhibits the TFAM-DNA dependent 
process of nucleoid formation.  The results also indicate that oxC7 inhibits nucleoid 
formation, and to a lesser extent oxC204.    
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Discussion 
 In this study I examined the effect of oxidation of TFAM on the TFAM mtDNA-
dependent process of nucleoid formation.  FRET assays revealed that oxTFAM has a 
3.7-fold reduction in binding affinity toward LSP and a 2-fold reduction in bending 
properties towards LSP.  FRET assays on the oxTFAM sulfur amino acid mutants also 
revealed that the formation of an intramolecular disulfide bond and terminal oxidation of 
the individual C7 and C204 residues are responsible for these reductions.  Oxidation of 
the cysteine residues to form both intramolecular disulfide bonds and terminal oxidation 
species resulted in decreased DNA compaction activity compared with TFAM.  These 
findings reveal a novel ability of ROS to inhibit nucleoid formation in the mitochondria.   
The effect of oxTFAM on DNA binding and bending properties 
Oxidation of HMG proteins have been shown to alter their function as an 
architectural DNA minor groove binding protein.  The formation of an intramolecular 
disulfide bond in HMGB1 and the oxidation of the primary intercalating methionine in 
HMGD weaken these proteins binding affinities towards DNA by perturbing the structure 
or creating electrostatic repulsion (Dow, et al., 1997; Malarkey and Churchill, 2015).  I 
observed that oxidation of the HMG protein TFAM also had weaken binding affinity and 
bending properties towards LSP.   
Electrostatic repulsion could be generated from the addition of oxygen(s) to the 
five methionines in TFAM to form methionine sulfoxide or methionine sulfonate when 
bound to LSP.  If it was generated, it appeared to not alter DNA binding or bending as 
observed with my FRET result from the oxidation of the double cysteine mutant in which 
all of the methionines were oxidized (ox2CS) or from the FRET results in which 
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elimination of the individual methionines did not restore or partially restore binding and 
bending to that of TFAM.  These results are not surprising as four out of the five 
methionines in TFAM do not directly associate with the DNA phosphate backbone of 
LSP (Figure 4.1).  TFAM linker region methionine 101 is centrally located, intercalating 
into the minor groove of the bent LSP (Figure 4.1).  Surprisingly oxM101 in ox2CS did not 
cause a deficiency in binding and bending to LPS, nor did elimination of M101 in oxM101L 
result in the restoration of binding and bending to that of TFAM (Figure 4.7B, 4.8C).  
These results indicate that the addition of oxygen(s) to M101 did not cause steric 
hindrance or electrostatic repulsion to LPS (Figure 4.7B, C).  Oxidation of any or all of 
the methionines in TFAM do not contribute to the reduction in binding and bending 
exhibited by oxTFAM to LSP.    
My FRET results indicate that the formation of an intramolecular disulfide bond 
did alter the structure of apo TFAM resulting in a deficiency in binding and bending LSP.  
At 37° apo TFAM is partially unfolded and becomes more rigid and structured when 
bound to DNA (Wong et al., 2009).  My results also indicate that the intramolecular 
disulfide bond facilitated the formation of a cavity in apo TFAM such that the 25 bp LSP 
was short enough to insert itself.  In addition, my results also indicate that the enhanced 
rigidity from the intramolecular disulfide bond would not allow TFAM to bend LSP 
optimally.   
Terminal oxC7 caused TFAM to have a more severe deficiency in binding and 
bending LSP than terminal oxC204.  This could be due to the location of C7.  C7 is 
located in box A of TFAM and has direct contact with the LSP backbone, while C204 is 
located at the end of the floppy C-terminal tail.  The addition of oxygen(s) to form sulfinic 
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and sulfonic acid on C7 could lead to greater electrostatic repulsion and steric 
hinderance to LSP than the addition of oxygen(s) to form sulfinic and sulfonic acid on 
C204.   
The effect of oxTFAM on nucleoid formation and the biological implications 
My EMSA results showed that formation of the intramolecular disulfide bond 
inhibited TFAM:DNA complex formation onto a longer piece of DNA (Figure 4.6A).  
Oxidized TFAM simply cannot bind to longer pieces of linear DNA to form nucleoids.  In 
the mitochondria under high levels of ROS, oxidation of TFAM would render the protein 
inactive.  oxTFAM would be unable to bind to and protect the DNA from ROS damage.  
In addition, both transcription and replication would not occur due to the inability of 
oxTFAM to bind to the promoter regions of mtDNA.  These events would eventually lead 
to mitochondrial dysfunction.   
In the mitochondria under low to moderate levels of ROS, oxidation of TFAM 
could be a form of regulating protein turnover.  Damaged TFAM or an excess of TFAM 
in the mitochondria could undergo oxidation.  Oxidation of these unbound TFAM 
species could now be targeted by Lon protease for preferential degradation.  To 
substantiate these claims further experiments are needed.    
Oxidized C7 rendered oxC204S unable to form nucleoids, much like oxTFAM.  
While oxidized C204 rendered oxC7S 30% deficient at forming nucleoids.  In the 
mitochondria under high levels of ROS, terminal oxidation of the individual cysteines 
could occur on unbound TFAM.  Terminal oxidation of one or both cysteines in TFAM 
would diminish nucleoid formation, which would lead to mtDNA being less protected and 
more susceptible to ROS damage.  In addition, mitochondrial transcription and 
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replication could be diminished due to a decrease in affinity for these oxidized species 
to bind and bend LSP.  
TFAM bound to DNA could also be susceptible to ROS in the mitochondria.  
Oxidation of TFAM bound to DNA could result in the formation of an intramolecular 
disulfide bond.  This would render the mtDNA inaccessible for other binding factors as 
oxTFAM would not be able to dissociate from mtDNA.  This could be a form of 
regulation for mtDNA accessibility under low to moderate levels of mitochondrial ROS.  
Under high levels of ROS, oxidation of bound TFAM to the mtDNA could result in the 
intramolecular disulfide bond protecting the mtDNA from ROS damage.  If the 
mitochondria are able to restore the ROS levels to normal, the disulfide bond can be 
reversibly reduced.  This could be a novel protective mechanism for inhibiting ROS 
damage to mtDNA.   
Oxidation of the individual cysteines could also occur to TFAM bound to mtDNA.  
This could lead to the mtDNA becoming more accessible for other proteins to bind and 
associate with the mtDNA.  These proteins could include proteins involved in 
transcription and replication. To substantiate these claims further experiments are 
needed. 
Conclusion 
The results presented in this study establish the in vitro impacts of oxidation of 
TFAM on TFAM:DNA dependent process of nucleoid formation.  Investigating the 
effects of oxTFAM on both transcription and replication would provide insight into 




CONCLUSIONS AND FUTURE DIRECTIONS  
Conclusions for Chapter III 
The evidence for reversible 5mCpG occurring in the mtDNA is mounting with 
correlations being made to dysfunctional mitochondria, mtRNA levels and mtDNA copy 
number.  Yet the direct mechanism in which 5mCpG could alter transcription, replication 
and ATP production are unknown.  The simple mechanism of mitochondrial 
transcription initiation, which involves only three components lends itself to very 
straightforward biophysical and biochemical studies to investigate the mechanism in 
which 5mCpG could alter mitochondrial transcription initiation.   
As such I set out to dissect how 5mCpG influences transcription initiation in the 
first part of this thesis.  Thermodynamic analyses showed that TFAM binds to 5mCpG 
HSP1 with enhanced nanomolar affinity to achieve a dissociation constant that is 2.4-
fold lower than HSP1.  Stoichiometric EMSAs revealed enhanced multimerization of  
TFAM onto 5mCpG HSP1.  Enhanced multimerization did not occur for nonspecific 
5mCpG.  Due to enhanced specificity and multimerization localized to HSP1, global 
5mCpG had no influence on nucleoid formation.   
In a tri-promoter context, 5mCpG altered transcription initiation.  Specifically, 
5mCpG HSP1 had a 2.4-fold enhancement of RNA production, while 5mCpG LSP had a 
suppressing of RNA production by 70% (Figure 5.1).  Interestingly 5mCpG HSP2 RNA 
production was unaltered.  In light of the data, I conclude that 5mCpG of the promoter 
region alters transcription initiation in a promoter specific context dependent manner.  





Enhanced affinity and multimerization 
specifically to HSP1 TFAM footprint.  
Promoter context dependent changes 
to mtDNA transcription initiation: 
HSP1 enhancement, LSP repression, 
HSP2 unaltered.
Unanswered questions:
Alterations to transcription elongation 
and termination?
Alteration to mtDNA replication?
Alteration to ATP production leading 
to mitochondrial dysfunction?
Is mtDNA 5mCpG inheritable?
Nuclear 5mCpG 
Unanswered questions:
Protein level changes in TFAM, POLRMT, 
TFB2M?
Protein level changes in POLG, Twinkle, 
single stranded binding protein, 
topoisomerase?
Neurological diseases, cancers, smoking, 
diabetes, nonalcoholic fatty liver disease, 
airborne pollutants
Figure 5.1:  The interplay between the nucleus and mtDNA 5mCpG in regulating 
mitochondrial transcription and replication?   Red represents unanswered 
questions in the field of mtDNA 5mCpG.  Black represents what this thesis has 
contributed to the field.  (Figure modified from Iacobazzi et al., 2013).   
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Future Directions for Chapter III 
In the below sections I have proposed more biochemical and structural studies to 
investigate how the various process of mitochondrial transcription and replication could 
be influenced by mtDNA 5mCpG.  In addition, I have proposed a multi-tiered in vivo 
study to investigate how global 5mCpG influences both mitochondrial transcription and 
replication with a hope to further address the discrepancies in the field of the mtDNA 
5mCpG.     
mtDNA 5mCpG controversy 
To further clarify the controversy in the mtDNA 5mCpG field I propose to use my 
5mCpG sensitive restriction enzyme digestion assay to screen  various cell and tissue 
cultures for %Cp5mCpGpG sites as an indication of 5mCpG levels.  Based on those 
findings more stringent 5mCpG identification assays including immunofluorescence, thin-
layer chromatography and bisulfite pyrosequencing should provide both global and 
single nucleotide resolution of mtDNA 5mCpG content.  In addition, Northern blots, RT-
PCR and immunoblots from the various cell and tissue cultures will provide information 
about in vivo mtRNA and protein levels.  The levels of 7S RNA primer would also 
indicate how mtDNA 5mCpG levels are influencing mitochondrial transcription initiation.  
qPCR from the isolated mitochondrial organelle will provide us with information about 
mtDNA copy number.  Correlations can then be made for mtDNA 5mCpG levels 
influencing mtRNA levels and mtDNA copy number.   
As the DNMTs and TETs identified in the mitochondria are also located in the 
nucleus, regulation of TFAM, POLRMT and TFB2M RNA production by nuclear 5mCpG 
would influence mtDNA 5mCpG transcription and replication initiation.  As such Northern 
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blots, RT-PCR and immunoblots will provide information about in vivo nuclear RNA and 
protein levels for the proteins involved in mitochondrial transcription, mitochondrial 
replication mtDNA methylation.     
These studies together will present for the first time a comprehensive look at how 
the nucleus is influencing mtDNA 5mCpG levels which in turn is regulating mitochondrial 
transcription and replication initiation.  The multi-technique approach to the identification 
of mtDNA 5mCpG in relation to DNMT and TET levels should provide evidence for the 
existence of mtDNA 5mCpG.  The levels of mitochondrial proteins in relation to mtDNA 
5mCpG and mtRNA levels should provide insight into how 5mCpG is influencing 
mitochondrial transcription in vivo.  Finally, the levels of mtDNA 5mCpG and protein 
levels of TFAM, POLRMT and TFB2M in relation to copy number should provide insight 
into how 5mCpG is influencing mitochondrial replication initiation in vivo.   
5mCpG HSP1 and 5mCpG MTIC structural and biophysical studies 
To gain further insight into how 5mCpG is altering the TFAM:5mCpG HSP1 
structure, crystallographic studies should be undertaken.  To gain further insight into 
how 5mCpG is altering the MTIC:5mCpG LSP structure and MTIC:5mCpG HSP1 structure, 
crystallographic studies should be undertaken.         
 My in vitro run-off transcription assay results for 5mCpG LSP88 promoter 
indicates that POLRMT and/or TFB2M might have enhanced affinities to 5mCpG 
promoter DNA.  In order to elucidate these affinities FRET assays should be performed 
for each of the  mtDNA 5mCpG promoters (LSP and HSP1) with the various 
mitochondrial transcription initiation components: TFAM, POLRMT, TFB2M, TFAM + 
POLRMT, POLRMT + TFB2M and TFAM + POLRMT + TFB2M.  These results will 
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provide further insight into how the location of each 5mCpG in each of the promoter 
regions influences MTIC:promoter DNA affinities.    
mtDNA 5mCpG influencing replication  
In the absence of TEFM, POLRMT gets stalled at the G-quadraplex located in 
CSBII region downstream of LSP in the D-loop (Figure 1.4).  This stalling event leads to 
POLG associating with the newly generated 7S RNA primer, thus initiating mtDNA 
replication.  The results from Chapter III indicate that 5mCpG of the tri-promoter region 
results in a 70% reduction of LSP transcription initiation.  Based on these results I would 
hypothesize that the generation of 7S RNA primer from LSP needed for mitochondrial 
replication would be repressed if 5mCpGs are present in the tri-promoter region.  In order 
to test this hypothesis, I propose using the overexpression of isoform 3 DNMT1 lung 
and colon cancer cells lines H1299 and HCT116 to measure 7S RNA levels in vivo 
(Saini et al., 2017) (Table 1.3).  Isolation of the mitochondria organelle during the first 
24-48 hours should yield hypermethylated mtDNA which can be verified by restriction 
enzyme digestion in conjunction with bisulfite pyrosequencing targeted to the D-loop 
promoter and OH regions (Saini et al., 2017).  Northern blots can determine the 7S RNA 
levels.   
In addition, in vitro mitochondria replication studies using the MTIC and the 
minimal mtDNA replisome (POLG, SSB and TWINKLE) should be performed (Wanrooij 
et al., 2008).  Using a minicircle template that encompasses the mtDNA tri-promoter 
region and extends 100 base pairs further than the G-quadruplex region, rolling-circle 
mtDNA replication can be measured for both nonmethylated and 5mCpG DNA.  In 
addition, using a minicircle template that encompasses the single mtDNA LSP promoter 
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region and extends 100 base pairs further than the G-quadruplex region, rolling-circle 
mtDNA replication can be measured for both nonmethylated and 5mCpG DNA.  These 
experiments should provide information on the context of 5mCpG of the promoter 
regions influencing mtDNA replication.  Taken together these studies should reveal if 
5mCpG of the promoter region is influencing mtDNA replication both in vivo and in vitro.   
mtDNA 5mCpG influencing mitochondrial transcription termination 
I have shown that the minor groove binding and bending protein TFAM has 
increased affinity for sequence specific 5mCpG HSP1.  Interestingly, the mitochondrial 
termination factor mTERF is a major groove binding and bending protein that could also 
have altered affinity for 5mCpG.  The binding site for mTERF  
5’-ATTACCGGGCTCTGCCATCTTA -3’  and complement 5’-
TAATGGCCCGAGACGGTAGAAT-3’  contains a single 5mCpG site that is only 3 base 
pairs upstream of the everted 3 nucleotides (in bold) (Martin et al., 2005; Yakubovskaya 
et al., 2010) (Figure 1.10).  One of the 5 arginine residues that determine the sequence 
specificity for mTERF, arginine 350 has direct contact with the G in CpG.  In addition, 
lysine 240, serine 382, serine 384 and lysine 385 all have electrostatic interactions with 
the CpG backbone.   The presence of one 5mC significantly facilitates a lower 
mechanical stability on double strand DNA (Severin et al., 2011).  As such I would 
hypothesize that 5mCpG on the 22 base pair sequence for mTERF would enhance 
strand separation leading to an enhancement of transcription termination.  Conversely, 
the single 5mC could alter the hydrophobic and electrostatic contacts which could result 
in enhancement or repression of mTERF affinity.  Performing EMSA would determine if 
the affinity of mTERF is altered due to 5mCpG on the 22 base pair binding site.  If it is, in 
	 142	
vitro termination activity assays would determine if 5mCpG enhances or represses 
termination of HSP1 and/or LSP (Asi -Cayuela et al., 2004).  These experiments would 
provide new insight into how 5mCpG regulates mitochondrial transcription termination.    
5mCpH mtDNA 
The focus of Chapter III has been on mtDNA 5mCpG , however 5mCpH (H = A, T 
or G) has been detected in human mitochondrial DNA samples (Bellizzi et al., 2013; 
Bianchessi et al., 2016; Blanch et al, 2016; Wijst et al., 2017) (Table 1.3).  It has been 
well documented that bacteria use DNA adenine methylation for regulation of gene 
expression (Casadesus et al., 2006).  These other types of methylation may indeed 
impact mitochondrial transcription because of the bacterial origin of the mitochondrial 
organelle.  Performing FRET and EMSA on synthetically generated 5mCpH LSP, HSP1 
and nonspecific DNA would reveal if 5mCpH alters the ability of TFAM to bind and bend 
both sequence specific and nonsequence specific DNA.   
Conclusions for Chapter IV 
The mitochondrion is an important source of ROS.  As such the proteins and DNA in 
the mitochondria can be susceptible to oxidative damage, including TFAM and mtDNA.   
Given its role as the primary protective agent of mtDNA, the functional consequences of 
oxidatively damaged TFAM have not been studies.  As such I set out to dissect how 
oxidation of TFAM influences nucleoid formation in the last part of this thesis.   
Thermodynamic analyses revealed that oxTFAM has 3-fold diminished nanomolar 
affinity to LSP and 2-fold diminished bending abilities to LSP.  This is due to the 
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of the individual cysteines.  Intramolecular disulfide bond formation renders TFAM 
nonfunctional in nucleoid formation.    While oxidation of the individual cysteines exhibits  
varying degrees of severity in the deficiency to form nucleoids.  The second part of this 
thesis is beginning to shed new light into the mechanism in which oxTFAM inhibits 
TFAM:DNA dependent processes (Figure 5.2).  However, many questions remain 
(Figure 5.2). 
Future Directions for Chapter IV 
In the below sections I have proposed more in vitro and in vivo studies to 
investigate how oxTFAM alters TFAM:DNA dependent processes.  To expand on my 
results from the second half of this thesis, I propose biochemical studies to investigate 
how mitochondrial transcription could be influence by oxTFAM.  In addition, I have 
proposed an in vivo study to investigate how oxTFAM influences TFAM degradation.   
oxTFAM influencing transcription initiation 
 In addition to TFAM’s role in nucleoid formation, TFAM is a transcription factor.  
From my in vivo nucleoid formation assay, oxTFAM was unable to bind to longer DNA, 
as such I hypothesize that oxTFAM could not bind to the tri-promoter region of mtDNA, 
thus abolishing transcription initiation.  I propose using the well-established tri-promoter 
in vitro run-off transcription assay on oxTFAM and oxTFAM mutants.  These results will 
shed new insight into how oxTFAM alters mitochondrial transcription initiation.  As 
mitochondrial transcription and replication are intertwined with the 7S RNA primer for 
replication generated from LSP, these results will also shed new insight into how 
oxTFAM influences the initiation of mitochondrial replication.   
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The functional consequences of oxTFAM in vivo 
 When TFAM is unbound mitochondrial cAMP-dependent protein kinase tags 
TFAM for degradation by Lon protease (Lu et al., 2013).  I hypothesize that ROS would 
create apo oxTFAM that cannot bind to DNA thus mitochondrial cAMP-dependent 
protein kinase will tag oxTFAM for degraded by Lon protease.  This will lead to a 
cascade effect in which a decrease of mitochondrial TFAM leads to unprotected 
mtDNA.  The unprotected mtDNA will be highly susceptible to oxidative damage.   
 To test this hypothesis, I propose inducing cellular stress in HEK293 cells in 
addition to exposing these cells to bortezomib.  The anticancer drug bortezomib is also 
a pharmacological inactivator of Lon protease and has been used by the Temiakov lab 
to block TFAM degradation in vivo (Lu et al. 2013).  Immunoblotting against TFAM from 
the mitochondria extracted from these cells run on a semi-denaturing gel would 
determine if ROS levels influence mitochondrial TFAM protein and degradation levels.   
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Immunofluorescence to Detect mtDNA 5mCpG In Vivo 
Rational:  To further address the controversy in the field involving the existence of 
mtDNA 5mCpG I have performed immunofluorescence on HeLa cells for the 
colocalization of 5mC and TFAM 1° antibodies.   
Materials and Methods:  This technique and all reagents except primary antibodies were 
obtained from Cecilia Caino’s lab.  Sterile poly-L-lysine coverslips (Corning) were 
placed in BioLite 12 well plates (Thermo Scientific) and HeLa cells were added at 40,00 
cells/well.  Media contained 10% FBS to promote cell attachment to coverslips.  The 
next day the cell were incubated with 20 µM of Mitotracker Red CM-H2XROS (M7513) 
(final concentration of 100 nM) for 1 hour at 37°C.  Cell were then fixed with the addition 
of 1 mL formalin (Fisher Scientific, 4% w/v formaldehyde, 1.5% w/v methanol in 7.5 mM 
sodium phosphate pH 7) and incubated at room temperature for 15 minutes.  Cells were 
then washed 3 times with PBS.  Permeabilization of the cells was done with 0.1% 
TritionX-100/PBS for 5 minutes at room temperature.   Cells were then washed with 
PBS (x3).  Cells were blocked with 5% normal goat serum/0.3M glycine/PBS for 30 
minutes.  Cells were then stained with primary antibody diluted in blocking buffer: TFAM 
1° antibody (RabMAb) (1:50,1:100, 1:200, 1:500 were tested), anti-5-methlycytosine 1° 
antibody (Sigma) (1:100, 1:200, 1:500, 1:1000, 10000 were tested) overnight at 4°C.  
The primary antibodies were then recovered the next day and stored at -20°C.  Cells 
were then washed with PBS (x3).  Secondary antibodies conjugated to Alexa  
fluorophores (1:1000) diluted in blocking buffer were added and incubated for 45 
minutes at room temperature.  For the anti-5-methlycytosine 1° antibody Alexa  
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Figure A.1:  Immunofluorescence images of HeLa cells to detect the 
colocalization of TFAM and 5mC.  (A) 5mC 1° (1:200 dilution) (B) mitotracker Red 
(100 nM) (C) TFAM 1° (1:200 dilution)  (D) Merged images of A, B and C. 
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fluorophore 488 was used and for the TFAM 1° antibody Alexa fluorophores 594 and 
647 were used.  Cells were then washed with PBS (x3).  Glass coverslips were then 
extracted for the 12 well plates and mounted on glass cover slides with ProLong 
Diamond Antifade with and without DAPI and ProLong Gold without DAPI.  The medium 
was allowed to curate at room temperature overnight and protected from light for at 
least 24 hours prior to imaging, but no longer than 1 week from being mounted.  Images 
were obtained on a fluorescence Nikon i80 microscope at 60X oil immersion.   
Results and Discussion:  Both mitotracker Red and TFAM 1° antibody are colocalizing 
to the mitochondria (Figure A.1).  The 5mC 1° antibody is localizing to both the 
cytoplasm and mitochondria, indicating that this antibody is either nonspecific or binding 
to cytoplasmic 5mC RNA (Figure A.1).  Further optimization of this technique with the 
5mC 1° antibody is needed.  Purchasing other 5mC 1° antibodies for immunofluorescence 
should be performed for further optimization.   
Immunoblots to Detect oxTFAM In Vivo. 
Rational:  A technique for the detection of oxTFAM in vivo is needed in the lab to further 
the study of oxTFAM abolishing TFAM:DNA dependent processes.  To detect the 
presence of oxTFAM in vivo I have isolated the mitochondria from the HEK293 cells and 
performed immunoblots against TFAM 1° antibody.   
Materials and Methods:  Mitochondria were isolated from HEK and Hela cells as 
described in CSHLP with some modifications. Briefly, cells were washed with 10 mL of 
cold PBS buffer and pelleted at 1,000 rpm for 5 minutes.  The cell pellet was 
resuspended in 11 mL of ice cold RSB Buffer (10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-
HCl, pH 7.4).  I performed several rounds of centrifugation to isolate the mitochondrial 
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from all other cellular fractions.  I then lysed the mitochondria by freeze thawing in 100 
mM Tris, 10 mM EDTA and 100 mM NaCl, pH 7.4 followed by centrifugation at 16,000 
rpm for 10 minutes to isolate the mitochondrial matrix.  Recombinant human TFAM, 
oxTFAM, in addition to cellular fractions resuspended in laemmli running buffer without 
SDS were loaded onto a 4-20% Mini-PROTEAN TGX precast protein gel (Bio-Rad) with 
running buffer 250 mM Tris, 1.92 M glycine, 0.11% SDS and run at 120V for 1 hour.  
The gel was transferred for 1hr at 500mA onto a PVDF membrane (Millipore).  The gel 
was blocked in 3% BSA for 4 hours, TFAM 1° antibody (RabMAb) 1:10,000 was added 
with 3% BSA overnight at 4°C and washed with TBST buffer (x3).  Secondary conjugate 
anti-rabbit 1:100,000 was added in TBST overnight at 4°C before a final wash with 
TBST (x3).  Pierce ECL plus western blotting substrate (ThermoFisher) was used to 
visualize the gel on the Typhoon 9400 Imager (Molecular Dynamics). 
Results and Discussion:  The detection of in vivo oxTFAM was performed using 
immunoblots.  Isolation of the mitochondrial organelle from the HEK293 cells was 
verified using GAPDH 1° antibody which localized to all isolated cellular fractions 
including whole cell lysate, nucleus, cytoplasm with mitochondria, cytoplasm without 
mitochondria, mitochondrial membrane and mitochondrial matrix.  Isolation of the 
mitochondrial organelle from the HEK293 cells was also verified using H3 1° antibody  
which localized to whole cell lysate, nucleus and cytoplasm with mitochondria.  
Recombinant human TFAM has an electrophoresis mobility in semi-denaturing gels that 
is slower than oxTFAM as seen in lanes 1 and 2, bottom two arrows (Figure A.2).  This  
is due to oxTFAM forming an intramolecular disulfide bond which inherently alters the 








































































Figure A.2:  Detecting oxTFAM in HEK293 cells.  Fractionation of HEK293 cells, 
whole cell lysate (WCL), nucleus, cytoplasm with mitochondria, cytoplasm without 
mitochondrial, mitochondria membrane and mitochondrial matrix immunoblots using 
TFAM 1°, and loading controls GAPDH 1° and histone 1.  Lane 1 is recombinant 
wildtype TFAM, Lane 2 recombinant oxidized TFAM.  Top arrow is pointing to the 
migration of intermolecular disulfide bond TFAM, middle arrow is pointing to wildtype 
TFAM and bottom arrow is pointing to intramolecular disulfide bond TFAM.  
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higher molecular weight structures as indicated by the top arrow (Figure A.2).  I 
confirmed that the level of TFAM in the whole cell lysate, nucleus, cytoplasm with 
mitochondria, cytoplasm without mitochondria to be nonexistent as TFAM is 
immediately shuttled from the cytoplasm to the mitochondria via the N-terminal 
localization sequence, lanes 3 to 6 (Figure A.2).  There are very faint bands in the 
mitochondrial membrane indicating the TFAM and oxTFAM may be present, lane 7 
(Figure A.2).  All three bands are distinct in the mitochondrial matrix, lane 7 (Figure A.2).  
There are also two faint bands below TFAM and oxTFAM suggesting that TFAM is 
being degraded.   
This representative immunoblot provides strong preliminary evidence that I can 
detect in vivo oxTFAM by performing immunoblots on a semi-denaturing gel.  
Optimization of the immunoblot by using BSA to load each sample with equal amounts 
to total protein is needed.  Upon optimization the detection of oxTFAM in vivo can be 
















Citation Enzyme Method of detection Cell type Disease Model
Saini et al., 2017 DNMT1 isoform 3 Immunofluorescence, CHIP H1299, HCT116 Cancer 
Ren et al., 2017 DNMT1 RNA-seq, qRT-PCR, CHIP-qPCR Mouse post-implanted embryos
Mishra and Kowluru, 2015 DNMT1 Immunoblot,
immunofluorescence 
Human retina endothelial cells Diabetic 
Retinopathy




Immunoblot HeLa and mice 3T3-L1 cells Cancer





Mice brain cells ALS





Mice spinal cord, skeletal muscle, 
testes and human cerebral cortex
Aging
Chen et al., 2012 TET1, TET2 Immunoblot Mouse fibroblast 3T3-L1 cells Down Syndrome
Shock et al., 2011 mtDNMT1
TET
Transient transfection followed by immunoblot,
immunofluorescence, immunoprecipitation 
Mouse embryonic mouse fibroblasts 
and human colon carcinoma cells
Colon cancer











detection Global 5mCpG D-loop 5mCpG Coding region  5mCpG D
Matsuda 
et al., 
2018 ESC, mice liver
Isolated mitochondrial by centrifugation, (linearization of 
mtDNA not performed) 
Bisulfite conversion sequencing by cycle sequencing,
Bisulfite conversion sequencing by next-generation 
sequencing,
McrBC restriction enzyme digestion,
LC/MS 0.01-5%
Bisulfite sequencing by next-
generation sequencing: no 
detectable amount (specific 
values not stated)
Restriction enzyme digestion: no 
detectable amount (specific 
values not stated)
LC/MS, global: 6%




Human iPS cells, 
Human liver,
Mouse liver
Whole cell treated with kit to isolate mtDNA (abcam)
(linearization of mtDNA) and gel purified
Bisulfite conversion and pyrosequencing,
Targeted bisulfite deep sequencing, 
Shotgun bisulfite sequencing 0.01-5%
Pyrosequencing: 0-9.3%, one site 30%
Bisulfite deep sequencing: 9.4-14.8%









Isolated mitochondrial by centrifugation, Qiagen kit for 
mtDNA isolation
Bisulfite conversion (linearization of mtDNA) and 
PCR sequencing 5%
Human myotubes,  
2 sites: 0-.6-1.1%
Human ovarian 
cells, 2 sites: 0.8-
1.5%  
Human myotubes: 0-1.1%
Human ovarian cells: 0-1.3%
Pawar
and Eide, 
2017 Mouse brain cells
Isolated mitochondrial by centrifugation, then used kit for 
mtDNA isolation (Qiagen)
HpaII and MspI restriction enzyme digestion, 
(linearization of mtDNA) bisulfite conversion, PCR 
sequencing and 5hmC glucosylation-dependent 
immunocapture 5% Restriction enzyme: 3-5%
3-5%
Bisulfite conversion: 16 cytosine 
methylated out of an unspecified 
amount of detectable cytosines
5hmC glucosylation:  60 fold increase in 
enrichment
Lui et al., 
2016
Human blood cells, 
saliva, and lung 
Isolation of mtDNA from Qiagen kit
Bisulfite conversion, PCR sequencing (linearization 
of mtDNA), PCR, pyrosequencing and SEQUENOM 
EpiTYPER MassARRAY 5% Blood, saliva and lung:  2% 
Blood, 
MassARRAY, 2 
CpG sites : 6% 
Blood, Bisulfite sequencing: 0-2.5%






Phenol-chloroform extract of DNA from whole cell
Bisulfite conversion (linearization of mtDNA), 
pyrosequencing, and analysis of genome wide sodium 











Bisulfite conversion, PCR sequencing, Single-Strand 
Conformation Polymorphism 5%
37 CpG sites: no detectable amount 
(specific values not stated)
Dawid, 
1974
Ovarian frog and 
HeLa cells
Organelle separation based on sucrose gradient.
32P incorporation and in-layer chromatograph
30 Cytosines 
/ DNA 
molecule 0.1% and 0.05%
















Coding region HSP1 RNA levels HSP2 RNA levels LSP RNA levels mtDNA copy #
Stoccor
o et al., 
2018
























ND4: 2.7-4.2 fold 
increase
Arsenic exposed 










































OH VitC and 5’-aza: 
0-1% 
VitC and 5’-aza 
treatment: 0.2-1.5 
fold decrease 
VitC and 5’-aza 
treatment 16s rRNA: 
2 fold decrease 
VitC and 5’-aza 













treated with siRNA 
DNMT1 and 5’aza-

















































cells (MSC) from 
heart and skin, 
neonatal and adult 
skin fibroblast cells
Bisulfite conversion 
and PCR and 
restriction enzyme 
digestion TaqI 
(TCGA cut site) and 
HpyCH4IV (ACGT 
cut site), HpyCH4IV 
is sensitive to 
A5mCGT 
HpyCH4IV did not 
digest various 
amount of mtDNA
from each of the 3 
cells (quantification 
of data not 
determined)
Bisulfite, neonatal 
skin fibroblast cells 
and MSC COXI, 
16s rRNA, ND2: 
100%, 
Bisulfite, senescent 
skin fibroblast cells 
and MSC COXI, 
16s rRNA: 40-60%,
Bisulfite, senescent 
skin fibroblast cells 
and MSC ND2: 90%








Citation Cell type/disease model Technique 
5mCpG DNA














human cortex and 
cerebellum Me-DIP data 





DIP data controlling 
for the NUMTs
74 tissue  
distinguishably 
different 5mC regions 
between cortex and 
cerebellum, 3  
hypomethylated and 
4 hypermethylated
Saini  et 
al., 
2017





PCR, CHIP 4-5% 4-5%
Tong  et 
al., 
2017
Human colon cancer cells 
(HCT116), Human colon 




cancer cells (SL-174T), 
colorectal  cancer cells (H-





All cell only 3 out of 14 
CpG sites are 5mCpG.
Untreated cells: 3-45%, 
5’aza-2’-deoxycytidine 


















HeLa, human colon cancer 
(HCT116), human ovarian 
cancer (SKOV3), human 
cervical cancer (C33A) 
transfected with M.SssI and 
M.CviPI,








HeLa and HCT116: 0%
HEK293, COXII: 8-20%,














IP, both cells ND6: 0.02-0.08, 
CHIP-qPCR epiblast ND6: 6%, 
CHIP-qPCR embryos ND6: 20%, 
IP, both cells 12sRNA: 0.01%, 
CHIP-qPCR 12sRNA epiblast: 6%,
CHIP-qPCR 12sRNA embryos 
12sRNA: 30%,
IP, both cells ND5: 0.04-0.06%,
CHIP-qPCR epiblast ND5: 6%,




Fetal placenta cord blood 
from intrauterine growth 
restriction (IUGR) and 
preeclampsia (PE) 
pregnancies 









IUGR 12sRNA: 5%, 
IUGR/PE 12sRNA: 6.5%,
PE 12sRNA: 4.5%,
Control COXI: 3%, 









o et al., 
2017





AD: 2.3-3.1% (25% 
decrease)












Global 5mCpG DNA D-loop
5mCpG DNA























passage 5 (P5) vs. 









P15 12sRNA: 0.5 
fold increase
P15 ND5: 3 fold 
increase,
P15 ND1,2,4,4L: 1 
fold increase, 7 other 
proteins: no change ND6: no change




Blood male weld 
workers exposed to 





High level particular matter: 
hypermethylation (values not 
given) 
12s rRNA and tRNAF: 
no changes with 




40 patients blood 






Body mass index 20-24: 1%,
Body mass index 30-39: 1.5%,
Body mass index >40: 1% 
ND6 body mass index 
20-24: 1%,
ND6 body mass index 
30-39: 1.5%,
ND6 body mass index 
>40: 1% 
Armstron




mothers foreskin of 
newborns, airborne 
pollutants




No difference in 
placenta: 45%,
No difference in 
newborn 
foreskin: 70%
Light strand non-smoker 
placenta: 5.72%, Light strand 
smoker placenta:  8.45%, Light 
strand non-smoker foreskin: 
3.75%, Light strand smoker 
foreskin:  4.97%,
HSP1 TFAM site non-smoker 
placenta: 4.1%,
HSP1 TFAM site smoker 
placenta: 4.5%,
HSP1 TFAM site non-smoker 
foreskin: 4.5%%, HSP1 TFAM 




Blood from 82 





sequencing 2-6% < 5% 0.1-12%











Normal 12s rRNA: 1.2%, PCO 
12s rRNA: 17.6%,
Normal 16s rRNA: 3.7%, PCO 
16s rRNA: 37%
Normal COXI: 2.5%, 
PCO COXI: 5.0%,
Normal COXII: 1.4%, 
PCO COXII: 0%,
Normal COXIII: 2.7%, 
PCO COXIII: 4.0%,
Normal ND4: 0.8%,  
PCO ND4: 6.7% 
PCO 12s rRNA, 16s 
rRNA: 0.5 fold 
decrease
PCO ND1,2,4L,5,6, 
CYTB, ATP8: 0.5 
fold decrease, 






PCO: 0.5 fold 
decrease
























(AD): human entorhinal 
cortex, Parkinson’s 
disease (PD): human 
substantia nigra,
AD: mouse neocortex 
tissue





AD 5mC: increase 
when compared to 
control, 
PD 5mC: decreases 
when compared to 
control, 
5hmC unchanged for 
both AD 10-25% 
and PD  35% 
ND1: 5hmC 
unchanged for both 
AD 27% and PD 
30%,
ND6: 5hmC 
unchanged for both 
AD 37% and PD 
37%
Control ND1: 0.3 
AD, ND1: 0.9




Blood and liver from 
mice fed high fructose 
diet (NAFLD)










High fructose ND1,2,3,4,4L: 3 
fold increase,
High fructose ND5: 4 fold 
increase,
High fructose COXI,II,III: -43 
fold increase,
High fructose ATP6,8: 3 fold 
increase,
High fructose CYTB: 4 fold 
increase 
High fructose 











stem cells (H9), lung 
epithelial cells (HUE), 
induced pluripotent 




analysis of 5hmC Me-
DIP data from 23 
different data sets 
encompassing 5 




































COXI normal: 4.45%, COXI 
CDV: 22.97%,
COXII normal: 1.22%, COXII 
CDV: 4.55%,
COXIII normal: 0.58%, COXIII 
CDV: 1.5%,
ATP6 no change: 2.5%, ATP8 




Human colon and 
rectal cancer tissue, 
5-Aza-2’-deoxycytidine 




mitochondria using a 
kit, bisulfite 




Stage 1:  4% 
Stage 2: 4%
Stage 3, 4: 1,0%












Jia et al.,  
2015
Blood from newborn 
calf of cow fed betaine 
5mC Me-DIP, 
immunoblot,  RT-PCR 0.5 fold decrease
COXI, III, ND4: no 
change 
ND1,2.3.4,5,6, COXI,II, ATP6 
and CYTB: 0.25-0.5 fold 
increase 
ND6: 0.25 fold 
increase
















Coding region HSP2 RNA levels
LSP RNA 







Kit to isolate total cellular 
DNA, bisulfite conversion and 
PCR, RT-PCR
LSP region Lean: 
0.25%, LSP region,
Obese: 1.25% (5.2 fold 
higher) 
Obese: 6.9-10 





Human and bovine 
retina endothelial 
cells (high glucose), 
retinal microvessels
from patients with 
diabetic retinopathy
Mitochondrial isolation with a 
kit, bisulfite conversion and 
PCR amplification, 
immunoprecipitation followed 
by crosslinking and PCR 
amplification, 
qPCR and Dnmt1-siRNA
Human cells: 2.5-fold 
increase,
Bovine cells: 3-fold 
increase,
Bovine cells, Dnmt1-




Human cells: 1.5 fold increase,
Bovine cells, CYTB: 2-fold 
increase, 
Bovine cells, COXII: no 
changes, 
Bovine cells, Dnmt1-siRNA: 
normal levels restored
Retinal microvessels, CYTB: 
no change
CYTB, all cells and 
microvessels: 
decrease, 




cells, CYTB, COXII: 
normal levels restored












tissue from mothers 
exposed to airborne 
pollutants Bisulfite pyrosequencing
High exposure: 27%, 
hypermethylation 








methylomes of 36 
different cell lines 






Computational analysis of 
downloaded bisulfite 
conversion and Me-DIP data 
from the Human Epigenome 
Consortium website
Identical pattern of 
0.1-0.6 methylation 





liver biopsies  
(NAFLD)













Blood from humans 
exposed to airborne 
pollutants
Bisulfite conversion and 
pyrosequencing
Control: 5.06%,
Steel workers: 6.47% 
Control 16s rRNA: 2.18%,










ALS mice: brain, 
skeletal muscle, 
liver and testes 










from exposure to 
airborne pollutants







hi et al., 
2013
Mouse oocytes and 
sperm 
DNA isolated on agarose gel, 
whole bisulfitome-amplified 
DNA sequencing
Wildtype oocytes: 6%, 
DNMT3-/- oocytes: 
4.5%, sperm: 15%, 
blastocysts: 1%, ESC: 
2.5%











Global 5mCpG DNA D-loop
5mCpG DNA
















and Me-DIP for 5mC 
and 5hmC followed by 
dot blot 
Control mouse ES 
5mCpG: 50%,
Mouse ES Dnmt1-/-, 
Dmnt3a-/-, Dnmt3b-/-
cells 5mCpG: 31%
HeLa : 23-27%, Fibroblasts10-21%, 
143B: 10-17%, human blood: 16-20%, 
mice blood: 70.6%
Human 5mCpG IP: 3.5-5 fold enrichment, 
Mice 5mCpG IP: 3-4 fold enrichment
Human blood and cells 5hmCpG, IP: 4-6 
fold enrichment, Mice blood and cells 
5hmCpG, IP: 3-8 fold enrichment
Feng et 
al., 2012
Colon and rectal 








Stage 1 cancer:  10% 
Stage 2 cancer: 14%
Stage 3, 4 cancer: 6%
5’-aza: hypomethylation, 2.03-0.92%
Control ND2:0.74 units,
















5hmC and 5mC 
detection via ELISA, 




and CviQI digestion 
and qPCR
Frontal cortex (FC), 
young and old 5mC: 0.1 
units,
FC young 5hmC: 0.55 
units,
FC old, 5hmC: 0.04 units, 
Cerebellum young and 
old 5mC: 0.3 units,
Cerebellum young and 
old 5hmC: 0.75 units
FC 5hmC young: 0.075 -0.15 units, 
FC 5hmC old: 0.03 units  
FC ND2, ND5 5hmC: 
hypomethylation
FC young ND2: 0.2 units,
FC old ND2: 0.3 units,
FC young ND4: 0.5 units, 
FC old ND4: 0.7 units, 
FC young ND4L: 0.01 units,  
FC old ND4L; 0.02 units, 
FC young ND5 0.2 units, 
FC old ND5: 0.4 units
Cerebellum Old and young 
ND2,4,5: no change,
Cerebellum young ND4L: 0.4 
units, Cerebellum old ND4L 
0.05 units  
FC young 
ND6: 0.3 




















and CviQI digestion 
and qPCR
day 1 VA: same as 
control, 0.9 units 5mC, 
0.045 units 5hmC
day 3 of VA: 5mC 0.03 
units and 5hmC 0.025 
units
day 3 of VA, no changes between VA 
and control cells: 1.75 units 5hmC
Control day 3, 5hmC 
ND5: 3.0 units, Day 
3 5hmC VA cells 
ND5: 1.5 units for 
5hmC,
Control day 3, 5hmC 
COXIII: 1.5units,












isolation kit followed 
by agarose gel 
extraction.  S1 
nuclease and 
phoshpodiestease I 















5mC and 5hmC 
immunoprecipitation 
(Me-DIP),
Gla 1 digestion 
HCC: 10-20 fold enrichment for 5mC, 38 
fold enrichment for 5hmC
HCC 12S, rRNA 
16S rRNA, COX2, 
ATP6: 10-20 fold 
enrichment for 5mC, 
85-580 fold 
enrichment for 5hmC ND1: 3 fold increase 
ND6: 2 fold 
increase 
Appendix Table 1.3 con’t: Summary of research identifying 5mCpG and 5hmCpG in the mitochondria: 2011-2013. (* NUMTs verified as not 









model Technique Limit of detection 
5mCpG DNA
Global
Pollack et al., 
1984
Mouse fibroblast cells 
deficient in thymidine 
kinase
Sucrose gradient organelle separation 
Southern blot and 32P thin-layered chromatography, linearized 
mtDNA for HpaII and MspI digestion 
(excess 20-60 U/1ug mtDNA) 0.1%
Thin-layered chromatography, Global: 3-5% exclusively 
5mCpG, or 
17-29 5mCpG per DNA molecule 
Restriction enzyme, site specific: 1-10%
Shookler et al., 
1983
Old and young human 







al., 1974 Beef heart
Sucrose gradient organelle separation 
Hydrolysis to individual bases followed by thin-layered 
chromatography and spectrophotometry
0.1% 46.4% 5mC 
Nass, 1973 mouse fibroblast, baby 
hamster kidney 
Sucrose gradient organelle separation and CsCl gradient to isolate 
mtDNA,
in vivo transfer of the methyl group from [methyl-3H]methionine 
and/or
in vivo incorporation of [32P]orthophosphate, in vivo incorporation of 
[3H]deoxycytidine, 
in vitro methylation of DNAs with 3H-labeled S-adenosylmethionine 
as methyl donor and DNA methylase preparations from mouse 
fibroblast nuclei n/d
0.2%, or 12-36 5mC per DNA molecule







CsCl gradient to isolate mtDNA,
incorporation of [32P]orthophosphate, hydrolysis to individual bases 
followed by thin-layered chromatography 0.1% 12 C/5mC
Appendix Table 1.3 con’t: Summary of research identifying 5mCpG and 5hmCpG in the mitochondria: 
1970-1984.
